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ABSTRACT
Recent advances in super-resolution fluorescence microscopy have pushed the spatial
resolution of biological imaging down to a few nanometers. The key element to the development
of such imaging modality is synthetic organic fluorophores with suitable brightness and
photostability. However, organic fluorophores are very difficult to use in live cells because of
their chemical compositions. Many excellent fluorophores, such as cyanine and Alexa Fluor
dyes, are highly charged with sulfonate groups and do not cross the plasma membrane. Even if
the fluorophores get inside cells, there exist few methods that can be used to target these non-
genetically encoded probes to specific cellular proteins with high specificity and minimal
interference.
We describe herein the development of new methods for cellular delivery and site-
specific targeting of organic fluorophores to proteins in living cells. Building on our lab's
previous work on engineering new substrate specificity for E. coli lipoic acid ligase (LplA), we
created a mutant ligase that catalyzes covalent conjugation of a 7-hydroxycoumarin fluorophore
onto a 13-amino acid peptide substrate, called LAP. We showed that enzymatic fluorophore
ligation is compatible with the living cell interior and is highly specific for LAP fusion proteins.
To extend the repertoire of fluorophores targetable by LplA inside cells, we devised a two-step
labeling approach based on enzymatic azide ligation, followed by chemoselective derivatization
with any membrane-permeable fluorophore via strain-promoted cycloaddition. As an auxiliary
tool for enzymatic probe ligation, we also developed a very efficient and biocompatible variant
of copper-catalyzed azide-alkyne cycloaddition that can be used for modification of cell-surface
proteins. To overcome the lack of membrane permeability of sulfonated fluorophores, we
identified a chemical reaction that efficiently masks charged sulfonate groups as esterase-labile
sulfonate esters. Such masked sulfonated fluorophores enter cells readily and can be site-
specifically targeted to intracellular proteins. Our efforts in developing protein labeling and
fluorophore delivery methods culminated in their application to super-resolution imaging of
cellular proteins in living cells.
Thesis Supervisor: Alice Y. Ting
Title: Ellen Swallow Richards Associate Professor of Chemistry
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MS mass spectrometry
NADH the reduced form of nicotinamide adenine dinucleotide
NEM N-ethylmaleimide
NES nuclear export signal
NHS N-hydroxysuccinimide
NLS nuclear localization sequence
NM1 nuclear myosin I
NMR nuclear magnetic resonance
NTA nitrilotriacetic acid
p-ABSA p-acetamidobenzenesulfonyl chloride
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OCT
PAGE
PALM
PBS
PCR
PDB
PDH
PET
PFA
Picolyl azide 8
PLE
PPTase
PSD
QY
RF
RNA
ROS
s.d.
s.e.m.
SDS
STED
STORM
SUMO
SV40
T. acidophilum
TBS
TBS-T
TBTA
TCEP
TCO1
TEA
Tet
TFA
THPTA
TIRFM
TLC
TM
TMR
Tris
tRNA
TsOH
Tz 1
UAA
WB
WT
YFP
cyclooctyne
polyacrylamide gel electrophoresis
photoactivated localization microscopy
phosphate buffered saline
polymerase chain reaction
protein database
pyruvate dehydrogenase
photo-induced electron transfer
paraformaldehyde
a picolyl azide substrate for lipoic acid ligase
pig liver esterase
phosphopantethiene transferase
postsynaptic density
quantum yield
release factor
ribonucleic acid
reactive oxygen species
standard deviation
standard error of the mean
sodium dodecyl sulfate
stimulated emission depletion microscopy
stochastic optical reconstruction microscopy
small ubiquitin-like modification
simian vacuolating virus 40
Thermoplasma acidophilum
Tris-buffered saline
Tris-buffered saline supplemented with Tween-20
tris-(benzyltriazolylmethyl)amine
tris(2-carboxyethyl)phosphine
a trans-cyclooctene substrate for lipoic acid ligase
triethylamine
tetracycline
trifluoroacetic acid
tris(hydroxypropyltriazlylmethyl) amine
total-internal-reflection microscopy
thin-layer chromatography
transmembrane
tetramethylrhodamine
tris(hydroxymethyl)aminomethane
transfer RNA
p-toluenesulfonic acid
a tetrazine structure used for Diels-Alder protein labeling
mutagenesis unnatural amino acid mutagenesis
western blotting
wild-type
yellow fluorescent protein
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Chapter 1: Introduction
Delivery and targeting of fluorescent probes
for live-cell and super-resolution imaging of proteins
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Introduction: recent advances and challenges in fluorescence microscopy
Biological microscopy, and fluorescence microscopy in particular, has revolutionized cell
biology by allowing scientists to visualize the location and movement of single organisms, cells,
and biomolecules; a more holistic description of these entities in their native context could
thereby be obtained. At a subcellular level, the ability to use fluorescence to detect localization,
quantify levels, and monitor dynamics of specific cellular molecules-proteins, nucleic acids, or
metabolites-has indeed led to the better understanding of molecular processes that mediate
cellular activities. From the development of the first fluorescence microscope by a German
physicist Oskar Heimstadt in 1911 onward, there have been many groundbreaking developments
in our physical understanding and instrumentation, both of which have driven the rapid
expansion in the utility of fluorescence microscopy. For instance, the invention of confocal (1)
and two-photon (2) microscopes have allowed scientists to achieve higher imaging resolutions
via elimination of out-of-focus information, either through the use of a pinhole (confocal
microscopy) or through the confinement of excitation volume (two-photon microscopy). These
two inventions have directly enabled the in vivo imaging of biological samples such as thick
tissue slces. In adudition, the realization that fluorescence recovery after photobleaching (FRAP)
(3) can elucidate the movement of cellular biomolecules or that F6rster resonance energy transfer
(FRET) (4) can be used as a spectroscopic ruler to measure distance between two molecules have
led to new studies providing insight into the various interactions and dynamics present within
living systems.
In recent years, the development of super-resolution fluorescence microscopic techniques
(5,6,7,8) have also broken the longstanding limitation of light microscopy where two objects
closer than 150-200 nm to each other were unable to be resolved spatially due to the diffraction-
limited property of light. Many biological objects whose size falls under the diffraction limit of
~200 nm-such as bacterial cells, viruses, transport vesicles, or individual protein molecules-
can now be imaged with a spatial resolution as high as 4 nm. (9) Two super-resolution imaging
techniques in particular have seen many uses on biological samples: stimulated emission
depletion microscopy (STED) (5) and stochastic optical reconstruction microscopy (STORM).
(10)
STED microscopy exploits the non-linearity of a fluorophore's response to excitation.
Exposure of excited fluorophores to a donut-shape de-excitation beam effectively suppresses the
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fluorescence of molecules under the beam, only allowing molecules at the very center of the
donut to fluoresce. Ensemble scanning of the central fluorescent spot across the sample then
produces a subdiffraction image. STED has been applied to the subdiffraction imaging of
organelles, (11) lipids, (12) and proteins (13) in cells, organisms, (14) and animals. (15) Spatial
resolutions of up to -40 nm have been obtained in living cells (13) using tetramethylrhodamine
bound to SNAP-tag (16) labeled proteins, and up to -70 nm in live mouse brains (15) using
yellow fluorescent protein.
On the other hand, STORM (and related techniques with different names such as PALM
(7) and FPALM (8)) relies on single-molecule localizations of fluorophores that can be switched
between bright, fluorescent states and dark, non-fluorescent states. During imaging, only a subset
of fluorophores is activated to an emissive state. The localization of each fluorophore molecule
can be resolved optically and determined with high accuracy by acquiring a single-molecule
image of the fluorophore and calculating its centroid position. The fluorophores are subsequently
deactivated before another subset is activated and imaged. Repeating such a
deactivation/activation cycle allows acquisition of a large collection of fluorophore localization
data from which a subdiffraction image can be constructed. Due to the unique demand for
fluorophores that can be turned on or off in a controlled manner, the development of STORM
proceeded hand-in-hand with the discoveries of "photoswitches" such as cy5, an organic
fluorophore, and mEos2, (17) a photoswitchable fluorescent protein. Cy5 and its related structure
Alexa Fluor 647 can be converted to their dark, non-fluorescent state in the presence of thiols
like p-mercaptoethanol by exciting the fluorophores with a strong red (647 nm) laser. (6) The
mechanism of cy5 switching to the dark state has been confirmed to be red laser-mediated
nucleophilic addition of a thiol onto the polymethine chain of cy5 to disrupt its conjugated
system. (18) A weak blue (405 nm) laser can be used to reactivate a subset of cy5 to its
fluorescent state. (19) STORM has been extended to multicolor, (10,19) three-dimensional, (20)
and live-cell (21) subdiffraction imaging of biological structures. To date, the highest three-
dimensional spatial resolution achieved in living cells using STORM is -30 nm in the lateral
direction (Alexa Fluor 647 targeted via SNAP-tag was employed). The best temporal resolution
was as fast as -1-2 seconds. (21)
Despite rapid advances in the physics and instrumentation of fluorescence microscopy,
especially those related to STED and STORM super-resolution microscopy, extending super-
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resolution imaging to living cells still presents a formidable challenge due to the lack of suitable
fluorescent probes and ways to target probes to specific biomolecules inside living cells. Despite
the frequent use of fluorescent proteins in live-cell super-resolution imaging, fluorescent probes
best suited for STED and STORM imaging are actually non-genetically encoded organic
fluorophores such as ATTO647N and cy5 (the best reported fluorophore for STED and STORM,
respectively). They have many superior photophysical properties over fluorescent proteins. (22)
For example, the high photon output of cy5 per imaging cycle (-6000) allows STORM images to
be acquired at much higher spatial resolutions (due to higher localization accuracy of each cy5
single molecule) than for the best photoconvertible fluorescent protein used with STORM,
mEos2, which has a photon output of ~500 per cycle (22). Cy5 and its sister dye Alexa Fluor
647, however, have mainly been used for STORM under fixed-cell conditions because the dyes
are highly charged and thus membrane-impermeable. Moreover, once the dyes are delivered into
cells, such as via invasive means like microinjection or electroporation, there exist few ways to
target them site-specifically to desired biomolecules such as a specific protein within cells.
Below, we review current methods for site-specific labeling of proteins that can be used
for fluorophore targeting, as well as methods for delivery of charged, membrane-impermeable
fluorophores into cells.
Methodologies for site-specific labeling of proteins in mammalian cells
Fluorescent proteins vs. small organic fluorophores for protein visualization in cells
Among different classes of cellular molecules, proteins are arguably the most well-
studied class in living cells, owing not only to their general importance as facilitators of
countless cellular functions, but also to the development of robust biochemical tools that aid
studies of protein location and dynamics. Green fluorescent protein (23,24,25) and its multicolor
variants, (26,27) which are collectively referred to as fluorescent proteins, or FPs, are examples
of such tools. The popularity of FPs stems from many factors: they are genetically encoded and
thus can be expressed as fusions to other proteins with both ease and absolute specificity; the
chromophore maturation process is autocatalytic and does not require any cofactor other than
molecular oxygen; (25) and they are generally versatile. The FPs have been developed and used
in advanced experiments such as in the detection of protein-protein interactions (via split FPs)
(28), super-resolution imaging via photoactivatable FPs (29), or mapping of neuronal circuits
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(30). While FPs that are most used by scientists are derived from fluorescent proteins found in
Aequorea Victoria and corals of the Discosoma genus (26), there also exist other genetically
encoded fluorescent protein tags such as engineered flavoprotein phototropins iLOV (31) and
miniSOG (32), the latter of which can be used as a tag for electron microscopy in addition to
fluorescence microscopy, further expanding the utility of fluorescent proteins.
Yet FPs are not without flaws, the most major of which is their payload of 238 amino
acids. FPs' large size has been shown to interfere with protein function, trafficking, and
interactions with other proteins (33,34). Moreover, the photophysical properties of most FPs are
inferior to those of many small organic fluorophores. FPs are generally dimmer and less
photostable than small organic dyes, making FPs unsuitable for demanding imaging applications
such as single-molecule tracking (35). For super-resolution imaging, the fluorophore
photophysics is especially important as the number of photons emitted per dye/FP molecule is
the determining factor in obtaining spatial and temporal resolution during imaging (22).
Despite having desirable photophysical properties, small organic fluorophores are not
frequently used in live-cell imaging experiments because they are typically not encoded
genetically and there exist few biochemical methods that can target them to desired proteins in
living cells with high specificity. The general concept underlying the specific targeting of non-
genetically encoded probes to proteins involves: 1) genetic targeting of a protein or peptide tag to
a protein of interest; and 2) posttranslational derivatization of the tag with a desired chemical
probe through tight binding or covalent capture. Often, when there is a limited set of probe
structures a given protein- or peptide-directed labeling method can utilize, bioorthogonal click
chemistry is used in combination with the labeling method to make it more modular and
generalizable towards diverse probe structures. Table I shows different protein labeling methods
whose utility has been demonstrated in a cellular context, either at the surface or inside of living
mammalian cells.
Current methods to target small organic fluorophores to proteins inside cells
Among posttranslational protein labeling techniques, the ones that are of great interest are
those demonstrated to work inside living cells: E.coli dihydrofolate reductase (DHFR (36)),
F36V mutant of FKBP12 (FKBP12 F3V), (37) variants of human 0 6-alkylguanine transferase
(SNAP/CLIP), (16) H272F mutant of bacterial dehalogenase (HaloTag), (38) and FlAsH (39).
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These intracellular compatible labeling methods need to be very robust and specific for a number
of reasons. The cellular interior represents a very challenging environment for efficient labeling
due to the high concentrations of diverse biomolecules, which could potentially interfere with the
labeling reactions. Additionally, various factors intrinsic to the cellular interior-viscosity,
availability of required cofactors, presence of machineries required for proper folding of
recombinant proteins, or unexpected posttranslational modifications on recombinant
proteins/peptides-cannot be controlled easily by the experimenter. Among the five methods
listed above, four, with the exception of FlAsH, utilize derivatives of natural proteins that have
strong binding to chemical probes and/or can enzymatically catalyze probe conjugation onto the
protein tags themselves. On one hand, DHFR and FKBP12 belong to the tight binder group, as
both tags can bind to specific small molecules-a competitive enzyme inhibitor trimethoprim for
DHFR and a synthetic, engineered ligand called SLF' for FKBP12 F3v-with high affinity (Kd ~
10-8 M (36) and 1010 M (37), respectively). Further engineering of DHFR allows covalent
labeling of a trimethoprim derivative via proximity-induced Michael addition between a newly
introduced cysteine (L28C mutation) on DHFR and an acrylamide electrophile on trimethoprim
(40).
On the other hand, SNAP/CLIP and HaloTag are self-labeling enzymes that can catalyze
transfer of specific probes onto their reactive residues. The SNAP tag can covalently link an 0-
benzylguanine derivative to its C145 residue (41); the CLIP tag functions similarly to SNAP but
recognizes an 0 6-propargylguanine derivative instead (16). The orthogonality of SNAP and
CLIP tags has enabled two distinct proteins to be imaged simultaneously in living mammalian
cells (16). Likewise, HaloTag is an engineered dehalogenase that catalyzes conjugation of a
chloro- or bromoalkane derivative onto its D106 residue (38). Labeling kinetics of both
SNAP/CLIP and HaloTag are excellent: the second-order rate constants of SNAP/CLIP with
their respective guanine substrates were found to be ~10 3-10 4 M-s-1, (16) while the rate constant
of HaloTag is -106 M s , (38) on the same order as the calculated binding rate of biotin to
streptavidin (42). Both SNAP/CLIP and HaloTag, much more so than DHFR and FKBP12F36V
have begun to supplant FPs in many biological studies that require use of bright and photostable
small organic fluorophores or probes with functionalities beyond fluorescence imaging (e.g. for
targeting of eosin, which can be used for chromophore-assisted light inactivation of proteins
(43)).
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FlAsH, for fluorescein arsenical hairpin binder (39), is the only peptide-based,
intracellular protein labeling method that is relatively widely used. Utilizing a 6-12 amino-acid
tag, FlAsH does not suffer from the same drawbacks of a large protein tag that is inevitably
present in that fluorescent proteins and the four labeling methods discussed above (sizes ranging
from 108 to 296 amino acids). The specificity of FlAsH labeling is derived from tight binding
between a tetracysteine motif and the appropriately spaced biarsenical moiety of fluorescein
arsenical (Kd 10-11 M). (44) The main limitation of FlAsH, however, stems from weak binding
of the biarsenical dye to many intracellular proteins containing free thiols (45), greatly reducing
the method's specificity compared to other protein labeling techniques described above. Other
problems with FlAsH labeling include: cellular toxicity from using the biarsenical dye, (46)
which can be reduced if an antidote such as 1,2-propanedithiol or 2,3-dimercaptopropanol is
used (47); farnesylation of the tetracysteine motif (39), leading to undesired subcellular
localization; and oxidation of the tetracysteine sequence in oxidizing cellular compartments such
as at the cell surface or in the secretory pathway (48), resulting in much reduced FlAsH labeling
efficiency in these compartments.
There thus exists a clear trade-off in using protein- versus peptide-directed labeling
methods. Protein-based methods generally offer better labeling specificity as they possess tags
consisting of a catalytically-efficient self-labeling enzyme or a larger interacting surface for
tighter binding. Peptide-based methods are less likely to perturb protein function and potentially
lead to more meaningful biological information. An ideal protein labeling method that would
address shortcomings of existing labeling methods should combine the advantages of having
high labeling specificity (like HaloTag) and use a minimally perturbative small tag (like FlAsH)
while still maintaining compatibility to the interior of a living cell.
Enzyme-mediated labeling to bridge labeling specificity and small tag size
One approach to confer more labeling specificity to peptide-based labeling methods is to
use bond-forming enzymes that can catalyze covalent conjugation of probes to peptide tags.
Various labeling techniques shown in Table I already made use of such enzymes, including
phosphopantethiene transferases (PPTases) (49), sortase (50,51), formylglycine-generating
enzyme/aldehyde tag (52), and biotin ligase (53,54). For each enzyme, there exists an engineered
peptide of size ranging from 6-15 amino acids, which can serve as a surrogate substrate in place
27
of the enzyme's natural protein substrate(s). PPTases and sortase have key advantages over other
enzyme-mediated labeling methods in that the enzymes can utilize a wide range of probe
structures as long as the probe is tethered to the substrate motifs of the enzymes (coenzyme A in
the case of the PPTases, and a 5 amino-acid GGGYK motif in the case of sortase).
Formylglycine-generating enzyme and biotin ligase, on the other hand, have restricted substrate
specificity and are only capable of efficiently installing an aldehyde functionality or biotin,
respectively, onto their corresponding peptide substrates. Subsequent derivatization with a
hydroxylamine- or hydrazide-containing probe is required to attach a desired probe onto the
peptide tag in the formylglycine-generating enzyme method, whereas for biotin ligase, the
biotinylated peptide can be detected via a (strept)avidin-probe conjugate.
For one reason or another, however, these four enzyme-mediated labeling methods are
not compatible with labeling experiments inside living cells; their cellular applications so far
have been restricted to derivatization of proteins at the cell surface. In the case of the PPTases,
sortase, and biotin ligase, the reagents required for labeling (coenzyme A-probe conjugate,
GGGYK-probe conjugate, and streptavidin) are not membrane-permeable. In addition, for
formylglycine-generating enzyme, the required derivatization reaction between an aldehyde and
a hydroxylamine- or hydrazide-probe has reduced specificity inside cells due to the presence of
aldehyde- and ketone-containing biomolecules within the cytosol (53).
Unnatural amino acid mutagenesis as a co-translational abeling method
While other labeling methods described so far involved posttranslational modifications of
proteins, genetic code expansion via unnatural amino acid mutagenesis (UAA mutagenesis)
allows for direct incorporation of chemical probes as proteins are synthesized. The substitution
of a single natural amino acid with any desired probe and the freedom to put the probe at any
position in a protein make UAA mutagenesis the least perturbative and potentially the most
powerful way to label specific proteins. A large set of orthogonal tRNAs and their aminoacyl-
tRNA synthetases from Methanococcus jannaschii have already been generated through in vitro
evolution, enabling genetic encoding of >50 unnatural amino acids in Ecoli or yeast cells (55),
although this set of tRNA/synthetases cannot be used in mammalian cells due to the loss of
orthogonality. Fortunately, recent work has demonstrated that pyrrolysyl-tRNA from archaeal
Methanosarcina genus is not recognized by endogenous tRNA synthetases in E.coli and
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mammalian cells, and the specificity of the pyrrolysyl tRNA synthetase can be altered via in
vitro evolution (56), now allowing incorporation of photocaged lysine analogs (56) and recently,
bioorthogonal handles for both inverse electron-demand Diels-Alder cycloaddition (57,58) and
strain-promoted [3+2] azide-alkyne cycloaddition (59).
The main drawback of using UAA mutagenesis in mammalian cells is the reliance on
amber codon suppression. While the amber stop codon is present in only 7% of endogenous
E.coli genes (60), the three stop codons are present in roughly equal distribution in mammalian
genes. For example, the distribution of stop codons in human genes is 23% amber, 30% ochre,
and 47% opal (61). It is thus possible that the unnatural amino acid can be incorporated in
endogenous proteins, reducing the method's labeling specificity. Generation of new "blank"
codons, such as quadruplet codons, that can be read with high efficiency and fidelity with
engineered ribosomes (62) can circumvent problems associated with the usage of natural codons.
Another problem with UAA mutagenesis is that low incorporation efficiencies of the unnatural
amino acid (due to competition from translation termination) can lead to potential dominant
negative effects from truncated protein by-products (63). Recently, it is found that release factor
1 (RF1), which recognizes the amber codon, can be knocked out in E.coli with surprisingly
minimal cytotoxic effects if release factor 2 (RF2) expression is not autoregulated (60) or if
essential genes bearing the amber codon are supplied in a plasmid form (64). Such modifications
to eliminate competition between translation and termination allow for more efficient unnatural
amino acid incorporation, including at multiple sites within the same gene in E.coli (60).
While promising, it remains to be seen how useful UAA mutagenesis is as a site-specific
protein labeling method, especially for fluorescence imaging in mammalian cells where
background incorporation of unnatural amino acids to endogenous proteins cannot be easily
removed due to mammalian cells' reliance on the amber codon.
Bioorthogonal click chemistries as auxiliary tools for site-specific protein labeling
Bioorthogonal chemical reactions are those that can occur in a living cell without
interfering with the cell's biochemical processes while enabling the derivatization of a
bioorthogonal functional group (such as one that is put on proteins via protein labeling methods
in Table 1) with a desired chemical reporter. These reactions are also considered to be a subset of
the click chemical reactions, as they function to join small units together in an efficient manner,
29
generally with good atom economy and only generating benign by-products. Several such
bioorthogonal click reactions have been developed in the past decade with varying kinetics,
selectivity, and chemical and biological inertness.
Three bioorthogonal click reactions stand out due to their speed. First, an adaptation of
the classic [3+2] Huisgen azide-alkyne cycloaddition makes use of alkynes activated by ring
strain, such as cyclooctynes (65,66,67,68,69), and most recently, cycloheptynes (70), to
accelerate the triazole-forming reaction. Such strain-promoted cycloadditions, even without
catalysts such as Cul, (71) high temperature, or pressure, (72) can proceed quite efficiently with
second-order rate constants of up to 1 M- s (68). Second, a more recent development of a very
fast inverse-electron demand Diels-Alder cycloaddition between tetrazines and trans-
cyclooctenes further pushes the boundary of a bioorthogonal click reaction rates, achieving
second-order rate constants of up to 103-104 M-' s-1 (73). The rates of such Diels-Alder reactions
are now comparable to those of a self-labeling enzymatic reaction involving the SNAP-tag.
Lastly, a clever modification of the traditional copper-catalyzed azide-alkyne cycloaddition
(CuAAC) introduces a series of water-soluble tris-triazole ligands that can simultaneously
accelerate the reaction and act as sacrificial reductants, quelling cytotoxicity generally associated
with CuAAC (74,75). Such cell-compatible CuAAC has excellent reaction kinetics with pseudo-
second-order rate constants of up to 106 M- s-I per molar Cu (76). The three bioorthogonal click
reactions described here also have good labeling selectivity, the only caveats being the tendency
of strained alkynes (for strain-promoted cycloadditions) and strained alkenes (for Diels-Alder
reactions) to react with endogenous nucleophiles such as reduced glutathione inside cells (77,78).
Both strain-promoted and Diels-Alder cycloadditions are compatible with intracellular labeling
whereas CuAAC is currently limited to labeling at the cell surface due to the presence of Cu-
chelating thiols inside cells and the difficulty in delivering all of the CuAAC reaction
components into cells.
Beyond protein tagging, bioorthogonal click chemistry has seen extensive use in the
labeling of classes of non-genetically encoded biomolecules and metabolites such as glycans
(65), nucleic acids (79), and lipids (80).
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Methodologies for delivery of membrane-impermeable fluorophores into cells
Many fluorophores of interest for live-cell imaging, especially for super-resolution
imaging, contain charged functional groups such as sulfonates (81) and carboxylates (82). While
these functional groups impart aqueous solubility to fluorophores and improve fluorophore
photophysical properties by reducing dye-dye association and self quenching (83), the resulting
high polarity of the fluorophore molecules precludes them from diffusing efficiently across the
cellular membrane. For carboxylate-containing compounds, there exist chemical masking
strategies in which the negatively charged carboxylate is converted to a neutral ester, such as an
esterase-labile acetoxymethyl ester (84), for cytosolic delivery; however, such a generalizable
chemical solution does not exist for cellular delivery of sulfonated molecules and fluorophores
due to difficulties in the synthesis of the desired sulfonated derivatives. While cells may take up
membrane-impermeable compounds via endocytosis, the process confines internalized
compounds to acidic cellular compartments (with pH as low as 4.5 in the lysosomes (85)) prior
to cytosolic release, during which time the compound might be destroyed. Moreover,
endocytosis cannot provide sufficiently high concentrations of fluorophores, which are needed
inside cells to produce efficient site-specific labeling on proteins.
A wide range of methods have been developed for cytosolic delivery of membrane-
impermeable small molecules, nucleic acids, proteins, and nanoparticles. The methods can be
loosely categorized as: mechanical (e.g. microinjection (86), electroporation (21), bead-based
loading (21), osmotic lysis (87)), chemical (e.g. detergents (88), pore-forming toxins (89)),
vesicle-based (e.g. cationic liposomes (90), virosomes (91)), or direct modification on the
molecule (e.g. conjugation to cell-penetrating peptides (92)). None of the existing methods,
however,. present a safe and efficient way to deliver sulfonated fluorophores into the cytosol.
Mechanical and chemical means are generally cytotoxic as they temporarily but severely disrupt
the cell membrane. Vesicle-based and cell-penetrating peptide methods still rely on endocytosis
of the cargo, which limits the amount of probes that can be delivered into cells.
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Conclusion
Despite many instrumental advances in fluorescence microscopy that allow scientists to
visualize objects at near-molecular resolution, the core components that enable such high-
resolution imaging modalities-small organic fluorophores and their excellent photophysical
properties-cannot be routinely used for imaging of cellular proteins for two main reasons. First,
there exist few ways to site-specifically target organic fluorophores to proteins inside cells.
Currently, the best labeling methods still suffer from either large tag size or poor labeling
specificity. Second, many of these fluorophores are highly charged and cannot penetrate into the
interior of cells. Existing methods for cytosolic delivery of charged small molecules are either
damaging to cells or inefficient.
The goal of this thesis is to bring the outstanding photophysical properties of organic
fluorophores to cellular protein imaging, especially for use in super-resolution microscopy,
through a series of steps. First, we describe in Chapter 2 and 3 a new peptide-directed protein
labeling method based on lipoic acid ligase-catalyzed ligation of small blue organic fluorophores
to specific proteins inside living cells. Second, in Chapter 4, we combine lipoic acid ligase-
mediated labeling and bioorthogonal chemistries to expand the repertoire of targetable
fluorophores to include membrane-permeable green and red fluorophores. Third, we describe in
Chapter 5 a new variant of bioorthogonal click reactions that can be used to efficiently target
membrane-impermeable, but very bright, fluorophores to specific cell-surface proteins. Fourth,
in Chapter 6, to overcome the delivery problem of sulfonated fluorophores, we developed a
general approach to modify the sulfonate functional groups on fluorophores with an esterase-
cleavable protecting group. And lastly, in Chapter 7, we applied new protein labeling and dye
delivery methods to target sulfonated fluorophores to cellular proteins for super-resolution
imaging.
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Method name Genetic tag Tag size Small-molecule Enzyme Bioorthogonal Covalent References
(amino acids) modifier mediator chemistry needed for labeling of final
Mrobe attachment re orter?
DHFR Dihydrofolate 157 Trimethoprim N/A N/A Yes (with 36
reductase DHFR L28C)
SNAP/CLIP 0 6-alkylguanine 182 Benzylguanine (for N/A N/A Yes 16
transferases SNAP); propargyl
guanine (for CLIP)
FlAsH Tetracysteine tag 12 Biarsenical dyes Yes 39
Methods that have been demonstrated on the cell surface
Sortase SorTag 6 GGGYK pentapeptide Sortase A N/A Yes 50, 51
. .... ........
Aldehyde tag Aldehyde tag 13 Probes containing an Formylglycin Hydrazone or oxime Yes 52
aminooxy or a e-generating formation
hydrazine group enzyme
Cutinase Cutinase 200 p-nitrophenyl Cutinase N/A Yes 94
phosphonate
Oligo-aspartate D4 peptide tag 4-12 Zn-dipicolylamine N/A N/A No 96
Table 1. Existing posttranslational methods for site-specific labeling of cellular proteins.
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Chapter 2
Development of a coumarin fluorophore ligase
for site-specific protein labeling inside living cells
The work discussed in this chapter has been published in part in: C. Uttamapinant, K. A. White,
H. Baruah, S. Thompson, M. Fernandez-Suirez, S. Puthenveetil, and A. Y. Ting, "A Fluorophore
ligase for site-specific protein labeling inside living cells", Proc Acad Natl Sci USA 2010 (107),
10914-10919. Dr. Hemanta Baruah and Samuel Thompson performed activity screening to
identify the coumarin ligase enzyme. Katharine White performed cellular imaging experiments
(comparison of labeling sensitivity to FlAsH methology, and compartment-specific labeling
using coumarin ligase), the results of which are not included in this thesis.
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Introduction
In order to develop a new protein labeling method that combines a small peptide tag with
high labeling specificity, the Ting Lab has used enzymes to mediate recognition and covalent
coupling of a chemical probe to a peptide tag. Escherichia coli biotin ligase (BirA) and lipoic
acid ligase (LplA) are cofactor ligases that catalyze ATP-dependent covalent attachment of small
molecules (biotin and lipoic acid, respectively) onto specific lysine residues of their protein
substrates. Two key features of BirA and LplA that we exploited in re-engineering both enzymes
into probe ligases are their supreme specificity towards the protein substrates (E coli BirA has
only one protein substrate (1), while LplA has three (2)), but a more relaxed specificity towards
the small molecule. BirA has been shown to utilize ketone isosteric analog of biotin (3), while
LplA and its engineered variants can use octanoic acid (4), an azidoalkanoic acid (5), and an aryl
azide photocrosslinker (6) in place of lipoic acid. After enzyme-mediated probe ligation, each
probe can be further derivatized with fluorophores; this modification is accomplished via
interactions with specific protein partners (streptavidin-biotin) or via bioorthogonal click
chemistry (hydrazone formation or strain-promoted azide-alkyne cycloaddition). Moreover, in
place of the enzymes' natural protein substrates, we use small peptide surrogate substrates for
BirA and LplA: 15-amino acid BirA acceptor peptide (AP) (3); and 22-amino acid LplA acceptor
peptide (LAPI) (5). Unlike large fluorescent protein tags, these peptides can be fused to any
protein with minimal functional interference.
All of the mentioned BirA and LplA labeling strategies have been used to image cell-
surface proteins; however, none are currently transposable to live-cell intracellular protein
imaging. Two key hindrances, both related to the second derivatization step, are poor kinetics
(3,7) and mediocre specificity of derivatization chemistry in the intracellular context (3,8,7).
Furthermore, in the case of LplA, the 22-amino acid LAP] tag, which was generated through
rational recapitulation of a p-hairpin loop existing in LplA's protein substrates, is not a
kinetically efficient substrate for LplA. The sequence specificity of LplA-catalyzed probe
ligation in an intracellular context had also not been demonstrated.
Fortunately, several efforts in the Ting Lab since I joined the lab have pushed us closer
towards the goal of performing peptide-directed, enzyme-mediated labeling inside living cells.
First, Dr. Irwin Chen, Dr. Yoon-aa Choi, and Dr. Sarah Slavoff have performed extensive work
on re-engineering of BirA, coercing it to efficiently utilize other small molecule substrates
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beyond biotin and ketone-biotin. However, BirA proved to be resistant towards even small
changes in the biotin structure, presumably because the intricate network of hydrogen bonds and
polar interactions mediating biotin recognition precludes acceptance of most analogues (9).
Without a suitable small molecule substrate for intracellular labeling in sight for BirA, we
refocused our engineering efforts more towards LplA, whose active site composition and
demonstrated active site plasticity suggest that the enzyme relies more on non-specific
hydrophobic interactions to recognize its substrates (10), and is more amendable to engineering.
Subsequently, Dr. Sujiet Puthenveetil used yeast display in vitro evolution to create a
much more kinetically efficient 13 amino-acid peptide substrate for LpIA. The new LAP
sequence, called LAP2, has a catalytic efficiency of 0.99 ptM' min' for the lipoylation reaction
catalyzed by wild-type LplA (11), only -8-fold worse than the analogous reaction performed on
LpIA's natural protein substrate H-protein (kcat/Km of 7.95 p1M' min-' (11)), and ~70-fold better
than when lipoylation is performed on the 22-mer LAP I (kcat/Km < 0.013 iMI min' (5)). LAP2
enabled more sensitive detection of specific cell-surface proteins compared to LAP1, and was
expected to be a viable substrate for intracellular protein labeling.
Lastly, Dr. Marta Fernindez-Sudrez and Dr. Hemanta Baruah laid the groundwork for
redirecting LplA towards accepting diverse small molecule substrates. Notably, through
examination of crystal structures of LplA with bound small-molecule substrates, Dr. Baruah
performed alanine scanning mutagenesis of residues that lie within 7.5 A of the dithiolane ring of
lipoic acid and discovered that the W37A variant of LplA is able to marginally accept a
derivative of an aryl azide photocrosslinker as its substrate (6). Subsequent mutagenesis of the
W37 residue to other residues with smaller sidechains than Trp, such as Val, Ser, and Gly,
further identified a Trp37--+Val mutant of LplA as most efficient in ligating the aryl azide probe
onto LAP-tagged proteins. Dr. Baruah's work demonstrated that LplA, unlike BirA, can be
engineered to recognize small molecules that bear little resemblance to its natural substrate,
lipoic acid.
In this chapter, we describe our efforts in expanding LplA's small-molecule substrate
repertoire to include a small blue fluorophore, 7-hydroxycoumarin, and the application of such a
direct "fluorophore ligase" to intracellular protein labeling and imaging (Figure 2-1). First, two
LplA variants capable of directly attaching a 7-hydroxycoumarin derivative were identified via
structure-guided mutagenesis. Second, we characterized ligation kinetics, and specificity of
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enzymatic coumarin ligation in vitro and in cell lysate. Third, to test intracellular coumarin
ligation, we synthesized a membrane-permeable variant of the coumarin probe and expressed
LplA variants inside mammalian cells. After empirical optimizations, we showed that coumarin
labeling inside cells is fast and specific to LAP2-fusion proteins. And lastly, we characterized the
sensitivity and in-cell labeling yields of the coumarin ligation. The demonstrations of generality
of our coumarin ligase and its applications are further described in Chapter 3. The work
described in this chapter represents the first example of specific intracellular labeling by LplA,
and the first successful creation of a ligase with a novel enzymatic activity in fluorophore
recognition and ligation.
A) Lipoic acid ligase o S-s
NH3 (LpLA) HN t
Lipoic acid, ATP
B W37V or W371 0.4 0T-9NH3I LpLA HN 4
Coumarin 4, ATP 0
13-amino acid
LAP
Figure 2-1. Natural and engineered ligations by Ecoli lipoic acid ligase (LplA). A) Lipoylation reaction
catalyzed by wild-type LplA. B) Direct 7-hydroxycoumarin fluorophore ligation onto a 13 amino-acid
LplA acceptor peptide (LAP), catalyzed by either the W37V or W371 mutant of LplA.
Structure-guided screening for and identification of a coumarin fluorophore ligase
(This work was done by Dr. Hemanta Baruah, with assistance from Samuel Thompson)
Similar to other bacterial lipoic acid ligases, the 39 kDa E.coli LplA catalyzes a 2-step
process that results in covalent attachment of lipoic acid onto a specific lysine residue in each of
its three protein substrates: the E2p subunit of pyruvate dehydrogenase; the E2o subunit of 2-
oxoglutarate dehydrogenase; and the H-protein of the glycine decarboxylase complex (2). First,
LplA activates the carboxylic acid arm of lipoic acid to form an adenylate ester intermediate
lipoyl-AMP, using ATP in the process. The enzyme then catalyzes the lipoyl transfer reaction by
positioning lipoyl-AMP and a lysine residue of its protein substrate for a nucleophilic
substitution, with AMP acting as a leaving group.
Structurally, E.coli LplA consists of two domains: a large N-terminal domain (residue 1-
244) and a small C-terminal domain (residue 253-337) (12). The binding site of lipoic acid
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resides solely in the N-terminal domain (10). At the time of our study, only two structures of
E.coli LplA have been determined crystallographically: its apo form (12) and the binary complex
with lipoic acid (12). The structures of the binary complex with lipoyl-AMP (10) and the ternary
complex with a non-hydrolyzable octyl-AMP and H-protein (10) have since been determined,
however, they were not available at the time we started to reengineer LplA. Peculiar features in
the lipoic acid-bound E.coli LplA structure that led us to mistrust it (for example: lipoic acid was
found to be bound at the interface of the N- and C-terminal domain instead of at just the N-
terminal domain; lipoic acid was not in close proximity to known key catalytic residues; and the
electron density of lipoic acid in the structure was weak). We thus chose to examine instead the
lipoyl-AMP-bound form of Thermoplasma Acidophilum LplA (13). T acidophilum LplA
consists of only one domain, which corresponds to bacterial LplA's N-terminal domain, and is
able to catalyze only the ATP-dependent lipoyl-AMP formation, but not lipoyl transfer.
To identify candidate positions for mutagenesis, we selected residues of T acidophilum
LplA that lie within 7.5 A of the dithiolane ring of lipoic acid: L18, D21, Y39, Y73, T74, H81,
S89, L159, and H161 (Figure 2-2A). These nine residues correspond to residues L17, V19, E20,
W37, S71, S72, H79, F147, and H149 in E.coli LplA (Figure 2-2B). We additionally picked four
more E.coli LplA residues-N16, F35, T87, R140-to include in our initial screen as their
analogous residues in the T acidophilum structure also appeared to make up the dithiolane
binding cavity. The only residue that lies within 7.5 A of the dithiolane ring of lipoic acid that we
omitted from screening is R70 (E.coli numbering), as it is part of the RRXXXGGG catalytic
loop of LplA. We mutated the thirteen residues (N16, L17, V19, E20, F35, W37, S71, S72, H79,
T87, R140, F147, H149) to alanine one by one, and found that all of them are still active for
lipoylation (data not shown).
In selecting an interesting unnatural probe for LplA to incorporate, we zeroed in on 7-
hydroxycoumarin, as it is the smallest fluorophore whose photophysical properties are still useful
for live-cell imaging. It has an extinction co-efficient (c) of 36,700 M'cm' and a quantum yield
(QY) of 0.7 (14) (For fluorescein: E = 75,000 M-cm'; QY=0.71 (15)). 7-hydroxycoumarin is
also ~3-times brighter than its fluorescent protein counterpart, EBFP (c = 31,500 M 1cm';
QY=0.2 (16)). While coumarin is a blue fluorophore, its excitation and emission maxima of 387
and 448nm evade direct excitation of autofluorescent molecules (NADH and FAD/FMN have
excitation maxima at 340 and 450 nm respectively (17,18)). As most of the key residues in the
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dithiolane binding site of LplA are hydrophobic or small polar ones, the general hydrophobicity
of 7-hydroxycoumarin also increases the likelihood that it would be accepted by LplA. We
synthesized four 7-hydroxycoumarin derivatives, with varying linker lengths separating the
coumarin moiety and the carboxylic acid group that would be activated as an adenylate ester by
LplA.
A)
T.acidophilum LplA with bound lipoyl-AMP
B)
UF14
S71 L
R140
S72 Lipoic acid
E.coli LplA with bound lipoic acid
Figure 2-2. Lipoate binding pockets of A) T. acidophilum LplA (PDB: 2ART) and B) E coli LplA (PDB:
IX2H, chain A). In A), residues within 7.5A of the dithiolane ring of lipoyl-AMP bound to T.
acidophilum LplA are rendered in green stick. In B), corresponding and proximal active site residues in
F coli LplA are similarly rendered. These residues of the E. coli structure were mutated to alanine for the
initial activity screening.
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Y39
Lipoyl-AMP
T acidophilum LplA with bound lipoyl-AMP
Lipoic acid
E.co/iLpIA with bound lipoic acid E.coli LpLA with bound lipoyl-AMP
Figure 2-3. Spatial relations between the dithiolane ring of lipoic acid/lipoyl-AMP and the W37 residue of
Eecoli LpIA (equivalent to the Y39 residue of T acidophilum LplA). In the T.acidophilum LplA structure
(top), the Y39 residue and lipoyl-AMP are rendered in stick. In E.coli LplA structures, the W37 residue
and either lipoic acid (bottom left) or lipoyl-AMP (bottom right, PDB: 3A7R) are similarly rendered.
Distances between the dithiolane ring and either amino acid residue are shown.
First, using a high-performance liquid chromatography (HPLC)-based activity assay
against LplA protein substrate E2p, we found that wild-type LpIA, not surprisingly, was not able
to utilize any of the four coumarin probes (data not shown). We then next tested the thirteen
LplA variants of our alanine scanning library as described above for activity against the two
smaller coumarins (coumarins 3 and 4; the suffix number indicates methylene linker length), and
found that only LplAW37A gave detectable ligation product. Upon examination of LplA
structures, W37 sidechain is positioned far (8.5 A) from the dithiolane ring of lipoic acid in the
E. coli lipoic acid-bound structure, but its analogous residue in the T. acidophilum structure,
Y39, is only 3.9 A from the dithiolane moiety (Figure 2-3, top and bottom left structures).
Fortunately, the later crystal structure of lipoyl-AMP-bound E. coli LplA reported in 2010
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showed that the W37 residue is positioned much closer to the dithiolane ring (3.6 A), and is right
at the tip of the lipoate binding tunnel (Figure 2-3, bottom right structure). We thus reasoned that
mutation of Trp37 to a residue with smaller sidechain like Ala potentially enlarges the lipoate
binding tunnel and allows probes larger than lipoic acid to be incorporated. The marginal
coumarin ligation activity we obtained with LplAW37A indicates a poor fit between the enzyme
and the coumarin substrate.
To potentially improve upon coumarin ligation turnover of LplAW37A, we performed
saturation mutagenesis at the W37 position, creating 18 more LplA W37 variants (in addition to
the wild-type and W37A variants). These W37X LplA mutants were screened against all four
coumarin probes for ligation activity (Figure 2-4A). We found that eight of these mutants (W37
-+ G, A, S, C, T, L, I, V) catalyze coumarin ligation onto E2p under a forcing reaction condition
(2 ptM enzyme, 100 ptM E2p, 500 ptM coumarin for an overnight reaction at 30 'C). The
coumarin ligation activities of the eight W37 Lp1A mutants were further differentiated using a
milder reaction condition (1 piM enzyme, 500 iM coumarin for 40 min at 30 'C), and with an
LplA acceptor peptide (LAP) as a substrate instead of E2p. For this comparison, we used a yeast-
evolved LAP sequence called LAP4.3D (11) even though it is a less superior LplA substrate than
LAP2, since fusion of LAP4.3D to a 9 kDa carrier protein heterochromatin-l (LAP4.3D-HPI)
produced an HPLC peak that is more easily quantifiable (little impurities, sharp peak) than
LAP2-HP 1.
Of the eight mutants, LplAW37V was shown to have highest coumarin ligation activity,
against coumarin 4, followed by LpIAW3 71, also against coumarin 4 (Figure 2-4B). This
demonstrates that enzyme active site enlargement does not necessarily correspond to better
small-molecule recognition and increase in ligation activity. Mutations of W37 to smaller
residues like Gly or Ala might over-enlarge the LplA active site, and result in poorer substrate-
enzyme shape or size complementation, while mutations to Val or Ile were observed to produce a
much better fit. The preference for hydrophobic sidechains at the W37 position additionally
suggests that the ligase recognizes the neutral form of 7-hydroxycoumarin instead of its anionic
form (phenoxyl pKa of 7-hydroxycoumarin =,7.5 (14)). The general preference of coumarin 4
over coumarins with other linker lengths regardless of the different sizes, shapes, and polarity
sampled by the sidechains in the W37X library, suggests that linker length plays an important
role in enzyme-substrate recognition, either by directly participating in hydrophobic interactions
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with residues in the lipoate binding tunnel, or by correctly orienting the coumarin moiety to
allow maximal interactions with the enzyme.
A) W37 mutant
GASCTL IVPNDQKEMH FRY
0H
HOA>4t n 1LAcn=6
B)
LpA mutant % Conversion
with Coumarin 4
W37V 100 ±8.3
W371 27.9 ± 5.6
W37A 15.5 ±2.8
W37L 5.9 ±1.1
W37G < 2
W37S <2
W37C < 2
W37T <2
Figure 2-4. Activity screening to identify a coumarin fluorophore ligase. A) Relative activities of different
W37 LplA mutants for ligation of four 7-hydroxycoumarin derivatives. B) Percent of LAP4.3D peptide
converted to its covalent adduct to coumarin (n=4) for the eight most active LplA mutants. Figure credit:
Dr. Hemanta Baruah and Samuel Thompson.
Characterizations of coumarin ligation kinetics and sequence specificity
We proceeded to characterize coumarin ligation as catalyzed by LpIAw37v and LpIAw371
These subsequent characterizations were now performed on LAP2, the most kinetically efficient
peptide substrate for LplA. First, an HPLC assay shows that coumarin ligation to LAP2 requires
ATP and is not catalyzed by wild-type LplA (Figure 2-5). The product peaks at minute 9 from
reactions with either ligase were collected and analyzed by electrospray ionization mass
spectrometry. Figure 2-6 shows that upon using either ligase, the observed product mass
corresponds to the calculated mass of the covalent LAP2-coumarin 4 adduct, formed via amide
coupling with accompanying loss of water. No other ligation product was observed in the HPLC
analyses, suggesting that enzymatic coumarin ligation is site-specific towards the lysine residue
of LAP2 over other potentially nucleophilic sites of LAP2 (such as the N-terminal amino group).
This further suggests that release of the active intermediate coumaryl-AMP into the reaction
solution, which would generate some non-specific labeling products, is unlikely.
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Coumarin 4 Coumarin 4-conjugated LAP2
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Figure 2-5. HPLC characterizations of LplAW37 v and LplAW371-catalyzed ligation of coumarin 4 onto
LAP2 peptide (red traces). Negative control traces with ATP omitted or wild-type LpIA replacing
coumarin ligases are shown in black. Starred peaks were collected for further analysis by mass
spectrometry (Figure 2-6).
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Figure 2-6. Mass spectrometric analysis of coumarin 4-LAP2 covalent adducts. Starred peaks from HPLC
traces in Figure 2-5 were collected and analyzed by electrospray ionization mass spectrometry. Top, the
mass of the LAP2 starting material. Bottom, the masses of the coumarin 4-LAP2 covalent adduct formed
using LpIAW37V (left) or LplAW3 71 (right).
We next determined the steady-state kinetic parameters of coumarin 4 ligation onto LAP2
by LplAW37V or LpIAW3 7I. HPLC-based analysis was used to quantify ligation product formation
at different coumarin 4 concentrations (ranging from 12.5 to 500 pM for LplAW37V
measurements, and 16 to 1600 pM for LplAW371 measurements). The initial reaction rates were
determined at each coumarin 4 concentration, and the resulting Michaelis-Menten plots reveal
the enzymatic turnovers kcat to be 0.0 19 s-' for LplAW37v and 0.016 s-' for LplAW3 71 (Figure 2-7).
The main kinetic difference between the two coumarin ligases lies in the Michaelis constant,
with Km for coumarin 4 ligation by LplAW37V of 56 pM -5-fold lower than the LplAW37 1
coumarin 4 Km of 261 gM.
A) B)
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1.00 V. = 2.3 0.5 VM/min >V, = 19 0.2 pM/min
km = 0.019 ± 0.004 s1  0.50 k, = 0.016 ± 0.002 s-I
K, 5 ± 2 MK, =261 ±69 pM
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Figure 2-7. Michaelis-Menten kinetics of (left) LplAw 7v- and (right) LplAw"7 -catalyzed coumarin 4
ligation onto LAP2. The initial rates (VO) were measured using an HPLC-based assay, with 2 p.M enzyme,
150 pM LAP2, and coumarin 4 concentration ranging from 12.5 p.M to 1600 pM. Each initial rate was
measured in duplicate. Error bars, I s.d. Figure credit: The kinetics measurements for LplAW37V_
catalyzed coumarin 4 ligation were performed by Dr. Hemanta Baruah.
Upon comparison to wild-typle LplA-catalyzed lipoylation (kat: 0.22 s-, Kmn: 13 pM
(11)), the kcat values for coumarin 4 ligation were -10-fold lower, while Km values were 4-20-
fold higher depending on the enzyme variant, resulting in overall -40-200-fold reduction in
catalytic efficiency. Comparison of coumarin ligation kinetics to those of other unnatural probe
ligation reactions also reveals that coumarin 4 turnover is 10-30-fold poorer than wild-type
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LplA-catalyzed ligation of 8-azidooctanoic acid (5), or LplA w37v-catalyzed ligation of an aryl
azide derivative (6). However, the coumarin Km with LplAW37v is slightly better than previous
Km values for unnatural substrates. While kcat limits the maximal reaction rate that can be
obtained, low Km values mean that we can realistically push the enzymes to Vmax by supplying
the reaction with higher coumarin 4 concentrations that the measured Km's. And while the
kinetic parameters of LplAW37V clearly exceeds that of LplAW371, we decided to carry both
ligases to testing inside living cells, as there are other factors such as enzyme folding and
intracellular stability that could not be easily predicted but could heavily influence the enzyme's
intracellular ligation activity. It is also worth noting that the resulting poorer specificity constants
of coumarin 4 ligation onto LAP2 merely reflects inefficient usage of coumarin by LplA variants
compared to lipoic acid, and is not indicative of the enzyme's reduced labeling specificity in the
milieu of other proteins.
Lastly, we proceeded to assess coumarin 4 ligation specificity in mammalian cell lysate.
It was unclear whether active site engineering of LplA via W37 mutations would affect the
enzyme's sequence specificity. Mammalian cells also express protein substrates for their own
lipoic acid ligase, which is localized to the mitochondria (19,20); it is unknown whether
recombinantly expressed LAP-tagged proteins can be lipoylated by mammalian LplA using trace
amount of lipoic acid present in the cell growth medium. Moreover, while protein substrates for
mammalian LplA are also confined in the mitochondria (19,20), they might cross-react with
cytosolically expressed coumarin ligases if these protein substrates are synthesized in the cytosol
before they get transported to the mitochondria.
To test for these possibilities, we created a LAP2 fusion to the N-terminus of yellow
fluorescent protein (LAP2-YFP) and expressed it inside human embryonic kidney (HEK) cells.
Once HEK cell lysate was harvested, we performed enzymatic coumarin labeling in the lysate
with coumarin 4, ATP, and either LpIAW37v or LplAW371. After electrophoretic separation of
proteins, coumarin 4-protein adducts were detected using in-gel fluorescence visualization of
coumarin, and lipoylated proteins were detected via anti-lipoic acid Western blotting. Analysis of
coumarin in-gel fluorescence shows that amidst a mass of endogenous mammalian proteins, only
LAP2-YFP was specifically labeled with coumarin by both coumarin ligase variants (lane 1 and
4, Figure 2-8). Specific coumarin ligation was observed even when LAP2-YFP expression levels
were low and could not be distinguished from endogenous proteins, as evident from coomassie
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protein staining. Negative controls showed that coumarin labeling is specific to an intact LAP2
sequence (lane 2 and 5 show abolished labeling when the key Lys residue of LAP is mutated to
Ala) and a dependence on the W37 mutation (lane 7). Thus, both coumarin ligases retain the high
sequence specificity of wild-type LplA. The experiment also verified that coumarin labeling is
covalent, as transient probe-protein association would not have survived the harsh treatment of
denaturing gel electrophoresis.
*3plA npA wild-type LpLA
LAP2-YFP + - - + - - + -
LAP2(K-+A)-YFP - + - - + - - -
Coumarin4 + + + + + + + -
Lipoicacid - - - - - - - +
Lane 1 2 3 4 5 6 7 8 1 2 3 4 5 6 7 8
82 kD - -82kD
37 kD- -37kD
26 kD - -26 kD
19 kD -
- 19 kD
15kD - 15 kD Counarin fluorescence
1 2 3 4 5 6 7 8 2kD 1 2 3 4 5 6 7 8
Endogenous 2_ 3_ 5_ _ _ 8 82 kD
lipoylated proteins kD
LAP2-YFP -+ 37 kD ' _==
Coumarin fluorescence (with increased contrast)
Figure 2-8. Specificity of coumarin labeling in mammalian cell lysate. Lanes 1 and 4 show coumarin 4
ligation into LAP2-YFP catalyzed by LplAW3 7V and LplAW3 71, respectively. Negative controls are shown
with an alanine mutation in LAP2 (lanes 2 and 5), wild-type LplA instead of coumarin ligase (lane 7), and
untransfected lysate (lanes 3 and 6). The same samples were also analyzed by blotting using anti-lipoic
acid antibody. Lysate in lane 8 was subjected to in vitro lipoylation with exogenously supplied wild-type
LplA.
Analysis of anti-lipoic acid Western blotting reveals that endogenous protein substrates
of mammalian lipoic acid ligase are present in the lysate, but are not detectably labeled by
coumarin. It is possible that these mammalian LplA substrates are not labeled by coumarin
because they are already labeled to saturation with lipoic acid. This idea is supported by the
observation that in vitro lipoylation of the lysate does not increase lipoylation extent of these
endogenous proteins (lane 8). We also found that LAP2-YFP proteins were not detectably
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lipoylated by mammalian LplA, even though free lipoic acid might be present in the cytosol
(lane 1, 4, and 7).
Synthesis and characterizations of a membrane-permeable coumarin 4 derivative in cells
Coumarin 4 bears 1-2 negative charges at physiological pH (the pKa of the 7-phenoxyl
proton is 7.5), and was shown to be membrane-impermeable. To enable intracellular coumarin
ligation, we synthesized a bisacetoxymethyl (AM) ester/ether (21) of coumarin 4 (coumarin-
AM 2: Figure 2-9) by combining coumarin 4 with excess bromomethyl acetate in the presence of
triethylamine. The AM protecting groups confer hydrophobicity and hence membrane
permeability. Once inside cells, the protecting groups are cleaved by endogenous esterases,
releasing the functional, LplA-active coumarin 4. To evaluate dye entry into cells ("loading"),
HEK cells were incubated with 10pM of coumarin 4, coumarin-AM (only the carboxyl group
was protected), or coumarin-AM 2. While coumarin 4 and coumarin-AM showed no noticeable
loading, coumarin-AM 2 showed clear cell entry, with intracellular coumarin fluorescence > 20-
fold over autofluorescence background (Figure 2-9).
OO HO 0 0 O0 HO H 
0
oj :0- H 0 0 H4
0 N" o0_
10 M Coumari 1M' M Coumarin-AM 10 M Coumarin
Figure 2-9. Cellular loading of differently protected coumarin probes. Unprotected, singly protected
(coumarin-AM) and doubly protected (coumarin-AM 2) coumarin 4 probes were incubated with HEK cells
for 10 minutes at 37 *C. Cells were washed once, then immediately imaged. Coumarin fluorescence
(blue) and differential interference contrast (DIC) images are shown.
To assess whether coumarin-AM2 and its deprotected derivatives can be cleanly removed
from cells ("washout"), a loading and washout study with various concentrations of coumarin-
AM 2 was next performed. The goal was also to identify the maximal coumarin-AM2 loading
concentration that still gave a clean washout from cells in a reasonable time. After empirical
optimization, the optimal coumarin-AM2 loading concentration was found to be -25 pM, which
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upon 10-minute loading, can be washed out from cells completely within 30 minutes (Figure 2-
10). Dye removal from cells is thought to be through the function of non-specific anion
transporters (22). Incubating 25 tM coumarin-AM2 with cells for a longer period (up to 6 hours)
did not exert any apparent cytotoxicity, judging from cell morphology and from mitochondrial
respiration (Katie White, Figure S8 of Uttamapinant et al PNAS 2010). Even dye distribution and
clean removal from cells suggested that coumarin is not retained specifically inside organelles,
nor reactive against intracellular biomolecules.
Washing time:
200 pM
100 pM
50 pM
0 min 10 min AO min 1 hr 1 -1 hr
25 pM
12.5 pM
Figure 2-10. Optimization of loading and washout conditions for coumarin-AM 2. Various concentrations
of coumarin-AM 2 were loaded into HEK cells for 10 minutes. The probe was then allowed to wash out
for 0 to 1.5 hours. Coumarin fluorescence images (blue) are shown as overlaid onto DIC images.
We used the "wedge method," to crudely estimate the intracellular concentration of
coumarin probe immediately after cellular loading. The wedge method uses a wedge-shaped
microchamber made from three glass coverslips, with the height of the chamber increasing
linearly from ~0-150 pm. The chamber was filled with a known concentration of coumarin 4
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solution, and the coumarin fluorescence of the region of the wedge with an interpolated thickness
of 5 pm (which is assumed to be the average thickness of HEK cells (5)) was measured under
conditions identical to those used for cellular imaging. Figure 2-11 shows estimated intracellular
coumarin concentration after 10 min cellular loading with a given concentration of coumarin-
AM 2. With -20 gM coumarin-AM 2 loading (the loading concentration found to give clean
washout after 30 minutes), the intracellular coumarin concentration was -469 pM, which
exceeds the coumarin Km for both LplAw37v and LplAwnI. Intracellular coumarin labeling thus
should be reasonably efficient given the high concentration of coumarin 4 that can be
accumulated inside cells.
Coumarin loading Average intracellular
condition coumarin concentration ± s.d. (pM)
10pM coumarin-AM 2, 10min 199 ± 44
20pM coumarin-AM 2, 10min 469 ± 263
40pM coumarin-AM 2, 10min 851 ± 572
10pM coumarin-AM 2, 30min 863 ± 348
Figure 2-11. Estimated intracellular coumarin concentrations after different dye loading conditions. Data
were collected from - 100 single HEK cells for each loading condition. Coumarin fluorescence intensities
were converted into absolute concentrations (in cells) by comparison to a coumarin 4 reference standard
within a wedge-shaped glass microchamber.
Confirming expression of lipoic acid ligase variants inside mammalian cells
The engineered LplAw37v and LpIAW17 1 also have to be expressed inside mammalian
cells to effect intracellular labeling. While the original wild-type E.coli LplA gene was found to
express poorly in HEK cells, LplA expression and folding were dramatically improved when we
resynthesized the LplA gene with human-preferred codons. Humanized genes for both LplAW37V
and LplAW371 gave robust and reliable expression of the ligase in a number of cell lines.
Interestingly, upon fusion of humanized LplA to the C-terminus of an orange fluorescent protein
mCherry, a trick commonly used to improve recombinant protein expression due to robust
expression of fluorescent proteins, the mCherry-LplAW37V fusion was found to aggregate inside
HEK cells and had greatly reduced activity; LplAw3 7 , on the other hand, did not aggregate and
maintained its ligation activity (Figure 2-12). This difference might be attributable to the weak
oligomerization tendency of fluorescent proteins and the intrinsically higher instability of
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LplA W37V compared to LplAW371. To take advantage of the better ligation kinetics of LplAW37V
the use of a non-fluorescent protein-tagged version is strongly recommended.
LpLA(W371) LpLA(W37V)
Coumarin mCherry-Ligase YFP + DIC Coumarin mCherry-Ligase YFP + DIC
3 min
10 min
Figure 2-12. Comparisons of coumarin ligation activity of mCherry-tagged LpIAW3 7v and LplAW3 71 in
cells. HEK cells co-expressing nucleus-targeted LAP2-tagged YFP and mCherry-tagged coumarin ligase
were labeled with coumarin-AM 2 for 3 or 10 min, followed by a washout period of 1 hour.
Epifluorescence images of coumarin, mCherry and YFP overlaid with DIC are shown. Scale bars, 10 pm.
The expression levels of LplAw37V and LplAW371 can be crudely modulated by titrating
the amount of LplA-encoding plasmid used during liposome-mediated transfection (Figure 2-
13). For other ways to control LpIA expression levels, we have also explored fusing LplA to the
FKBP-rapamycin binding domain of the mTOR protein (FRB) to increase protein turnover
(resulting in much lower constitutive expression levels of FRB-LplA compared to non-tagged
LplA) (data not shown). LpIA expression can also be put under a tetracycline operator to effect
inducible protein expression (23) (data not shown); the expression level of LplA under the
tetracycline regulation (T-REx TM system) can be increased via addition of higher concentrations
of tetracycline, whose binding to the Tet repressor weakens the repressor's binding to the
operator element on LpIA-expressing plasmids. We did not fully pursue FRB and TRExTM
systems as modulators for coumarin ligase expression, since FRB can only negatively affect
protein expression levels and we feared that the lower ligase expression levels would be too low
to be useful. The TRExTM system requires the use of cell lines stably expressing the Tet repressor
and limits the generality of the labeling method.
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Amount of transfected wM7vLpIA plasmid
200 ng 80 ng 40 ng 20 ng
C
Figure 2-13. Calibration of ligase expression levels via plasmid amount titration in HEK cells. The
indicated quantities of the mammalian expression plasmid for FLAG-tagged LplAw37v (plus 400 ng of the
expression plasmid for LAP2-YFP) were transfected into HEK cells. LplA protein was detected post-cell
fixation via anti-FLAG immunofluorescence staining. Two cell fields of view are shown for each amount
of plasmid used.
Intracellular coumarin labeling specificity and efficiency with LplAw7 vs. LplAw7
Now that we had established an optimized coumarin-AM 2 loading protocol and an
effective means to express LplA variants inside mammalian cells, we proceeded to test for
coumarin ligation on LAP2-tagged proteins (such as LAP2-YFP) inside living cells. We first
started conservatively by transfecting HEK cells with expression plasmids (all under a
constitutive CMV promoter) for LAP2-YFP (400ng plasmid per 0.95 cm 2 dish) and either
LplAw7 or LplAw37(200ng plasmid per 0.95 cm2 dish), hoping to achieve strong expression of
both LAP2-YFP and the ligase. After 10 min incubation with 20 pM coumarin-AM 2 followed by
3 0-60 min washout of excess probe, we were delighted to observe coumarin labeling that was
highly specific to LAP2-YFP-expressing cells (Figure 2-14). Coumarin labeling extent
(normalized against LAP2-YFP expression levels) upon using LplAw 37v as a coumarin ligase
was in average ~-5-fold higher than that upon using LplAw 37 1 , consistent with the superior
ligation kinetics of LplAw7 comred to the W37I variant. As we tested for site-specificity of
labeling by using inactive LAP2(Lys-+Ala)-YFP instead of LAP2-YFP, however, we were
confounded to observe non-specific labeling with LplAw 37v, as cells transfected with the ligase
but with a catalytically inactive LAP also received significant coumarin labeling (Figure 2-14).
The non-specific labeling problem only affected LplAw37v, as cells expressing LplAwn1I and
LAP2(Lys--Ala)-YFP did not show coumarin labeling.
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Figure 2-14. LAP substrate-independent background labeling observed when using LplAW37V coumarin
ligase. HEK cells transfected with expression plasmids for LplAW3 7V (200ng plasmid per 0.95 cm 2
culture surface area) and either LAP2-YFP or LAP2(K-+A)-YFP (400 ng plasmid) were labeled with
coumarin-AM 2 for 10 min.
There are at least three possibilities that could explain the non-specific labeling observed
with LplAW3 7V:
1) LplA W37V catalyzes formation of the coumaryl-AMP intermediate, and without an
active protein or peptide substrate present, the enzyme/coumaryl-AMP binary complex docks
onto LAP2(Lys--+Ala)-YFP possibly because the ternary complex is more stable. The
interactions that maintain LplA/coumaryl-AMP binding to LAP(Lys-+Ala) are likely non-
covalent, as there is no obvious nucleophile on LAP(Lys--+Ala) that can react with coumaryl-
AMP.
2) LplAw37v catalyzes formation of coumaryl-AMP, and without a protein or peptide
substrate present, releases coumarin-AMP from its active site and causes promiscuous labeling
on any proximal endogenous proteins (including on the enzyme itself).
3) LplA W37V catalyzes formation of coumaryl-AMP, and without a protein or peptide
substrate present, simply retains coumaryl-AMP in its active site. This mechanism does not
require the presence of an additional binder like LAP2(Lys-*Ala) to stabilize the
enzyme/coumaryl-AMP binary complex.
Analysis using LplAw37V constructs targeted to different compartments of the cell
showed that the third explanation seemed the most likely. First, we confirmed that coumarin
labeling background occurred in cells expressing LplAW37v alone, without the need to co-express
LAP2(Lys-*Ala)-YFP, thereby ruling out the first explanation. Second, upon using LplAW37V
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that is targeted to the cell nuclei or excluded from the cell nuclei via fusion to appropriate
localization sequences, we saw that the labeling background correlates tightly with LplAW37V
localization (Figure 2-15). This observation supported the third hypothesis and ruled out the
second one, since if LplAW37v were labeling endogenous cellular proteins, we would expect
diffusion of the coumarin signal over the 60-minute labeling/washing time window.
Nevertheless, it remains unclear to us whether LplAw37v/coumaryl-AMP binary complex
remains non-covalent, or due to close confinement, the activated coumaryl-AMP reacts
covalently to lysine residues within the enzyme active site. The catalytic Lys 133 residue is one
such lysine candidate: Lys133 helps chelate the key Mg 2  in the active site and provides
electronic stabilization to ATP and probe-AMP binding (10), and thus is positioned closely to the
phosphoanhydride bond of the activated probe-AMP.
coumarin H2B + DIC
Whole-cell
LplAw3lv
Nucleus-targeted
LplAw3 E
Figure 2-15. Enzyme-specific labeling background observed when using LplAw37 v coumarin ligase. HEK
cells expressing whole-cell or nucleus-targeted LplAW37V, without any LAP substrate co-expressed, were
labeled with coumarin-AM 2 for 10 min. Histone 2B fused to yellow fluorescent protein (H2B-YFP)
serves as a transfection marker.
Interestingly, LplA's homologous enzyme E. coli biotin ligase is known to similarly
retain biotin-AMP in its active site (24). Unlike LplAw37v, LplAW3 71 does not exhibit this probe-
AMP retention behavior, likely due to its much higher Km for coumarin 4 (Figure 2-16).
To reduce such enzyme-dependent but protein substrate-independent coumarin labeling
with LplAW37v, we attempted to modulate LplAW37v expression levels in cells in order to
minimize labeling background on the enzyme, but still obtain maximal labeling signal on LAP2
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fusion proteins. After empirical optimizations, we found that using 20ng of LplAW37V-expressing
plasmid instead of 200ng (per 0.95 cm2 dish, with co-transfection of 400ng LAP2-YFP or
LAP2(Lys-+Ala)-YFP plasmid) is effective in reducing LplA expression level, and
consequently, enzyme-dependent labeling background to non-detectable levels (Figure 2-16).
Specific coumarin labeling on LAP2-YFP could still be observed clearly under this expression
condition, suggesting that LplAW37v does not need to be present at high levels for it to catalyze
efficient, multiple-turnover coumarin ligation onto LAP2. The specific coumarin labeling
intensity obtained from using 20ng of LplAW37V plasmid is -1.5-fold higher than that obtained
from 200ng of LplAW371 plasmid. We therefore conclude that LpIAW37V is still the best coumarin
ligase, capable of giving more sensitive labeling than LplAW3 7 1 even when LplAW37V is expressed
at lower levels than LplAW37I. However, using LplAW3 7 1 as a coumarin ligase could be
advantageous in applications where ligase overexpression cannot be easily controlled, as
LplAW371 offers very specific, albeit less sensitive labeling, even at high ligase expression levels.
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Figure 2-16. Coumarin labeling specificity in cells with different ligase expression levels. A) HEK cells
were transfected with 20 ng or 200 ng FLAG-LplAW3 7V or FLAG-LplA per 0.95 cm2 culture surface
area, and coumarin labeling was performed on LAP2-YFP, or LAP2(K-+A)-YFP as a negative control.
Epifluorescence images are shown for coumarin and YFP. B) Quantitation of cellular coumarin and YFP
fluorescence from A). For each condition, coumarin fluorescence intensity is plotted against YFP
fluorescence intensity (which correlates with LAP2-YFP or LAP2(K-+A)-YFP expression level) for > 60
single cells. Figure credit: the quantitative analysis in Figure 2-16B was performed by Katie White.
Characterizations of coumarin labeling specificity, sensitivity, and ligation yields in cells
We characterized coumarin labeling with either LpIAw 37V or LplAw371 in HEK cells,
using an optimized expression protocol tailored for each coumarin ligase construct. First, we
performed coumarin labeling with negative controls and assessed its labeling specificity. Figure
2-17 shows that for both coumarin ligases, after I 0-min incubation with coumarin-AM 2 followed
by a 60-min washout, only cells expressing LAP2-YFP retained coumarin fluorescence, whereas
neighboring untransfected cells were not labeled. In the case of LplAW3 7 1 where an mcherry-
LplAW37 I fusion can be used, coumarin labeling was observed only in cells co-expressing both
the YFP (fused to LAP) and mCherry (fused to the ligase) markers. A Lys--Ala mutation in
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LAP2 sequence or using wild-type LplA instead of either engineered coumarin ligase eliminated
coumarin labeling.
A) B) mCherry-Ligase
Coumarin LAP2-YFP + DIC Coumarin LAP2-YFP + DIC
W37vLpLA W37ILpLA
+ LAP2 + LAP2
war7vLpLA W37'41IA
+ LAP2(K-A) + LAP2(K-+A) f l
Wild-type LpLA Wild-type
+ LAP2 LpA
+ LAP2
Figure 2-17. Specific coumarin ligation with A) LplAw3 7 v and B) LplAW37 1 inside living mammalian cells.
For A), HEK cells co-expressing FLAG-tagged LplAW37V (with 20 ng DNA transfection) and LAP2-YFP
were labeled with coumarin-AM 2 for 10 min. For B), HEK cells co-expressing mCherry-tagged LplAW37 1
(with 200 ng DNA transfection) and LAP2-YFP were similarly labeled with coumarin. Negative controls
are shown with a Lys-+Ala mutation in LAP2, and with either coumarin ligase replaced by wild-type
LplA. Confocal images are shown for all. All scale bars, 10 tm.
We then estimated coumarin labeling sensitivity using the aforementioned wedge
method. Here, the wedged microchamber was filled with 10 pM purified YFP solution. By
measuring fluorescence at the wedge region with the thickness of 5 pm (HEK cell thickness), we
could crudely correlate YFP fluorescence intensity with the estimated YFP concentration in
cells. Using this correlation, we found that coumarin labeling can only achieve an acceptable
signal-to-noise ratio of 4:1 with 10-20 jM of LAP2-YFP (Figure 2-18). Since only a few
intracellular proteins are expressed at this high level in cells (mainly cytoskeletal proteins and
translation factors (25)), we still need to further improve coumarin ligation kinetics or its
photophysical properties before we can routinely detect most intracellular proteins using
coumarin ligase. As a benchmark, green fluorescent protein can be used to detect 1IM protein
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with signal-to-noise ratio of -3:1 (26), and thus is still ~10-times more sensitive than coumarin
ligase labeling.
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Figure 2-18. Estimation of coumarin labeling sensitivity in cells. HEK cells co-expressing LplAW3 7v and
LAP2-YFP were labeled with coumarin-AM 2 for 10 min. Average coumarin and YFP epifluorescence
intensities were collected for -80 single cells. YFP fluorescence was converted into absolute
concentrations by comparison to a purified YFP standard of known concentration, using the wedge
method. Coumarin signal-to-noise of labeling is defined by coumarin fluorescence on YFP-expressing
cells over coumarin fluorescence on untransfected cells.
To estimate the intracellular coumarin ligation yield, we similarly used the wedge method
to determine single-cell concentrations of LAP2-YFP and ligated coumarin probe after labeling.
We first found that LAP-ligated coumarin 4 is -4-fold dimmer than the free coumarin 4 probe,
likely due to photoinduced electron transfer (PET)-based quenching of ligated coumarin by a
proximal +2 tryptophan residue in the LAP2 sequence (GFEIDKVWYDLDA) (Daniel Liu and
Samuel Thompson, data not shown). To accurately assess ligated coumarin concentrations in
cells, we therefore used purified LAP2-coumarin 4 as a fluorescence standard in the wedge
instead of free coumarin 4. After correlating YFP and coumarin fluorescence to their cellular
concentrations, we found that -24% of LAP2-YFP was labeled with coumarin using the 10-min
labeling protocol by LplAw37V (with 20ng LplA plasmid transfection, Figure 2-19). The yield
could be increased to -53% after 1-hour incubation with the coumarin probe. Similar
characterization shows that coumarin labeling yields with LplAw3 71 (with 200ng LplA plasmid
transfection) were -18% and -44% after 1 0-min and 1-hour labeling, respectively.
W37VLpLA
Coumarin LAP9-YFP + nir.
W3 'LpLA
Coumarin LAP2-YFP + DIC
10 min
60 min
12.* LDLAA37i). 10-nwwie Imbebig
* LptA(W371). 60-anmte Iabelng
a LpLA(W37V), 10-,nnute labeing
100 - LPIA(W37V), 60-rnmute labeing
* 0
0
0 20 40 60 80 100 120 140 160
[LAP2-YFP in cells, pM
Coumarin ligation yield by warvLpLA (20 ng LpLA DNA transfection):
After 10 min: 24 ± 13%
After 60 min: 53 ± 26%
Coumarin ligation yield by w7nLplA (200 ng LpIA DNA transfection):
After 10 min: 18± 11%
After 60 min: 44± 16%
Figure 2-19. Estimation of coumarin ligation yields in cells. A) HEK cells co-expressing LAP2-YFP and
either LpAW37V or LplAW37 1 were labeled with coumarin-AM 2 for 10 or 60 minutes. Average coumarin
and YFP epifluorescence intensities were collected for -40 single cells for each condition, and converted
into absolute concentrations by comparison to purified YFP and LAP2-coumarin 4 reference standards of
known concentration via the wedge method. Coumarin ligation yields were estimated from the plot in B).
Errors, ± 1 s.d.
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Conclusion
In summary, we have developed a new peptide-based protein labeling technology that
can be used inside living mammalian cells. The method is based on an engineered fluorophore
ligase, which is derived from an E. coli enzyme lipoic acid ligase. Through structure-guided
mutagenesis, we have created mutant ligases that are capable of recognizing a 7-
hydroxycoumarin substrate and catalyzing its covalent conjugation to a 13 amino-acid LplA
acceptor peptide. Using a membrane-permeable variant of the coumarin probe, we showed that
coumarin fluorophore ligation can occur in cells under labeling time as short as 10 min, and that
it is highly specific for LAP fusion proteins over other cellular endogenous proteins. We
characterized coumarin ligation kinetics and sequence specificity in vitro, as well as labeling
specificity, sensitivity, and yields in mammalian cells.
In addition to the work presented in this chapter, Katie White performed a side-by-side
comparison of specificity, sensitivity, and toxicity of coumarin labeling to the FlAsH labeling
methodology (27). FlAsH utilizes tight binding between a tetracysteine-containing peptide and
biarsenical dyes, and is the gold standard for peptide-directed labeling methods that work inside
cells. Katie found that, compared to FlAsH, coumarin labeling is more specific, similarly
sensitive (both methods can detect ~10 pM protein with signal-to-noise ratio of ~2:1), and
considerably less toxic. FlAsH has some advantages over coumarin labeling in that there is no
need to introduce an additional transgene construct (i.e. the ligase) to the cells, and there exist
many fluorescent biarsenical dyes spanning the blue, green, and orange-emitting regions that can
be used for labeling and imaging.
The next chapter presents the extension of coumarin labeling methodology to detection of
different proteins in various cell types and compartments of the cell, the utility of coumarin
ligase in imaging the nuclear pool of p-actin, and a modification to the coumarin structure to
allow for visualization of proteins in acidic cellular organelles.
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Experimental methods
Cloning
Constructs used in this study are summarized in Table 2.
General synthetic methods
Chemicals were purchased from Sigma-Aldrich, Alfa Aesar, or TCI America unless specified
otherwise. Analytical thin layer chromatography was performed using 0.25 mm silica gel 60 F25 4
plates and visualized with p-anisaldehyde, bromocresol green, or short and long-wavelength UV
light. Flash column chromatography was performed using silica gel (ICN SiliTech 32-63D).
Mass spectra were recorded using electrospray ionization (ESI) on an Applied Biosystems 200
QTRAP Mass Spectrometer. NMR spectra were recorded on a Varian Mercury 300 MHz
instrument or a Bruker AVANCE 400 MHz instrument. Chemical shifts were reported in delta
units, parts per million (ppm), and referenced to the residual solvent peak (CD 30D or CDCl 3).
Coupling constants (J) are reported in hertz (Hz). The following abbreviations for multiplets are
used: s, singlet; d, doublet; dd, doublet of doublets; t, triplet; m, multiplet.
Synthesis of coumarin probes and AM (acetoxymethyl) derivatives
HO 0 00
HO 0 H2N fA.lOH HO H 0
0 0;TEA, 30 OC n N OH
To a solution of 7-hydroxycoumarin-3-carboxylic acid, succinimidyl ester (5.0 mg, 16.4
pmol, from AnaSpec) in dry DMF (250 pl) was added 5-aminovaleric acid (49.2 tmol) and
triethylamine (4.5 pL, 32.8 pmol). The reaction proceeded for 12 hours at ambient temperature
in the dark. The reaction mixture was diluted with ethyl acetate and IM HCl. Layers were
separated, and the aqueous layer was extracted with ethyl acetate three times. The combined
organic layer was washed with brine, dried over magnesium sulfate, and concentrated in vacuo.
The residual oil was purified using preparatory-scale thin-layer chromatography (silica: 90:5:5
ethyl acetate:methanol:acetic acid). ESI-MS characterization gave:
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Coumarin 4 (n=4): ESI-MS 304.14 observed; 304.09 calculated for [M-H]-. 'H NMR for
Coumarin 4 (CD 30D, 300 MHz): 8.75 (s, 1H), 7.66 (d, IH, J=8.7), 6.87 (dd, IH, J=2.1, 8.6),
6.76 (d, IH, J=1.8), 3.54 (m, 2H), 2.31 (t, 2H), 1.68 (m, 4H).
HO CO 
O Q 0
0-
HO 0 0 >"-0 Br 0
H Coumann-AM
N4 OH DIEA, RT +
0 0
0
Coumarin-AM2
To a solution of Coumarin 4 (20 mg, 65.6 pmol) in dry DMF (600 pl) was added NN-
diisopropylethylamine (600 p1) and bromomethyl acetate (25.7 pl, 262.3 pmol). The reaction
was monitored by thin layer chromatography (5% methanol in ethyl acetate). Coumarin-AM (Rf
0.67; DMF removed in vacuo) was formed in quantitative yield within 15 minutes. Overnight
stirring at 23 0C allowed formation of Coumarin-AM2 (Rf 0.91; DMF removed in vacuo). The
reaction mixture was condensed under reduced pressure and the resulting residue was dissolved
in dichloromethane. The crude mixture was purified by silica chromatography (20-50% ethyl
acetate in hexane). Purified probes were stored as 100 mM stock solutions in DMSO at -20 'C.
Coumarin-AM: ESI-MS 376.18 observed; 376.35 calculated from [M-H]-. 'H NMR
(CDCl 3, 400 MHz): 8.83 (s, 1H), 7.57 (d, IH, J=8.5), 6.89 (dd, 1H, J=2.4, 8.5), 6.86 (d, 1H,
J=2.3), 5.74 (s, 2H), 3.47 (m, 2H), 2.42 (t, 2H), 2.11 (s, 3H), 1.71 (m, 4H).
Coumarin-AM2: ESI-MS 450.42 observed; 450.41 calculated from [M+H]*. 'H NMR
(CDCl 3, 400 MHz): 8.86 (s, 1H), 8.79 (m, 1H), 7.64 (d, 1H, J=8.4), 7.07 (m, 1H), 5.84 (s, 2H),
5.75 (s, 2H), 3.48 (m, 2H), 2.44 (t, 2H), 2.16 (s, 3H), 2.13 (s, 3H), 1.72 (m, 4H).
Protein expression and purification. LplA variants were expressed in E. coli BL21-DE3 with
IPTG induction as previously described (5). After Ni-NTA purification, LplA enzymes were
stored in 20 mM Tris pH 7.5, 1 mM DTT and 10% glycerol in aliquots at -80 'C.
In vitro coumarin ligation reactions (Figure 2-5). Reaction conditions were as follows: 150 ptM
LAP2 synthetic peptide (GFEIDKVWYDLDA, synthesized by the Tufts Peptide Synthesis Core
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Facility) was incubated with 5 ptM LplA (W37V, W371, or wild-type), 500 p.M coumarin 4
probe, 5 mM ATP, and 5 mM Mg(OAc) 2 in 25 mM Na2HPO4 pH 7.2 at 30 'C for 2 hours.
Reactions were quenched with EDTA (Cf 100 mM) and analyzed on a Varian Prostar HPLC
using a reverse-phase C18 Microsorb-MV 100 column (250 x 4.6 mm). Chromatograms were
recorded at 210 nm. We used a 10-minute gradient of 30-60% acetonitrile in water with 0.1%
trifluoroacetic acid at 1 ml/minute flow rate. LAP2 has the retention time of 7 minutes under this
gradient; upon conjugation to coumarin 4, the retention time is shifted to 9 minutes.
Mass spectrometric analysis (Figure 2-6)
Starred peaks from Figure 2-5 were manually collected and injected onto an Applied Biosystems
200 QTRAP mass spectrometer. The flow rate was 10 pl/min and mass spectra were recorded
under the positive-enhanced multi-charge mode.
Kinetic measurements (Figure 2-7)
Km and kcat values were determined using coumarin 4 probe and LAP2 synthetic peptide. 2 p.M
W37vLpIA or W371LpIA was combined with 150 p.M LAP2, 1 mM ATP, and 5 mM Mg(OAc)2 in
25 mM Na2HPO 4 pH 7.2. Coumarin 4 concentrations ranged from 12.5 to 500 pM for the
w37vLpIA measurements, and from 16 to 1600 pM for W37ILpIA. Aliquots were removed and
quenched with EDTA at points when the product conversion did not exceed 10%. Conversion
was determined by HPLC analysis as described for "In vitro coumarin ligation reactions" above.
To compensate for differences in extinction coefficients of LAP2 and LAP2-coumarin 4
conjugate, a calibration curve was obtained that correlated the ratio of integrated HPLC peak
areas of LAP2:LAP2-coumarin 4 conjugate to the actual peptide concentration ratio. The amount
of product obtained at each time point was plotted against time to obtain the initial velocity (Vo)
for each concentration of coumarin 4. Vo values were then plotted against coumarin 4
concentration and fit to the Michaelis-Menten equation (Vo = Vmax [coumarin 4 ]/(Km +
[coumarin 4])), using Origin 7.0 software. From the Vmax value, kcat was calculated using the
equation Vmax= kcat [E]total.
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Mammalian cell culture
HEK, HeLa, and COS-7 cells were cultured in Dulbecco's modified Eagle medium (DMEM;
Cellgro) supplemented with 10% v/v fetal bovine serum (FBS; PAA Laboratories). All cells
were maintained at 37 'C and under 5% CO2. For imaging, cells were plated as a monolayer on
glass cover slips. Adherence of HEK cells was promoted by pre-coating the coverslip with 50
pig/ml fibronectin (Millipore).
Coumarin labeling of mammalian cell lysate (Figure 2-8).
HEK cells expressing LAP2-YFP (or LAP2(K-+A)-YFP) were lysed under hypotonic conditions
in 1 mM HEPES pH 7.5 with 5 mM MgCl 2 , 1 mM phenylmethylsulphonyl fluoride, and protease
inhibitor cocktail (Calbiochem). After three cycles of freeze-thaw, cells were mixed by vortexing
for 2 minutes. Lysate was cleared by centrifugation and stored in aliquots at -80 'C. To label
with coumarin or lipoic acid, lysates were incubated with 200 nM LplA, 500 piM coumarin 4 or
250 piM lipoic acid, 1.5 mM ATP, and 5 mM Mg(OAc) 2 in 25 mM Na2HPO 4 pH 7.2. After
overnight incubation at 30 'C, reactions were boiled in protein loading buffer containing 2-
mercaptoethanol for 7 minutes, then separated on a 12% SDS-PAGE gel. Coumarin fluorescence
was visualized on an Alpha Innotech Chemilmager 5500 instrument using 365 nm UV light for
excitation.
Western blotting of mammalian cell lysate (Figure 2-8).
Lysates were labeled with coumarin 4 or lipoic acid as described above, boiled, run on a 12%
SDS-PAGE gel, and transferred onto a nitrocellulose membrane. The membrane was blocked
with 3% BSA solution in TBS + 0.5% Tween-20 (TBS-T) for 1 hour. For anti-lipoic acid
blotting, the membrane was incubated with rabbit polyclonal anti-lipoic acid antibody
(Calbiochem) in 3% BSA in TBS-T at 1:1000 dilution for 40 minutes, followed by three five-
minute washes with TBS-T. The membrane was then incubated with anti-rabbit horseradish
peroxidase conjugate (Bio-Rad) in 3% BSA in TBS-T at 1:20,000 dilution for 40 minutes,
followed by washes with TBS-T. The blots were developed using Supersignal West Femto
substrate (Pierce) and visualized on an Alpha Innotech Chemilmager 5500 instrument.
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Fluorescence imaging
Cells were imaged in Dulbecco's Phosphate Buffered Saline (DPBS) in epifluorescence or
confocal modes. For epifluorescence imaging, we used a Zeiss AxioObserver inverted
microscope with a 40x or 63x oil-immersion objective. Coumarin (400/20 excitation, 425
dichroic, 435/30 emission), YFP/FlAsH (493/16 excitation, 506 dichroic, 525/30 emission),
mCherry/Alexa Fluor 568 (570/20 excitation, 585 dichroic, 605/30 emission), Alexa Fluor 647
(630/20 excitation, 660 dichroic, 680/30 emission) and differential interference contrast (DIC)
images were collected and analyzed using Slidebook software (Intelligent Imaging Innovations).
For confocal imaging, we used a Zeiss Axiovert 200M inverted microscope with a 40x oil-
immersion objective. The microscope was equipped with a Yokogawa spinning disk confocal
head, a Quad-band notch dichroic mirror (405/488/568/647), and 405 (diode), 491 (DPSS), and
561 nm (DPSS) lasers (all 50 mW). Coumarin (405 laser excitation, 445/40 emission), YFP (491
laser excitation, 528/38 emission), mCherry/Alexa Fluor 568 (561 laser excitation, 617/73
emission), and DIC images were collected using Slidebook software. Fluorescence images in
each experiment were normalized to the same intensity ranges. Acquisition times ranged from
10-1000 milliseconds.
The wedge method to estimate intracellular concentrations of coumarins (Figure 2-11)
Untransfected HEK cells were incubated with coumarin-AM 2 as described in the figure legend.
After brief washing to remove excess coumarin-AM 2 from the labeling solution, epifluorescence
images were immediately acquired in DPBS at 40x magnification. We used the "wedge method"
(5) to estimate absolute concentrations of coumarin and LAP2-YFP inside single cells. In
parallel, a wedge-shaped microchamber was constructed from three glass coverslips. The length
along the x direction was 5 mm and the height of the chamber (z-direction) increased linearly
from 0 to 150 gm. The chamber was filled with 10 pM coumarin 4 probe in PBS pH 7.4. The
fluorescence of the wedge was imaged under conditions identical to those used for cellular
imaging. We assumed an average cell thickness of 5 pm and therefore interpolated to the region
of the wedge with thickness of 5 pm and used coumarin fluorescence intensities measured there
as reference standards for their concentrations in single cells.
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General protocol for coumarin labeling in living cells
HEK cells were transfected at ~70% confluency with expression plasmids for LplAW37V (20 ng
for a 0.95 cm2 dish) or LplAW37 (200 ng for a 0.95 cm 2 dish) and the LAP2 fusion protein of
interest (400-600 ng) using Lipofectamine 2000 (Invitrogen). 8-24 hours after transfection, cells
were incubated with 20 pM coumarin-AM 2 in serum-free DMEM (Dulbecco's modified Eagle
medium, Cellgro) for 10 minutes at 37 'C. 0.1% w/v Pluronic F-127 (Invitrogen) can be
optionally added to the labeling solution to give more even coumarin distribution in cells. The
media was then replaced 3-4 times over 30-60 min at 37 'C, with DMEM supplemented with
10% FBS (Fetal Bovine Serum), to wash out excess coumarin.
Estimation of coumarin labeling sensitivity in cells (Figure 2-18)
HEK cells were transfected with LpIAW37 and LAP2-YFP plasmids as described. Twelve hours
after transfection, cells were labeled with coumarin-AM 2 as described above for 10. After 1-hour
washing, epifluorescence images were acquired in DPBS at 40x magnification. Next, we used
the wedge method was used to estimate intracellular YFP concentrations. A wedge-shaped
microchamber was constructed from three glass coverslips as described above, and filled with
pM purified YFP solution. The fluorescence of the wedge was imaged under conditions identical
to those used for cellular imaging. We assumed an average cell thickness of 5 gm and therefore
interpolated to the region of the wedge with thickness of 5 ptm and used YFP fluorescence
intensities measured there as reference standards for their concentrations in single cells.
Coumarin signal-to-noise of labeling is defined by background-corrected coumarin fluorescence
on YFP-expressing cells over background-corrected coumarin fluorescence on untransfected
cells. Background is defined by fluorescence detected in the non-cell area under imaging
conditions identical to coumarin imaging.
Quantitation of PRIME labeling yield (Figure 2-19)
HEK cells were transfected with LplAw37V or LplAW371 and LAP2-YFP plasmids as described.
12 hours after transfection, cells were labeled with coumarin-AM 2 as described above for 10 or
60 minutes. After washing, epifluorescence images were acquired in DPBS at 40x magnification.
We used the wedge method to estimate absolute concentrations of coumarin and LAP2-YFP
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inside single cells. Here, the wedge-shaped microchamber was filled with 9 pM purified YFP
and 12 pM purified LAP2-coumarin-4 conjugate in PBS pH 7.4. The fluorescence of the wedge
was imaged under conditions identical to those used for cellular imaging. We assumed an
average cell thickness of 5 pm and therefore interpolated to the region of the wedge with
thickness of 5 pm and used YFP and coumarin fluorescence intensities measured there as
reference standards for their concentrations in single cells. The ratio [coumarin]/[LAP2-YFP]
represented coumarin ligation yield in cells. Data for each enzyme and coumarin incubation time
(10 or 60 minutes) were obtained from ~40 cells.
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Chapter 3
Generality and applications of a coumarin fluorophore ligase for specific protein labeling
The work discussed in this chapter has been published in part in: C. Uttamapinant, K. A. White,
H. Baruah, S. Thompson, M. Fernandez-Suirez, S. Puthenveetil, and A. Y. Ting, "A Fluorophore
ligase for site-specific protein labeling inside living cells", Proc Acad Nat Sci 2010 (107),
10914-10919; and X. Jin, C. Uttamapinant, and A.Y. Ting, "Synthesis of 7-aminocoumarin via
Buchwald-Hartwig cross coupling for specific protein labeling in living cells," Chembiochem
2011 (12), 65-70. Xin Jin performed the synthesis and in vitro characterization of 7-
aminocoumarin.
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Introduction
In the previous chapter, we describe the development of a coumarin fluorophore ligase
that can be used for site-specific labeling of proteins inside cells. We describe here further
explorations of utilities of the coumarin ligase. First, we demonstrate the general applicability of
coumarin ligase by performing labeling on different proteins in the cytosol and nucleus of
various mammalian cell types. Second, we show that coumarin ligase can be used in conjunction
with E. coli biotin ligase to produce orthogonal labeling on two different proteins in the same
cell. Third, to highlight the advantage of using a peptide-directed protein labeling method, we
used coumarin ligase to label and image the nuclear pool of f-actin, a controversial actin pool
that has been difficult to study due to the lack of suitable tagging methods. Lastly, we explored
coumarin labeling within the oxidizing environment of the cell's secretory pathway, as well as
coumarin imaging in the acidic environment of the endosomes. The very last effort of coumarin
imaging in acidic organelles requires a synthesis of a novel coumarin fluorophore, 7-
aminocoumarin, whose fluorescence is not sensitive to pH changes. The synthesis of 7-
aminocoumarin was accomplished by Xin Jin via a novel, efficient synthetic route that makes
use of palladium-catalyzed Buchwald-Hartwig cross coupling.
Overall, the work in this chapter represents our efforts towards expanding the utilities of
coumarin ligase to encompass labeling of different proteins in all compartments of the cell, as
well as demonstrating how coumarin ligase can be used to gain new biological insight that other
protein labeling methods, including fluorescent proteins, cannot provide.
Intracellular coumarin ligation in different cell types, subcellular compartments, and on
various proteins
To test the generality of intracellular coumarin ligation, we labeled LAP2 fused to
different localization sequences, proteins, and in different cell types. First, we performed
coumarin labeling on LAP2-YFP targeted to different cellular compartments. For targeting to
cell nuclei, LAP2-YFP was fused to three tandem SV40 nuclear localization sequences (NLS)
(1). For expression in the cytosol, LAP2-YFP was fused to a nuclear export signal (NES) from
HIV Rev protein (2). For targeting to the cytosolic side of the plasma membrane, LAP2-YFP
was expressed with a C-terminal CAAX prenylation motif (3). Coumarin labeling in all cases
produced expected localization patterns based on the targeting sequences (Figure 3-1), providing
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additional evidence of labeling specificity onto LAP-tagged proteins, since the ligase itself is
untargeted.
In addition, LAP2 was fused to the N-terminus of p-actin and microtubule-associated
protein 2 (MAP2), and the C-terminus of an intermediate filament protein vimentin. In each case,
co-expression of coumarin ligase (either LplAW3 7V or LplAW7 1) and addition of coumarin-AM 2
allowed specific, localized coumarin labeling onto LAP2 fusion proteins (Figure 3-1, images
shown for labeling with LplAW37V). LAP2 thus was shown to be a transposable peptide tag,
capable of giving strong labeling when fused to either the N- or C-terminus of a protein.
LAP2-NES LAP2-CAAX LAP2-NLS LAP2- actin Vimentin-LAP2 LAP2-MAP2
Coumarin
Coumarin + DIC
Figure 3-1. Coumarin labeling of different LAP2 fusion proteins. NES = nuclear export sequence. CAAX
= prenylation tag. NLS = nuclear localization sequence. MAP2 = microtubule-associated protein 2.
Indicated cell types expressing LplAW37v and the desired LAP2 fusion protein were labeled with
coumarin-AM 2 for 10 min. Confocal images are shown. Scale bars, 10 pim. Figure credit: the NES, NLS,
and CAAX images were generated by Katie White.
Nuclear LAP2-YFP could also be labeled with coumarin in all five mammalian cell types
we tested: HEK, human cervical cancer cells (HeLa), African Green Monkey kidney fibroblast
cells (COS-7), Chinese hamster ovary cells (CHO-KI) and mouse embryonic fibroblast cells
(NIH-3T3) (Figure 3-2). Coumarin labeling efficiency varies in different cell types, which can be
attributed to different transgene expression levels in each cell type. HEK, HeLa, and COS-7 cells
were generally transfected to greater efficiency than CHO-KI and NIH-3T3, and produced
strong co-expression of both the ligase and the LAP2 fusion protein. Exploration of other
transfection means could improve coumarin labeling efficiency in CHO-KI and NIH-3T3 cells.
Unfortunately, Katie White showed that we were not able to use coumarin ligase to label
proteins along the cell's secretory pathway, such as in the endoplasmic reticulum (ER) or in the
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Golgi apparatus. The reason(s) why coumarin ligase has reduced activity within such
environment is still unclear. It is thought that the ER's oxidizing environment could cause
coumarin ligase to dimerize or aggregate, via intermolecular disulfide bond formation. However,
mutagenesis to remove potential surface-exposed cysteine candidates did not restore the
enzyme's activity. Similarly, removal of the ligase's potential glycosylation site via mutagenesis
did not improve the ligase activity. We then suspected that other factors intrinsic to the
environment of the ER might inhibit coumarin ligase activity. Particularly, the ER and Golgi are
the main cellular storage centers for Ca2+, with Ca 2+ concentrations in resting stage in the range
of hundreds of pM (around 1000-10000-fold higher than that in the cytosol) (4). Ca2+ is known
to act as an inhibitor towards ATP- and Mg2+- dependent enzymes such as nucleic acid
polymerases (5,6), by competitively coordinating with ATP.
A) LAP2-YFP-NLS B) mCherry-LpiAW371
Coumarin + DIC Coumarin LAP2-YFP + DIC
HEK HEK
HeLa HeLa
COS-7 C OS7
CHO NIH 3T3
Figure 3-2. Coumarin labeling in different cell types. Cells expressing nucleus-targeted LAP2-YFP and
either LplAW3 7V (A) or mCherry-LplAW37 1 (B) were labeled with coumarin-AM 2 for 10 min. Confocal
images are shown. Scale bars, 10 pim.
To test for any effects that high Ca2+ concentrations might have on coumarin ligase
activity, we first tested whether LplA can utilize Ca2+ in place of Mg2+. It is known that LplA can
utilize other divalent cations, particularly Mn2+, in its ligation reaction, although the efficiencies
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in using these non-native cations were not characterized (7). We found that even under forcing in
vitro labeling conditions (10 pM enzyme, 100 ptM LAP2, 500 ptM probe, 1 mM ATP, 5mM
M2+), LplAwm' could not utilize Ca2+ in place of Mg2+ (Figure 3-3). Moreover, Ca was also
shown to have an inhibitory effect on LplA W37 -mediated coumarin ligation, even in the presence
of Mg2 +. We found that coumarin ligation product formation rate was reduced by -45% when
2+ 25mM Ca was supplied to the reaction containing 500 pM Mg . Ca2+ is particularly deleterious
for coumarin ligation, since in comparison, LpIA still maintains around 25% of its lipoylation
activty22
activity when Ca was used in placed of Mg . As coumarin ligation is already not very
kinetically efficient due to a much reduced turnover (kcat -0.02 s~) compared to lipoylation (kcat
= 0.22 s- ), addition of an inhibitor like Ca 2 might stall the reaction completely.
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Figure 3-3. Coumarin ligation in the presence of different cations. A) Representative HPLC traces
showing conversion to ligation product upon supplying different cations to the ligation reaction. Reaction
condition: 10 iM LplAw37 1, 100 iM LAP2, 500 iM coumarin 4, 1 mM ATP, and 5 mM MCl 2 (M = Mg,Ca, or Mn, or use 5 mM KCI). Reactions were allowed to proceed for 30 min at 30 'C before quenching
with EDTA. Reactions were performed in duplicate. B) Percent of LAP2 converted to its covalent adduct
with coumarin 4 under different cation conditions in A). Errors, ± 1 s.d.
We attempted to artificially deplete Ca2 + concentrations inside the ER through a variety
of strategies: agonist-triggered ER Ca2+ release of into the cytosol; promotion of extracellular
transport of intracellular Ca 2 concentrations using Ca 2 ionophore and EGTA-containing media;
and direct capture of intracellular Ca using a membrane-permeable Ca2 chelator. These efforts
had not resulted in observable coumarin labeling with ER-retained or cell-surface LAP. In
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unpublished work, however, Katie White has produced successful LplA-mediated labeling inside
the ER, by using a yeast display evolution method to identify a probe ligase with better ligation
kinetics to simply overcome whatever inhibitory effects are present in these subcellular
compartments. The example of successful LplA labeling inside the ER will be further discussed
in Chapter 5.
On a fortuitous side-note, Mn2+ was found to accelerate coumarin ligation compared to
Mg 2+. The increase in ligation efficiency was confirmed in a cell-surface labeling experiment on
LAP4.2-neurexin-1p, with Mn2+ giving 1.4-fold higher average signal than Mg2+ (Figure 3-4).
The use of Mn2+ in place of Mg 2+ might aid in demanding cell-surface labeling applications, such
as when the enzyme is not exogenously supplied in excess concentrations but rather, present in
small amounts through secretion or tethered to the plasma membrane of the cell.
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Figure 3-4. Coumarin labeling of cell-surface proteins with Mn 2 . A) Two different fields of view of HEK
cells expressing c-myc-tagged, LAP4.2-tagged neurexin-1p were incubated with 10 pM LplAw3 7 1, 200
pM coumarin 4, 1 mM ATP, and 5 mM of either MgCl 2 or MnCl 2 for 20 min at room temperature.
Thereafter, cells were fixed, and anti-c-myc immunofluorescence staining, with secondary antibody
conjugated to Alexa Fluor 488, was performed to detect expression levels of LAP-neurexin. Coumarin
and Alexa Fluor 488 fluorescence were collected for -25 single cells from each labeling condition to
generate the plot in B).
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Two-color orthogonal labeling with coumarin ligase and biotin ligase
It is desirable to have two orthogonal, peptide-directed labeling methods that can work
inside living cells. E. coli biotin ligase (BirA) has been demonstrated to have excellent labeling
specificity towards BirA acceptor peptide (AP)-tagged proteins inside mammalian cells (8), but
its orthogonality and compatibility with LplA-based labeling inside cells are unknown. Even
though intracellular biotin labeling of BirA can only be detected post-cell fixation via
streptavidin-probe conjugate, we still envision the addition of the second imaging color to be
useful. For example, a given protein can be tagged with both LAP2 and AP, labeled in living
cells with co-expressed coumarin ligase to study protein dynamics, then labeled with biotin/BirA
followed by post-fixation derivatization with imaging probes suitable for high-resolution
imaging modalities (e.g. cy5 for STORM superresolution imaging (9), or eosin for electron
microscopy (10)). Alternatively, two different proteins in the same cell can be tagged with LAP2
or AP; the dynamics of the first protein can be studied using coumarin ligase, while its spatial
relation to the biotin-labeled second protein can be further observed post-cell fixation.
It is not known how E. coli LpIA and BirA recognize their engineered peptides
substrates, but it is known how the two enzymes exhibit differences in their protein substrate
recognition processes. While the structures of the lipoyl domain of E2p, E2o, and H-protein, and
the biotinyl domain of biotin carboxyl carrier protein (BCCP) are quite similar, all comprised of
a flattened 7-8-stranded p-barrel with the main lipoylated or biotinylated lysine residue at the tip
of an exposed p-turn (11), subtle electronic and structural cues in these domains allow BirA and
LplA to distinguish their respective protein substrates efficiently. BirA is sensitive to residues
flanking the target lysine residue, with preference for uncharged, hydrophobic residues; in
BCCP, the motif is Met-Lys-Met. The presence of charged residues flanking the key lysine
residue in lipoyl domains (Asp-Lys-Ala) is sufficient to thwart BirA recognition of these lipoyl
domains (12). On the other hand, LpIA is more sensitive to structural cues present in its
substrate, and the presence of a thumb domain between the P2 and P3 strands in the BCCP
biotinyl domain, a motif absent from all lipoyl domains, prevents LplA recognition of the
biotinyl domain (13). It is worth noting that while the thumb domain mechanism for substrate
differentiation of the two enzymes is clearly absent when the substrates are shrunk to short
peptides, the electronic preference of each enzyme for residues flanking the key lysine is
83
preserved in the two acceptor peptides: LAP2 has the Asp-Lys-Val motif preferred by LplA; AP
has the Gln-Lys-Ile motif preferred by BirA.
To test for orthogonality of the two labeling methods, we prepared LAP and AP
constructs fused to different intracellular proteins, and expressed them inside HeLa cells along
with coumarin ligase and biotin ligase. After incubation with coumarin-AM 2 and biotin, cells
were fixed and stained with streptavidin-cy5. Figure 3-5, top row, shows that within the same
cell, nuclear-targeted LAP2-tagged YFP was selectively labeled by coumarin, whereas AP-
tagged actin was selectively labeled by cy5. Similar results were obtained when LAP2-tagged
vimentin was used in conjunction with AP-tagged actin, or when the AP and LAP2 tags were
swapped to be on vimentin and actin, respectively. Thus, coumarin ligase/LAP2 and BirA/AP
labeling systems appeared to be highly orthogonal, and simultaneous labeling and imaging of
cells with coumarin ligase and biotin ligase are feasible, without sacrificing the high specificity
of each system.
Coumarin ligase Blotin ligase
labeling labeling (cy5) coumarin + cy5
Figure 3-5. Two-color, orthogonal protein labeling with coumarin ligase and biotin ligase. HeLa cells
expressing LplAW3 7 V, BirA, and indicated LAP-tagged and AP-tagged proteins were incubated with 20
pM coumarin-AM 2 and 50 pM biotin for 20 min. Biotinylated proteins were detected post-cell fixation
via addition of streptavidin-cy5 conjugate.
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Coumarin ligase for studying the nuclear pool of actin
Introduction
Actin is the most abundant intracellular protein in most eukaryotic cells. The cellular
concentration of actin can range from 100-500 ptM, but can be as high as 5 mM at certain local
sites in the cytosol (14). p-actin, one of the six actin isoforms found most predominantly in the
leading edge of fibroblasts, constitutes the cytoskeletal microfilament network and has a well-
recognized role in the cytosol in controlling internal cell motility and morphology (15). In vitro
and in the cytosol, the monomeric form of p-actin, or G-actin, can polymerize in a concentration-
dependent manner in the presence of ATP (the in vitro critical concentration of G-actin is -100
nM (16)) to form its filamentous form, or F-actin. Despite the low critical concentration, actin
does not exist purely in its polymeric form inside cells but rather, can be sequestered in its
monomeric form by binding to more than 100 different actin-binding proteins in cells (17).
At 42 kDa, monomeric P-actin is right at the general size cut-off (-40 kDa) for passive
diffusion through the nuclear membrane (18), so such passive diffusion might be heavily
impeded by the nuclear membrane, especially if actin remains bound to other proteins. The only
known mechanism for actin nuclear import is via binding of actin to cofilin. a protein which
contains a nuclear localization sequence (19). Once actin gets inside the cell nucleus, there exist
at least two mechanisms for actin nuclear export. First, all actin isoforms contain two leucine-
rich type nuclear export sequences at its surface, which are necessary for export via exportin 1
(20). Treatment of cells with an exportin 1 inhibitor leptomycin B is known to cause actin
accumulation within the nucleus (20). Second, actin can bind to profilin and gets exported out of
the nucleus via exportin 6 (21). The presence of strong actin accumulation in the nuclei of
oocytes-the only cell system where the presence of nuclear filamentous actin has been
universally accepted and confirmed to have a functional structural support role-has been
attributed to the lack of exportin 6 expression in these cells (18,22).
Within the past few decades, p-actin in somatic cells has been implicated as a functional
component of many processes in the cell nucleus, both in its monomeric and polymeric forms.
For instance, the nuclear export of MKLI/myocardin-related transcription factor A, or MAL,
requires that it interacts with G-actin within the nucleus, and concomitant increases in cytosolic
actin levels and nuclear accumulation of MAL are required for active transcription of MAL-
responsive genes (23). Nuclear actin is associated with and is a required component for efficient
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transcription by all 3 RNA polymerases (24,25,26); in vitro transcription mediated by RNA
polymerase II and III can be inhibited by addition of anti-actin antibodies or an actin
depolymerization agent latrunculin, suggesting that the functional form of actin in the RNA
polymerase complexes might be oligomeric/polymeric (27). Other factors that regulate actin
polymerization, such as N-WASP and Arp2/3, are also found to be associated with
transcriptional complexes, further hinting at the possible participation of polymeric actin in the
process (28). Actin's important binding partner, myosin, also has an isoform called nuclear
myosin I (NM1) that is present in the nucleus. Recent evidence supports NMI function with
polymeric actin as a molecular motor which has essential roles in RNA polymerase I-mediated
transcription and active transport of chromatin within the nucleus (24). Chromatin remodeling
complexes in mammalian cells such as BAF or PBAF all contain actin and/or actin-related
proteins (Arps) as its integral, stoichiometric component (29).
Despite the accumulating biochemical data on the participation of both monomeric and
polymeric actin in machineries in the cell nucleus, actin existence in the somatic cell nuclei still
is heavily debated. The degree of acceptance varies partly, in our opinion, because the tools used
tU Uirectly visualize tle presence-anu lorm- nuclear act:-Lin iII an unbiased manner uo not
exist. Phalloidin, the most ubiquitous tool used for actin imaging, binds at the oligomerizing
interface of actin subunits in F-actin (30) and does not detect actin monomers or polymeric actin
that might exist in other forms or compositions (such as polymeric actin-cofilin rods (31)).
Several anti-actin antibodies exist, but they selectively detect certain forms of actin or epitopes
that might be masked upon actin binding to other proteins (32). For example, anti-actin antibody
clone 2G2 detects G-actin and a supposedly distinct polymeric form of actin in the nucleus, but
does not recognize F-actin (33). Phalloidin and anti-actin antibodies also require fixation, which
can disrupt actin distribution and form in cells. An actin-binding peptide called Lifeact binds to
both monomeric and polymeric actin (34) and upon fusion to fluorescent proteins can be used to
image endogenous actin in living cells. However, Lifeact does not detect some forms of stress-
induced twisted F-actin (35), and detection of monomeric actin is complicated by the likely
presence of unbound Lifeact-FP which cannot be washed away.
Fluorescent protein fusion to actin potentially allows dynamic imaging of actin in all
forms, yet such an actin fusion is shown to be functionally impaired in retrograde flow, dendritic
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cell migration, and neuronal polarization, possibly due to the large FP tag size (34). There exist
studies that make use of FP-actin to decipher the forms and polymerization state of p-actin in the
cell nuclei via fluorescence recovery after photobleaching (FRAP) (36), but usage of FPs
compounded the findings as the presence of potentially polymeric actin within the nuclei could
be artificially induced by the FP's tendency to oligomerize. Moreover, we and others have
consistently observed GFP-actin exclusion from the cell nuclei (37,36), which might stem from
its impaired binding to cofilin, a nuclear importer of actin. Co-crystal structures of monomeric
actin with the actin-depolymerizing factor-homology (ADF-H) domain-the domain of which
many actin-binding proteins including cofilin use to bind to actin-shows the binding of ADF-H
to the interface between domain I and III of actin, where the N-terminus of actin resides (38).
Therefore, introduction of a large protein tag at the N-terminus of actin should severely disrupt
actin binding to cofilin and prevent actin's nuclear entry. It is also known that the nuclear import
of Actin-related protein 5 (Arp5), which shares significant sequence and structural homology to
actin and uses the same nuclear export mechanism, is impaired by fusion to GFP (39).
Imaging nuclear actin with coumarin ligase
We have made a fortuitous discovery that in HeLa and COS-7 cells, overexpressed,
coumarin-labeled LAP2-p-actin did not show the nuclear exclusion pattern routinely observed
when using p-actin fused to a fluorescent protein. Presumably, the use of a small peptide tag
fusion to actin still allows actin to bind to cofilin and permits nuclear entry. Coumarin ligase
labeling of LAP2-p-actin thus might allow global, live-cell imaging of actin, including the
nuclear pool, with minimal functional perturbation. To visualize coumarin labeling of nuclear
actin, we co-transfected cells with YFP fused to histone 2B (H2B-YFP) to serve as a nuclear
marker, and used confocal microscopy to ensure unambiguous sectioning through the nucleus,
and for higher resolution. Figure 3-6 shows coumarin signal (from LplAW37v labeling) clearly
overlapping with YFP of the nuclear marker in COS-7 cells. Nuclear coumarin labeling appeared
as a diffuse staining pattern, with no obvious polymeric structures. Though actin was
overexpressed in these experiments, the diffuse coumarin labeling pattern suggests that nuclear
actin may exist predominantly as monomers or short oligomers.
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coumarin-P-actin H2B-YFP + DIC
Figure 3-6. Coumarin labeling of LAP2-tagged p-actin in HeLa cells. Labeling was performed with co-
expressed LplAW3 7V. Histone 2B-YFP (H2B-YFP) serves as a transfection marker. Confocal images are
shown.
To confirm that the nuclear actin labeling observed with coumarin ligase was not a
labeling artifact arisen via using this particular labeling method, we prepared two additional
recombinant p-actin constructs bearing a small peptide tag at their N-termini: one with a 12-
amino acid tetracysteine (Cys 4) peptide, which can be labeled with FlAsH in living cells (40);
and the other with a 9-amino acid human influenza hemagglutinin (HA) epitope tag, which can
be detected post-fixation with an anti-HA antibody. The three actin constructs bearing small
peptide tags (LAP2, Cys4, and HA) were labeled using their respective means, and their
subcellular localizations were also compared to an actin construct fused to a monomeric orange
fluorescent protein, mApple (41). Figure 3-7 shows labeling and imaging of these constructs in
HeLa cells. Aside from the usual actin filamentous features in the cytosol, the three small-tag
methods all produced diffuse labeling pattern of actin in the cell nuclei. mApple-actin, on the
other hand, was clearly excluded from the cell nuclei.
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Figure 3-7. Effects of label size to nuclear entry of -actin in HeLa cells. Coumarin ligase, FlAsH, and
immunostaining are all small-tag labeling methods with tag sizes of 9-13 amino acids which do not
interfere with actin's nuclear entry. Fusion of mApple to actin adds 238 amino acids as a payload, and
results in nuclear exclusion of actin.
To further validate coumarin labeling on LAP2-p-actin as a viable method for actin
visualization, we directly compared, in the same cell, coumarin-labeled actin to two traditional
means for actin imaging: phalloidin and antibody staining in the same cell, both performed after
cell fixation. Fiure 3-8 shows that the coumarin signal on actin overlaps well with the other two
stains and clearly highlights actin stress fibers and cortical actin, but has the additional benefit of
compatibility with imaging in living cells.
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Fiure 3-8. Additional validations of coumarin ligase as an actin visualization method. Coumarin labeling
was performed in live COS-7 cells expressing HA-LAP2-p-actin. After cell fixation, actin of the same
cell sample was further detected by staining with phalloidin-Alexa Fluor 647 and anti-HA antibody.
We have also observed that coumarin-labeled actin in early-passage HeLa cells (< 20
passages) showed a markedly different nuclear actin accumulation than very late-passage HeLa
(estimated to be > 40 passages). While nuclear actin in younger HeLa cells had diffuse staining
pattern at similar fluorescence intensity levels to the diffuse labeling patterns of actin in the
cytosol, nuclear actin in older HeLa cells showed much stronger nuclear accumulation, with a
fraction of cells even showing some higher-ordered structures, such as filaments (Figure 3-9).
Indeed, nuclear accumulation of actin has been previously reported as a marker for cellular
senescence (42), and is thought to be related to higher levels of dephosphorylated cofilin (43), a
form of cofilin that actively performs nuclear actin import, as a result of reduced activity of LIM-
kinase I (an actin-binding kinase) in senescence cells (42).
Courmarin
(focal plane 1)
Coumarin
(focal plane 2)
F igure 3-9. An example of coumarin-labeled filamentous p-actin structures in the nuclei of late-passage
HeLa cells. Two focal planes of coumarin images are shown to highlight the perinuclear (left) and pan-
nuclear, criss-cross (right) actin filaments in the same cell nucleus. The nuclear actin pattern can be
compared to more diffused, unstructured pattern in younger HeLa cells shown in Figures 3-6 and 3-7.
Cm rin Phalinidin anti-HA
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Imaging nuclear actin upon heat-shock treatment
Previous work has shown that cell stress, such as heat shock, can increase the abundance
of nuclear actin (44). The molecular mechanisms underlying such actin translocation from the
cytosol to the nucleus are not known, but could be related to heat shock-induced cofilin
dephosphorylation (45) and subsequent nuclear accumulation of cofilin, or to global syntheses of
heat-shock proteins upon stress, one of which (Hsp90) is known to function in
nucleocytoplasmic shuttling of other proteins (46) and is confirmed to be an actin-binding
protein (47). We therefore imaged actin after 30-90 min of heat shock (43 'C), and indeed found
that coumarin-labeled actin accumulates in the nucleus within 30 min (Figure 3-10A). In
contrast, mApple-actin accumulation in the nucleus following heat shock treatment was much
slower. In a small fraction (< 10%) of heat-shocked cells, we observed interesting coumarin-
labeled nuclear actin structures, such as filamentous nuclear actin, and actin localized to the
nucleoli (Figure 3-101B). The filamentous nuclear actin structure was confirmed to have F-actin
morphology via phalloidin staining (Figure 3-10C). The heterogeneity of coumarin-labeled
nuclear actin patterns in stress cells contrasted with the uniformly diffuse distribution of nuclear
actin in non-stressed cells, as well as mApple-actin in the nuclei of stress cells.
It remains unclear why nuclear actin would exhibit such heterogeneous morphologies
upon heat shock, and what the significances of these structures are. Filamentous nuclear actin
might simply occur as a result of such high nuclear accumulation of monomeric actin upon heat
shock, with inadequate amounts of actin-binding proteins inside the nucleus such that its
concentration exceeds actin's critical concentration of polymerization. Actin clusters in the
nucleolus, on the other hand, could have a biological role, as it is known that actin works in
concert with NM1 to regulate transcription of ribosomal genes in the nucleolus (48).
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Figure 3-10. Imaging of nuclear actin upon heat shock treatment. A) Comparison of mApple- and
coumarin-labeled-p-actin in COS-7 cells before and after heat shock. Coumarin labeling was performed
for 10 minutes with W37vLplA prior to heat shock at 43'C for 30-90 minutes. B) Examples of nuclear
actin structures seen in some cells after heat shock treatment. The top panel shows filamentous actin in
the cell nucleus, while the middle and bottom panels show actin residing in the nucleoli. C) Phalloidin-
Alexa Fluor 647 staining of LAP2-0-actin after cell fixation shows that filamentous nuclear actin has F-
actin morphology. Prior to fixation, these COS-7 cells were labeled with coumarin and heat-shocked for
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60 minutes. Confocal images are shown in A) and B); epifluorescence images are shown in C). H2B-YFP
serves as the nuclear YFP marker in all images. All scale bars, 10 pm.
Imaging SUMOylation-deficient actin with coumarin ligase
It has been postulated that certain posttranslational modifications on actin also regulate its
nucleocytoplasmic shuttling. Particularly, the modification with small ubiquitin-like modified
(SUMO), or SUMOylation, can occur on p-actin at lysine 68 and lysine 284, and is thought to
have connections to actin's nuclear functions (49). Mutagenesis studies at the two SUMOylated
lysine sites showed that SUMOylation of actin is important for the retention of actin in the
nucleus: actin fused to YFP and a nuclear localization sequence (NLS) was shown to have strong
nuclear accumulation, whereas a K68R K284R double mutant of YFP-NLS-actin caused actin to
be nuclear-excluded (49). The nuclear retention of SUMOylated actin seems to be a result of
SUMO's interference with actin binding to exportin 1 (49).
Coumarin Coumarin
(field of view 1) (field of view 2)
Figure 3-11. Coumarin labeling on SUMOylation-deficient actin. HeLa cells expressing LplAw37 and
LAP2-0-actinK6 8R,K284R were labeled with coumarin-AM 2 for 10 min. Coumarin labeling on this actin
mutant appears identical to labeling on LAP-tagged wild-type actin. We did not observe the expected
nuclear exclusion of P-actinK68 RK 2 8 4 R.
We were interested to see how mutagenesis to the SUMOylation sites would affect
shuttling of coumarin-labeled LAP2-j-actin, and prepared the K68R K284R double mutant of
LAP2-actin. However, upon imaging, we found that both wild-type LAP2-actin and LAP2-
actinK68R, K284R exhibited identical nucleocytoplasmic distribution (Figure 3-1), in contrast to the
expected result of LAP2-actin K68R, K284R showing more nuclear exclusion. Our result is in striking
contrast with the aforementioned study that made use of YFP-NLS-actin, where SUMOylation
deficiency on YFP-NLS-actin apparently overrode the typically strong NLS-directed nuclear
import and caused nuclear export phenotype. We did not further investigate the reason(s) behind
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the differences in shuttling behaviors of LAP2-actin and FP-actin with the SUMOylation-
deficient mutations.
Visualizing polymeric nuclear actin using Forster resonance energy transfer
We have also started to investigate the possibility of using intermolecular F6rster
resonance energy transfer (FRET) between coumarin-labeled actin monomer and fluorescein-
labeled actin monomer (labeled via FlAsH) as a readout for the actin polymerization state inside
the nucleus. The distance between actin monomers in F-actin of 55 A is within the typical range
for FRET to occur (10-100 A) (50). An intermolecular FRET reporter for actin polymerization
has been developed previously, using CFP- and YFP-tagged actin (50), but an FP-based reporter
will have problems related to nuclear entry and is not suitable for nuclear actin studies.
Coumarin-fluorescein has been used as a successfully FRET donor-acceptor pair, owing partly to
coumarin's high quantum yield of 0.7 (51). However, LAP2-ligated coumarin and Cys4-bound
biarsenical fluorescein will likely have a lower FRET efficiency compared to free coumarin-
fluorescein, due to the red-shifted excitation maximum of biarsenical fluorescein (508nm (52),
compared to the 494 nm excitation maximum of fluorescein), and the photoinduced electron
transfer-based quenching of coumarin by a Trp residue in LAP2, which acts as a competing
pathway to deactivate the excited states of the coumarin donor.
Preliminary cellular FRET experiments showed that we could label coumarin and
fluorescein onto their respective tagged actins in the same cell with high specificity, and there
were increases in coumarin/fluorescein emission ratios along the actin stress fibers, as well as
within the nucleus, indicative of FRET and actin's polymeric state in the nucleus (Figure 3-12).
However, the emission ratio change along stress fibers and in the nuclei is not very high (~15%),
and we also observed high FRET background in the mitochondria. Daniel Liu recently
discovered that substitution of a +2 Trp residue of LAP2 with a Phe residue does not
dramatically affect probe ligation kinetics on LAP2, and ligation-dependent fluorescence
quenching is reduced from 80% with LAP2, to -30% with LAP2 Trp--Phe (Dan Liu, unpublished
observations). Using coumarin-labeled LAP 2Trp-Phe in conjunction with FlAsH labeling might
permit a more sensitive FRET detection of actin polymerization state in the cell nucleus.
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(Intensity-modulated
coumarin FlAsH Display mode)
Excitation: 405 nm 491 nm 405 nm
Emission: 445 nm 528 nm 528 nm
Figure 3-12. FRET imaging of HeLa cells transfected with LAP2-actin and Cys 4-actin. The coumarin
image (left) and the FlAsH image (middle) represent LAP-actin and Cys4-actin distributions, respectively.
The bar on the top right of the FRET image (right) shows the correlation between FlAsH/coumarin
emission ratio and cell pseudocolor. Warmer hue indicates higher FRET.
Developing 7-aminocoumarin ligase for protein labeling and imaging in acidic organelles
(This work was done in collaboration with Xin Jin)
One limitation of the 7-hydroxycoumarin probe used thus far in our studies is its pH-
dependent fluorescence. The 7-phenoxy substituent has a pKa of 7.5 (53), and the fluorophore is
only emissive in its anionic form. Proteins labeled with 7-hydroxycoumarin (on the extracellular
side of the cell surface, or the luminal side of the secretory pathway) therefore cannot be
visualized in acidic compartments of the cell such as the endosomes (pH 5.5-6.5 (54)) and
lysosomes (pH 5 (55)), where > 90% of the fluorophore is expected to be in its neutral, non-
fluorescent form. This problem impedes the potential use of the 7-hydroxycoumarin ligase in
studies of regulated endocytosis of receptors or host-pathogen interactions. We therefore sought
to identify a coumarin derivative that would be bright in the entire physiological pH range of 5.5-
8.
A potential solution is to use 6,8-difluoro-7-hydroxycoumarin (Pacific Blue) (Figure 3-
I 3A, middle structure), which has a reduced phenoxy pKa of 3.7 (53). However, we found that
our existing coumarin ligases, LpIAW37v or LplAw37 1, do not efficiently ligate the isosteric
Pacific Blue substrate onto LAP2. We postulated that the coumarin ligase active site prefers an
uncharged, hydrophobic substrate, and rejects Pacific Blue, which predominantly exists in its
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anionic form at physiological pH. Dr. Justin Cohen and Samuel Thompson later discovered a
ligase double mutant, LplAE20G,W37 T, which is capable of efficiently ligating Pacific Blue (56).
The E20G mutation is thought to remove repulsive electrostatic interactions with Pacific Blue,
while the W37G mutation sufficiently enlarges the binding pocket for Pacific Blue to fit in.
An alternative coumarin structure that we decided to explore is 7-aminocoumarin (Figure
3-13A, right structure). In contrast to 7-hydroxycoumarin and Pacific Blue, 7-aminocoumarin is
expected to be both neutral and highly fluorescent over a wide range of pH values. We also
predicted that it would be a good substrate for our existing coumarin ligases, since it is sterically
similar to 7-hydroxycoumarin and is uncharged at physiological pH. However, the synthesis of
7-aminocoumarin that is isosteric to our 7-hydroxycoumarin is not straightforward. Previous
synthetic routes to 7-aminocoumarin derivatives have used either Pechmann (57) or Perkin (58)
condensation. The former reaction condenses aminoresorcinol with p-ketoesters and unavoidably
produces 4-alkyl substituted aminocoumarins. The latter reaction condenses
aminoresorcinoldehyde with malonic acid and requires N-alkylation to prevent spontaneous
Schiff base formation of aminoresorcinaldehyde. Both N-alkylation and 4-alkylation introduce
steric bulk that will prevent recognition by our existing coumarin ligase.
To access the simple, minimally bulky 7-aminocoumarin, Xin Jin designed a novel
synthetic route for coumarin fluorophores that utilizes a palladium-catalyzed cross coupling
reaction (Figure 3-13B). Palladium-catalyzed reactions are widely used in synthesis of natural
and medicinal products, but only recently have they begun to see uses in fluorophore syntheses.
For example, fluorescein monotriflate can be coupled with a variety of amines via Buchwald-
Hartwig cross coupling to afford different rhodamine dyes (59). Our synthesis of 7-
aminocoumarin is inspired by the same Buchwald-Hartwig cross coupling reaction, which can
convert the 7-phenoxy group of 7-hydroxycoumarin to an unsubstituted primary aniline group.
The key transformations involve conversion of 7-hydroxycoumarin into its triflyl derivative,
which can then be coupled to benzophenone imine in a palladium-catalyzed reaction to form
benzophenone imine-coumarin adduct. Benzophenone imine-coumarin is then hydrolyzed to
yield 7-aminocoumarin. Xin characterized the photophysical properties of 7-aminocoumarin and
found it to be similar to 7-hydroxycoumarin. The main photophysical difference between the two
coumarins is their fluorescence at different pH's. As expected, 7-aminocoumarin fluorescence is
fairly constant across pH range 3-10, whereas 7-hydroxycoumarin fluorescence drops sharply at
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pH values < 6.5. More details on the synthesis and characterizations of 7-aminocoumarin are
described in X. Jin, C. Uttamapinant, and A. Y. Ting, ChemBioChem, 2011, 12, 65-70.
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Figure 3-13. Design and synthesis of the 7-aminocoumarin substrate for LplA. A) Different coumarin
substrates for lipoic acid ligase. B) Synthesis of the 7-aminocoumarin substrate for LplA.
After we confirmed that LpIAW37V can efficiently utilize 7-aminocoumarin as its
substrate, even better than 7-hydroxycoumarin (data shown in the ChemBioChem manuscript
above), we proceeded to perform site-specific protein labeling with the probe. Neurexin-1p, a
transmembrane neuronal synaptic adhesion protein, was fused to a LAP sequence called LAP4.2
(which has improved surface trafficking compared to LAP2) at its extracellular N-terminus. It
was then labeled with 7-aminocoumarin and LplAW37v added to the growth medium. Figure 3-
14A shows cell images after 20 min of 7-aminocoumarin labeling on HEK cells expressing
LAP4.2- neurexin-1 P and a transfection marker (histone 2B fused to yellow fluorescent protein,
B)
0
N'
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0 H
MeO 4
0 H
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97
H2B-YFP). Only cells expressing YFP marker received coumarin labeling. A Lys--*Ala point
mutation in the LAP4.2 sequence, or replacement of LplA w37v with wild-type LpIA, abolished 7-
aminocoumarin labeling.
To test the ability of 7-aminocoumarin to visualize neurexin in acidic compartments, we
incubated 7-aminocoumarin-labeled cells at 37 'C for 20 min to allow endocytic internalization
of surface pools of neurexin-1 . Figure 3-14B shows the appearance of internal 7-
aminocoumarin puncta in cells after this 20-minute internalization period. In contrast, cells
similarly labeled with 7-hydroxycoumarin and then incubated at 37 'C did not show substantial
internal fluorescence due to quenching of the 7-hydroxycoumarin fluorescence in acidic
compartments.
A)
Coumarin YFP marker + DIC
B)
Coumarin Coumnarin
___37*C
20 minUAt A
NUdtpLpA37*C20 min
Figure 3-14. 7-Aminocoumarin labeling to LAP-neurexin on the surface of living mammalian cells. A)
HEK cells expressing LAP-neurexin- 10 were labeled with 7-aminocoumarin and purified W37vLplA added
to the culture media. Negative controls are shown with a Lys-*Ala mutation in LAP (second row), and
with W37vLplA replaced by wild-type LplA (third row). H2B-YFP is the YFP transfection marker. Scale
bars, 20 pm. B) Visualization of internalized LAP-neurexin using 7-aminocoumarin. Top row, HEK cells
expressing LAP-neurexin were labeled as in A), then incubated at 37'C for 20 minutes prior to imaging.
Bottom row shows the same experiment using 7-hydroxycoumarin instead of 7-aminocoumarin. Scale
bars, 10 pm.
98
We also tested 7-aminocoumarin for intracellular protein labeling. To deliver the probe
across the cell membrane, Xin derivatized the carboxylic acid of 7-aminocoumarin as an
acetoxymethyl (AM) ester. Similar to coumarin-AM 2, the AM group aminocoumarin-AM can be
cleaved inside mammalian cells by endogenous esterases to yield the parent 7-aminocoumarin
probe. To perform intracellular protein labeling, HEK cells were transfected with expression
plasmids for both the coumarin ligase and a LAP2-fusion protein. 7-aminocoumarin-AM was
incubated with cells for 10 min, then the medium was replaced over 60 min to allow endogenous
anionic transporters to clear excess, unconjugated probe from the cell. Figyure 3-15 shows
specific labeling in cells expressing LAP2-YFP, but not in neighboring untransfected cells. An
alanine mutation in the LAP2 sequence eliminated 7-aminocoumarin labeling. To illustrate
generality, we also labeled LAP2-YFP targeted in the nucleus (LAP2-YFP-NLS) and LAP2
fused to p-actin. We note that the signal-to-noise of labeling obtained with 7-aminocoumarin for
intracellular labeling is not as good as with 7-hydroxycoumarin, because the excess, unlabeled
probe cannot be washed away as cleanly as with 7-hydroxycoumarin.
LAPUK -AYFP LAP-YFP-NLS
Figure 3-15. Specific labeling of LAP in the cytosol, nucleus, and on a cytoskeletal protein (p-actin).
Labeling was performed for 10 minutes with co-expressed W37vLpIA. A negative control is shown with a
Lys-*Ala mutation in LAP (second column). NLS = nuclear localization sequence. Confocal images are
shown. Scale bars, 10 ptm.
Coumarin
LAP-YFP
+ DIC
Coumarin
Coumarin
+ DIC
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Conclusion
We showed that the coumarin fluorophore ligase can be used to label proteins in different
mammalian cell types, and in various compartments of the cell except for oxidizing
compartments such as the ER and the Golgi apparatus, and that it can be used in conjunction
with biotin ligase for two-color imaging applications.
Coumarin ligase technology is shown to be a viable tool for the study of nuclear actin,
and the ability of coumarin ligase to detect nuclear pools of polymeric and non-polymeric actin
in living cells differentiates it from phalloidin, antibodies, Lifeact, and fluorescent protein
visualization techniques. We found that under non-stressed, overexpressed conditions, nuclear
actin exists as monomers or short oligomers. Under heat-shock stress, actin accumulates more in
the nucleus and is capable of forming higher-ordered structures, such as filamentous F-actin and
nucleolar actin clusters. While the recombinant actin expression levels in our studies were clearly
not physiological, and any observations and conclusions related to levels and forms of actin in
the nucleus must be made with reservation, we hope that coumarin ligase labeling will at least
prove to be a useful tool for further studies of the forms and functions of nuclear actin.
We also developed a concise synthesis of a novel fluorophore, 7-aminocoumarin, via
Buchwald-Hartwig cross coupling. We demonstrated that 7-aminocoumarin could be site-
specifically targeted to LAP fusion proteins via coumarin ligase, both on the surface of and
inside living mammalian cells. 7-Aminocoumarin is advantageous over 7-hydroxycoumarin in
two respects: its fluorescence is pH-insensitive, which allows visualization of proteins in acidic
subcellular compartments; and it is ligated with better kinetics by w37vLp1A due to its lack of
charge.
Aside from the uses of coumarin ligases mentioned in this chapter, other Ting lab
members also explored applications of the technology in diverse contexts. For example, Katie
White tested a unique feature of enzyme-mediated labeling: its ability to selectively highlight
protein subpopulations via genetic targeting of the coumarin ligase. She showed that a cytosolic
or nuclear population of LAP2-YFP can be specifically labeled via cytosol-targeted and nucleus-
targeted ligases, respectively. The cell-surface pool, the plasma membrane-associated pool, or
the total intracellular pool of a synaptic adhesion protein neurexin-Ip can also be imaged via
appropriate targeting or provision of the coumarin ligase. Lastly, Katie used nucleus-targeted
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coumarin ligase, in conjunction with an inhibitor of actin nuclear export, to unambiguously label
the trapped nuclear pool of actin.
In another example, Dr. Sarah Slavoff discovered that enzymatic coumarin ligation can
be used as a reporter for protein-protein interactions (60). By using a LAP sequence that has low
affinity for coumarin ligase, coumarin ligation would only occur when LAP and coumarin ligase
are brought together in close proximity, such as when each of them is fused to interacting protein
partners. Interaction-dependent coumarin ligation has some advantages over existing protein-
protein interaction detection methods in that it is compatible with living cells and does not
irreversibly trap the interacting protein complexes.
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Experimental methods
Mammalian cell culture
HEK, HeLa, and COS-7 cells were cultured in Dulbecco's modified Eagle medium (DMEM;
Cellgro) supplemented with 10% v/v fetal bovine serum (FBS; PAA Laboratories). CHO KI
cells were cultured in DMEM supplemented with 10% v/v FBS, 70 mg/L L-proline and 220
mg/L sodium pyruvate. NIH-3T3 cells were cultured in DMEM supplemented with 10% v/v
newborn calf serum (PAA Laboratories). All cells were maintained at 37 'C and under 5% Co 2.
For imaging, cells were plated as a monolayer on glass cover slips. Adherence of HEK cells was
promoted by pre-coating the coverslip with 50 ptg/ml fibronectin (Millipore).
Fluorescence imaging
Cells were imaged in Dulbecco's Phosphate Buffered Saline (DPBS) in epifluorescence or
confocal modes. For epifluorescence imaging, we used a Zeiss AxioObserver inverted
microscope with a 40x or 63x oil-immersion objective. Coumarin (400/20 excitation, 425
AL.- AI/'1t1 X~tflIU1 A _"L tjf(V2 /1 4 :+-: _ AA A -- 2- Cs)I/WAUdi1roic, 43/U111311i1), YP/IlAsH (9-t73/16 exciLaLIII, JU dichric, 525/30 eiionu),
mCherry/Alexa Fluor 568 (570/20 excitation, 585 dichroic, 605/30 emission), Alexa Fluor 647
(630/20 excitation, 660 dichroic, 680/30 emission) and differential interference contrast (DIC)
images were collected and analyzed using Slidebook software (Intelligent Imaging Innovations).
For confocal imaging, we used a Zeiss Axiovert 200M inverted microscope with a 40x oil-
immersion objective. The microscope was equipped with a Yokogawa spinning disk confocal
head, a Quad-band notch dichroic mirror (405/488/568/647), and 405 (diode), 491 (DPSS), and
561 nm (DPSS) lasers (all 50 mW). Coumarin (405 laser excitation, 445/40 emission), YFP (491
laser excitation, 528/38 emission), mCherry/Alexa Fluor 568 (561 laser excitation, 617/73
emission), and DIC images were collected using Slidebook software. Fluorescence images in
each experiment were normalized to the same intensity ranges. Acquisition times ranged from
10-1000 milliseconds.
General protocol for coumarin-AM 2 (7-hydroxycoumarin) labeling in living cells.
Cells were transfected at -70% confluency with expression plasmids for LplAW3 7V (20 ng for a
0.95 cm 2 dish) or mCherry-LplAw3 71 (200 ng for a 0.95 cm 2 dish) and the LAP2 fusion protein of
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interest (400 ng) using Lipofectamine 2000 (Invitrogen). 8-24 hours after transfection, cells
were incubated with 20 pM coumarin-AM 2 in serum-free DMEM (Dulbecco's modified Eagle
medium, Cellgro) for 10 minutes at 37 'C. The media was then replaced 3-4 times over 30-60
min at 37 'C, with DMEM supplemented with 10% FBS (Fetal Bovine Serum), to wash out
excess coumarin.
In vitro coumarin ligation in the presence of different divalent cations (Figure 3-3)
Reaction conditions were as follows: 100 pM LAP2 synthetic peptide was incubated with 10 pM
LplA 37', 500 jM coumarin 4 probe, 1 mM ATP, and 5 mM MCl 2 (M = Mg, Ca, or Mn, or use 5
mM KCl) in 25 mM Na2HPO 4 pH 7.2 at 30 'C for 30 min. Reactions were then quenched with
EDTA (Cf 100 mM) and analyzed on a Varian Prostar HPLC using a reverse-phase C18
Microsorb-MV 100 column (250 x 4.6 mm). Chromatograms were recorded at 210 nm. We used
a 10-minute gradient of 30-60% acetonitrile in water with 0.1% trifluoroacetic acid at I
ml/minute flow rate. LAP2 has the retention time of 7 minutes under this gradient; upon
conjugation to coumarin 4, the retention time is shifted to 9 minutes. Percent conversions were
calculated by dividing the product peak area by the sum of (product + starting material) peak
areas.
Cell-surface protein labeling with coumarin ligase (Figure 3-4)
HEK cells were transfected at ~70% confluency with an expression plasmid for c-myc-LAP4.2-
neurexin-1 (400 ng for a 0.95 cm2 dish) using Lipofectamine 2000. Sixteen hours after
transfection, cells were incubated with 10 pM LplAW371, 200 ptM coumarin 4, 1 mM ATP and 5
mM of either MgCl2 or MnCl2 for 20 min in full growth media at room temperature. Thereafter,
the media was replaced 2-3 times to remove excess labeling reagents.
To perform anti-c-myc immunostaining, cells were immediately fixed after coumarin
labeling with 3.7% formaldehyde in PBS pH 7.4 for 10 min, followed by cold methanol
treatment for 6 min at -20 *C. After blocking in 3% BSA in DPBS for 1 hour, cells were stained
with 4 pg/ml mouse anti-c-myc antibody (calbiochem) in 3% BSA in DPBS for 40 min at room
temperature. After washing, cells were further incubated with 4 jig/ml goat anti-mouse antibody
conjugated to Alexa Fluor 488 (Life Technologies) in 3% BSA in DPBS for 40 min at room
temperature, then washed and imaged.
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Two-color, orthogonal protein labeling with coumarin ligase and biotin ligase (Figure 3-5)
HeLa cells were transfected with expression plasmids for LplAw3 y (20 ng for a 0.95 cm 2 dish),
BirA (50 ng) and the indicated LAP2- and AP-tagged protein fusions (400 ng plasmid for each
construct) using lipofectamine 2000. 24 hours after transfection, cells were incubated with 20
pM coumarin-AM2 and 50 pM biotin in serum-free DMEM for 20 min. The media was then
replaced 3-4 times over 1 hour to remove excess coumarin and biotin from cells, before cells
were fixed with 3.7% formaldehyde and methanol, and blocked, as described in methods for
Figure 3-4. Streptavidin-cy5 (~2.5 gg/ml) staining was then performed in 3% BSA in DPBS for
30 min at room temperature, then washed and imaged.
FlAsH labeling on Cys4-actin (Figure 3-7)
HeLa cells were transfected with an expression plasmid for HA-Cys 4-p-actin (400 ng for a 0.95
cm2 dish). 24 hours after transfection, cells were labeled with 2.5 gM FlAsH-EDT 2 (Life
Technologies) for 30 minutes in serum-free DMEM. Cells were rinsed twice with 250 gM
British anti-Lewisite (BAL) wash buffer (Life Technologies) over 30 minutes before imaging.
Phalloidin and anti-HA staining on actin (Figure 3-8)
After coumarin labeling was performed on COS-7 cells as described in the general protocol, cells
were fixed with 3.7% formaldehyde in PBS pH 7.4, permeabilized with 0.5% Triton X-100 in
PBS pH 7.4, and blocked in 3% BSA in DPBS. Cells were then stained with 165 nM phalloidin-
Alexa Fluor 647 (Life Technologies) in the presence of 3% BSA. HA epitope tag
immunofluorescence staining was performed with 4 ptg/ml anti-HA antibody (Rockland Labs) in
1% BSA in DPBS. After washing, cells were incubated with 4 gg/ml goat anti-rabbit antibody
conjugated to Alexa Fluor 568 (Life Technologies) in 1% BSA in DPBS, then washed and
imaged.
Imaging nuclear actin upon heat-shock treatment (Figure 3-10)
Labeling of LAP2-p-actin in COS-7 and HeLa cells was performed as described in the general
protocol. After excess coumarin washout, cells were heat-shocked at 43 'C in Tyrode's buffer
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(120 mM NaCI, 2 mM CaC 2, 3 mM KCI, 2 mM MgCl 2 , 0.5 mM NaH2PO4, 30 mM glucose, 25
mM HEPES pH 7.4) for 0, 30, 60, or 90 minutes before imaging.
For Figure 3-1 OC, cells were fixed post-heat shock with 3.7% formaldehyde in PBS pH
7.4, permeabilized with 0.5% Triton X-100 in PBS pH 7.4, blocked in 3% BSA in DPBS, stained
with 165 nM phalloidin-Alexa Fluor 647 (Life Technologies) in the presence of 3% BSA,
washed, and imaged.
Two-color labeling on actin with coumarin ligase and FlAsH (Figure 3-12)
HeLa cells were transfected with expression plasmids for LplAW37V (20 ng for a 0.95 cm2 dish),
LAP2-actin (400 ng) and Cys4-actin (400 ng). 16-24 hours after transfection, cells were treated
with 20 piM coumarin-AM 2 in serum-free DMEM for 10 min, followed by a washout period of I
hour. Thereafter, cells were labeled with 2.5 gM FlAsH-EDT2 in serum-free DMEM for 30 min,
followed by 2 washes with British anti-Lewisite (BAL) wash buffer, as described for Figure 3-7
before imaging. The FRET image was acquired using 405 nm laser excitation, 528/38 emission
filter, and a Quad-band notch dichroic mirror (405/488/568/647). The intensity-modulated
display image was generated by dividing the FRET image by the coumarin image.
7-aminocoumarin labeling onto LAP-neurexin-1p on HEK cell surface (Figure 3-14)
HEK cells were transfected at -70% confluency with expression plasmids for LAP4.2-neurexin-
1P (400 ng for a 0.95 cm 2 dish) and H2B-YFP (100 ng) using Lipofectamine 2000 (Invitrogen).
18 hours after transfection, cells were treated with 10 gM LplAw37V enzyme, 200 pM coumarin
probe, 1 mM ATP, and 5 mM Mg(OAc) 2 in cell growth media for 20 minutes at room
temperature. After removal of excess labeling reagents by replacing media 2-3 times, cells were
immediately imaged, or incubated at 37'C for 20 minutes to induce cell surface protein turnover.
Intracellular protein labeling with 7-aminocoumarin (Figure 3-15)
HEK or HeLa cells were transfected with expression plasmids for LpIA W7V (20 ng) and LAP
substrate (LAP2-YFP, LAP2-YFP-NLS, LAP2-p-actin, or LAP2(K--*A)-YFP; 400 ng) using
Lipofectamine 2000. 18 hours after transfection, cells were treated with 20 pM 7-
aminocoumarin-AM in serum-free DMEM for 10 minutes at 370C. Excess coumarin probe was
105
removed by washing cells with cell growth media 4 times, for 15 minutes each time. Cells were
imaged thereafter.
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Chapter 4
Site-specific targeting of diverse fluorophores via enzymatic azide ligation
and click chemistries
The work discussed in this chapter has been published in part in: J. Z. Yao, C. Uttamapinant, A.
Poloukhtine, J. M. Baskin, J. A. Codelli, E. M. Sletten, C. R. Bertozzi, V. V. Popik, and A. Y.
Ting, "Fluorophore targeting to cellular proteins via enzyme-mediated azide ligation and strain-
promoted cycloaddition," JAm Chem Soc 2012 (134), 3720-3728.
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Introduction
Even though coumarin ligase-mediated protein labeling is specific and versatile,
coumarin fluorophores themselves have several limitations. 7-hydroxycoumarin, 7-
aminocoumarin, and Pacific Blue are all blue-emitting fluorophores, and their excitation (380-
405 nm) and emission (444-450 nm) maxima overlap to some degree with cellular
autofluorescence, particularly with the reduced form of nicotinamide adenine dinucleotide
(phosphate) (NAD(P)H, excitation and emission maxima of 340 and 460 nm, respectively (1)).
While coumarins are considerably bright, they are generally not very photostable, emitting only a
few thousand photons before they are completely photobleached, whereas more superior organic
fluorophores like cy5 or ATTO647N can emit about 200,000 photons before they are
photobleached (2). Coumarins are therefore not suitable for imaging applications which require
continuous or long-term illumination on the biological samples, such as single-molecule
tracking. Coumarins also do not exhibit unique photophysical properties, such as reversible
photo-induced switching properties of cyanine dyes (3), and thus do not lend themselves to other
advanced imaging modalities like localization-based super-resolution imaging techniques (4,5).
Ideally, we would like to extend LpIA-mediated labeling to encompass labeling with more red-
shifted fluorophores, to take advantage of potentially higher signal-to-noise ratios of labeling due
to their greater separation from cellular autofluorescence. Several fluorophores belonging to
xanthene, rhodamine, carbopyronine and cyanine classes are commonly used green-, orange-,
and red-emitting dyes with demonstrated excellent photophysical properties. Moreover, many of
them are membrane-permeable or exist in forms that can be readily made membrane-permeable,
and therefore are amendable to intracellular protein labeling. The structures of fluorophores of
interest (all membrane-permeable except for cy5) are shown in Figure 4-1.
To generalize LplA-mediated protein labeling to include diverse fluorophores, we need
an alternative approach to identifying a specific, efficient ligase mutant for each fluorophore.
While such one-step, direct protein labeling with a desired fluorophore would yield high labeling
specificity and is convenient for users, the lipoate binding pocket of LplA likely cannot be
modified to accommodate probe structures much larger than coumarins. Examination of E. coli
LplA crystal structure with bound lipoyl-AMP (6) reveals that the dithiolane moiety of lipoic
acid is completely enclosed by the active site, with little room to spare for larger substrates
(Figure 4-2). While mutagenesis of residues surrounding the dithiolane ring has allowed LpIA to
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incorporate bicyclic benzopyrone structures like coumarins, and recently, a linear tricyclic
structure of an orange resorufin fluorophore (Dan Liu, unpublished results), it is unlikely that the
binding pocket can be enlarged further to accommodate non-linear tetracyclic structures like
those of fluorescein and tetramethylrhodamines, or two bicyclic indole rings linked by a long
polymethine chain like cyanine dyes. Aside from size consideration, many of these fluorophores
bear permanent charges, a feature that makes direct incorporation by LplA even more difficult as
LplA prefers hydrophobic substrates. It might be possible to craft an LplA/probe pair in which
the probe is branched and has bifunctional modifications-one is for binding to LpIA and the
other is a fluorophore-and LplA has an "exit tunnel" to accommodate the fluorophore moiety
without directly interacting with it. Such an engineering feat, however, is expected to be very
challenging and would likely require techniques beyond structure-guided mutagenesis, such as in
vitro evolution or computational methods.
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Figure 4-1. Left, chemical structures of current lipoic acid ligase substrates. Right, other fluorophores of
interest that we wished to target to proteins via LplA.
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Figure 4-2. Cutaway view of E. coli LplA active site with bound lipoyl-AMP (PDB: 3A7R). The middle
proteinaceous area is rendered white, except for the gatekeeper Trp37 residue shown in grey stick.
Cavities in the structure, including the lipoate and adenosine binding tunnels, are shown in blue. For
efficient catalysis, the AMP moiety of probe-AMP has to remain bound in the configuration shown in the
structure. The extension of the lipoate binding tunnel towards the Trp37 residue is a possible engineering
route to enlarge the existing binding tunnel, as we have shown with Trp37 coumarin ligase mutants. But
there seems to be no other obvious way to enlarge the existing lipoate binding tunnel, and to make LplA
incorporate probes much larger than coumarins.
Our approach to site-specific targeting of any fluorophore structure is via two-step
labeling. First, LplA ligates a small molecule bearing a reactive, bioorthogonal functional group
handle onto LAP-tagged proteins. The functional group handle then can be chemoselectively
derivatized with the desired fluorophore. Upon reviewing biooorthogonal functional group
handles that have been used in chemical biology, we selected to proceed with alkyl azides. Alkyl
azides are absent from most biological organisms and inert towards functional groups present in
biological systems, but can be chemically reactive under a variety of conditions when their
diatomic nitrogen can be extruded, or when they act as 1,3-dipoles. The first mode of reactivity
of azides has been exploited in Staudinger ligation (7), where dinitrogen liberation is the driving
thermodynamic force behind the covalent conjugation between an azide and a methyl ester
triarylphosphine (Figure 4-3, top). 1,3-dipole mode of reactivity of azides has also seen uses in
many cycloaddition reactions, including the copper(I)-catalyzed [3+2] azide-alkyne
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cycloaddition to terminal alkynes (CuAAC) (8) , and strain-promoted [3+2] cycloaddition to
cyclooctynes (9) (Figure 4-3).
MeO
0 PPh2 0
Staudinger ligation HO
n O0O' h
O + Cu' N
N3  -Nzd-lye H
HO n Copper-catalyzed azide-alkyne n
cycloaddition (CuAAC)
O N:7N
HO n N
Strain-promoted azide-alkyne
cycloaddition
Figure 4-3. Bioorthogonal reactions for azide derivatization. Top, in Staudinger ligation, azides react with
triarylphosphines to form a covalent phosphine oxide adduct. Middle, in copper-catalyzed azide-alkyne
cycloaddition (CuAAC), azides react with terminal alkynes in a Cu'-mediated process to form stable
triazoles. In strain-promoted cycloaddition (bottom), azides react with strain alkynes to form triazoles
without the need of Cu'.
While Staudinger ligation, CuAAC, and strain-promoted cycloaddition represent the
three most common bioorthogonal click reactions to derivatize azides, their compatibility and
suitability for usage inside living mammalian cells differ. Staudinger ligation has been applied
successfully for protein modifications at the living cell surface, but its second-order rate constant
is low (~104 M~' s-1 (7)), and the triarylphosphine reagent tends to oxidize in the mammalian
cytosol when it is conjugated to fluorophores. CuAAC, in contrast to Staudinger ligation, is the
fastest reaction of the three, with second-order rate constants as high as 106 M- s- per molar Cu
(10). However, the reaction is highly toxic due to Cul-mediated generation of reactive oxygen
species (ROS). In recent years, ROS-intercepting tris-triazole Cul-ligands have been developed
to effectively curtail the reaction's toxicity (11,12), but application of CuAAC to the interior of
living cells is still complicated by the need to deliver Cu' into the cytosol, and the likely
sequestration of Cu' within the cytosol by endogenous thiols. Compared to the other two
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reactions, strain-promoted cycloaddition between azides and cyclooctynes provides a nice
compromise between cell compatibility and sufficient reactivity. The reaction has been
demonstrated successfully inside living mammalian cells (13), and many cyclooctyne structures
have been developed (14) that vary in terms of ring strain and electronic substituents, which
affect their specificity, hydrophobicity, and reactivity (second-order rate constants range from
10- to 1 M-1 s~1 (15,16,17,9,18,19)). We thus decided on strain-promoted cycloaddition as our
azide derivatization chemistry of choice for two-step labeling of intracellular proteins in living
cells (Figure 4-4).
HN ON
Fbced-cell labeling
LpLA/Azide 7 CuAAC
or
N, LplA'^W2/Azide 9 H
ATP, Mg N
13-amino acid
LAP HN
Live-cell labeling
Figure 4-4. Two-step labeling approach for site-specific intracellular protein labeling. In the first step,
LplA ligates an azidoalkanoic acid onto its acceptor peptide, LAP, fused to a protein of interest. Two
functional azide substrates are 8-azidooctanoic acid (azide 7) which can be ligated by wild-type Lp1A, or
I 0-azidodecanoic acid (azide 9), which is ligated by LpIAW371. In the second step, azide-modified proteins
can either be chemoselectively derivatized with a termimal alkyne probe via CuAAC in fixed cells, or
with a cyclooctyne via strain-promoted cycloaddition inside living cells.
Dr. Marta Femndez-Suirez has previously utilized strain-promoted cycloaddition and
accomplished two-step labeling on cell-surface proteins, using wild-type LplA, which can
recognize an alkyl azide substrate 8-azidooctanoic acid ("azide 7"), and derivatization with
monofluorinated cyclooctyne-fluorophores (20). To extend a similar two-step scheme to
intracellular protein labeling-where analyses of labeling results could be complicated due many
factors that can affect the first enzymatic azide ligation step, the cycloaddition step, or both-we
decided to proceed systematically. First, we wished to confirm that the enzymatic azide ligation
step could proceed specifically and efficiently to LAP-modified proteins in the presence of other
cellular proteins, regardless of the strain-promoted cycloaddition step. We did this by detecting
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azide-modified proteins via CuAAC instead of strain-promoted cycloaddition, since CuAAC is
more kinetically efficient and can be performed with high specificity on fixed cells, where we
did not have to worry about delivering derivatizing agents across the cell membrane. We found
that enzymatic azide ligation suffers from enzyme-dependent background labeling, similar to
what we encountered with coumarin ligase, but this problem could be alleviated using co-
expression of an inactive mutant of LplA's natural protein substrate E2p. After the azide labeling
specificity was rescued, we proceeded to optimize cellular loading and washout of a membrane-
permeable cyclooctyne-fluorescein reagent, and eventually performed strain-promoted
cycloaddition inside living cells on azide-modified cellular proteins.
Jennifer Yao of our lab also worked concurrently to improve the two-step labeling with
azide ligation and strain-promoted cycloaddition. Jen discovered an LplA mutant/azide pair
which has improved ligation kinetics over wild-type LplA/azide 7 pair, and also investigated the
suitability of different cyclooctynes for cellular labeling (21). We used Jen's further optimized
two-step labeling protocol to target fluorescein, tetramethylrhodamine (TMR), ATTO647N, and
cy5 fluorophores to specific proteins inside living cells. We also developed a protocol to reduce
labeling background III Lhe IIIILocIdIIUIIa, VVich11 is a c oIIIIIIII prUIeIII VVhe11 h1yurphoLIc,
positively-charged fluorophores (such as ATTO647N) are used.
The 9 kDa E2p, a subunit of pyruvate dehydrogenase and one of the three protein
substrates of E. coli LplA, was used as the LplA acceptor protein tag in most of the experiments
present in this chapter, as kinetically efficient peptide substrates for LplA such as LAP2 did not
exist until a year after we started the project. E2p has almost identical catalytic turnover for
lipoylation catalyzed by wild-type LplA as LAP2 (22).
Optimization of LplA-mediated azide 7 ligation on fixed cells
We started our exploration into the two-step labeling procedure with the simplest cellular
labeling assay: performing both LplA-mediated azide 7 ligation and CuAAC derivatization on
fixed cells. Performing enzymatic azide ligation on fixed cells would allow us to maximize azide
labeling yields, as all factors relevant to labeling-enzyme and azide concentrations, labeling
time, temperature-could be precisely controlled without having to concern for cell viability.
The high azide labeling efficiency would facilitate our optimization of CuAAC conditions on
-A
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fixed cells, which would be the readout we used, in turn, to analyze azide ligation as it is
performed in living cells.
Labeling on E2p-BFP Negative control (no protein substrate of LpIA)
3 DIC BFP c 3+BFP c 3 DIC BFP c 3+BFP
Field of view 1
Field of view 2
Figure 4-5. Azide 7 ligation and CuAAC derivatization on fixed cells. Fixed HeLa cells expressing E2p-
tagged blue fluorescent protein (E2p-BFP) were incubated with 10 pM wild-type LplA, 500 tM azide 7,
1 mM ATP, and 5 mM Mg(OAc) 2 for 20 min at 30 'C. Thereafter, CuAAC was performed on cells with I
mM CuSO 4 , 100 pM TBTA, and 3 pM cy3-alkyne for 1 hour at ambient temperature. A negative control
is shown with BFP fused to an alanine mutant of LAPI.
To perform azide 7 ligation on fixed cells, we expressed E2p fused to blue fluorescent
protein (E2p-BFP) inside cells, fixed, and blocked the cells by incubating them in 3% w/v bovine
serum albumin (BSA) in PBS, to prevent non-specific sticking of reagents to cells. For CuAAC
detection, we synthesized cy3- and cy5-alkyne via amide coupling of their respective
succinimidyl ester derivative with propargylamine. Upon performing wild-type LpIA-mediated
azide 7 ligation and CuAAC labeling with cy3-alkyne, we observed cy3 labeling signal that was
specific to BFP-expressing cells, suggesting that both the ligation step and click step worked to
some degree (data not shown). However, we also observed non-specific labeling background on
untransfected cells that were dependent on the presence of active LplA, suggesting that the
source of background was not non-specific sticking of probes (azide 7, cy3-alkyne), but rather
LplA-mediated non-specific labeling, such as the release of reactive azide 7-AMP into the
environment. Using this information, we identified conditions that gave rise to specific labeling
on E2p-BFP and nucleus-targeted E2p-BFP with a good signal-to-noise ratio of labeling (-10:1)
compared to background on untransfected cells (Figure 4-5). The key to maximize signal-to-
noise was short azide ligation duration (<20 min), in order to only allow specific labeling to
occur, before non-specific labeling took over. It was also found that addition of detergents like
Triton X-100 during LpIA labeling step could increase background, in contrary to the expected
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effect of preventing stickiness, presumably because the activated azide 7-AMP can be released
from LplA even more readily in the presence of detergents (data not shown).
Overall, we settled on the following LplA-mediated azide 7 ligation condition for fixed-
cell labeling: 2-10 pM LplA, 500 pM azide 7, 1 mM ATP, 5 mM Mg(OAc) 2 or MgCl 2, in 3%
w/v BSA in PBS for 20 min at 30 'C.
Optimization of CuAAC labeling on fixed cells
We next proceeded to empirically improve the CuAAC reaction conditions for detection
of azide-modified proteins on fixed cells, prepared as mentioned above. First, several reducing
agents for conversion of Cu" to Cu' were examined. It was found that sodium ascorbate and
copper wire are both excellent Cu reducing agents (Figure 4-6), and are better than tris(2-
carboxyethyl)phosphine (TCEP), which is known to independently reduce azides (23).
Temperature of the reaction of either 4 'C or 21 'C was found to yield no difference on labeling
efficiency when sodium ascorbate was used as a reducing agent (data not shown). To completely
remove non-specific sticking of fluorophore-alkynes, we replaced 3% w/v BSA solution in PBS
with a much better blocking solution, 0.5-1% w/v casein solution in PBS (data not shown). We
also experimented with the addition of a thiol blocker N-ethylmaleimide (NEM) prior to
performing CuAAC, as it is suggested that free thiols present during CuAAC could be activated
as thiyl radicals and react with fluorophore-alkynes (24). NEM was found to help further reduce
labeling background, but not significantly (data not shown).
We also tested different tris-triazole ligands for CuAAC. Tris-(benzyltriazolylmethyl)
amine, or TBTA (25), is the most commonly used tris-triazole ligand for in vitro biological
applications, and we found TBTA to work extremely well for fixed-cell protein labeling, even at
low ligand loading concentration of 100 ptM (TBTA cannot be loaded at higher concentrations
than 100 pM due to its poor aqueous solubility). Recently, a more water-soluble tris-triazole
ligand for CuAAC, tris-(hydroxypropyltriazolylmethyl)amine, or THPTA, has been developed
(26). THPTA is shown to be a more efficient click ligand than TBTA in an in vitro reaction
between biotin-alkyne and a fluorogenic coumarin-azide fluorophore (27) (Figure 4-7A);
however, its Cu-chelating efficiency is drastically negatively affected by the presence of a
protein blocking solution like BSA or casein (Figure 4-7A), which can competitively bind to
Cu"". As protein blocking reagents are required for labeling in fixed cells due to general
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stickiness of the fixed-cell environment, we unsurprisingly found that CuAAC with THPTA on
fixed cells yielded worse signal-to-noise ratio of labeling compared to CuAAC with TBTA
(Figure 4-7B). Attempts to improve THPTA-based CuAAC on fixed cells included: performing
CuAAC at higher [Cu""] (2.5 mM instead of 1 mM); lowering [BSA] from 3% to 1% w/v;
performing the reaction at 37 'C instead of 21 C; and adding 1 mM NiCl2 to compete out Cu""
binding to BSA. All attempts did not produce better labeling signal than what we could obtain
with TBTA (data not shown).
cy3 BFP DIC
TCEP
Sodium
ascorbate
Cu wire
Figure 4-6. Effects of reducing agents on cellular CuAAC labeling efficiencies. Fixed HEK cells
expressing E2p-BFP were labeled with azide 7 via LpIA. Thereafter, CuAAC was performed on cells
with 1 mM CuSO 4 , 100 pM TBTA, 3 jiM cy3-alkyne and either 2 mM TCEP, 2.5 mM sodium ascorbate,
or -2 mg of Cu wire per 0.95 cm2 dish for I hour at ambient temperature.
Overall, we settled on the following CuAAC labeling condition for fixed-cell detection: I
mM CuSO 4, 100 pM TBTA, 2.5 mM sodium ascorbate, 5 ptM fluorophore-alkyne in 0.5-1% w/v
casein in PBS, for 60-120 min at 21 'C. 20 mM NEM blocking for 30-60 min is an optional step
prior to CuAAC labeling.
Note that while THPTA performs poorly on CuAAC on fixed cells, the ligand is
excellent for live-cell CuAAC, capable of both accelerating the CuAAC reaction while acting as
a sacrificial reductant to quench toxic reactive oxygen species. The use of THPTA for live-cell
CuAAC is discussed in Chapter 5.
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Figure 4-7. Click labeling efficiencies with TBTA vs. THPTA on fixed cells. A) Fluorogenic CuAAC
reaction to assess CuAAC rates with TBTA or THPTA in vitro. The reaction condition for TBTA click:
100 pM TBTA, I mM CuSO 4 , 2.5 mM sodium ascorbate, 100 pM biotin-alkyne, and 100 pM coumarin-
azide. The THPTA click was performed with 250 pM THPTA, 50 pLM CuSO4 , and otherwise identical
conditions as TBTA click. Reactions were performed in Dulbecco's phosphate buffered saline (DPBS), in
the presence or absence of 30 mg/mL (~3% w/v) BSA, for 10 min at room temperature. As coumarin
azide is non-fluorescent until its 7-azido group reacts under CuAAC to form 7-triazolyl coumarin, we
monitored the CuAAC reaction progress via plate-reader measurements of fluorescence increase at 490
nm. B) CuAAC with TBTA or THPTA in fixed cells. Fixed HeLa cells expressing nucleus-targeted
LAP2-YFP were labeled with azide 7 via LpIA. CuAAC was then performed on cells in 3% w/v BSA in
DPBS with 2.5 mM sodium ascorbate and 5 pM cy5-alkyne, with either 100 pM TBTA and 1 mM
CuSO 4, 250 pM THPTA and 50 PM CuSO 4, or 2.5 mM ptM THPTA and 500 PM CuSO 4.. CuAAC on
cells was allowed to proceed for I or 6 hour at room temperature. The inset cy5 images show cy5
fluorescence normalized to a wider intensity range, to highlight low signal over background when
THPTA is used, regardless of CuSO4 concentrations.
Assessing specificity of LplA-mediated azide 7 ligation in living cells
To perform azide 7 ligation inside living cells, we co-transfected HEK cells with
expression plasmids for codon-optimized mCherry-tagged wild-type LpIA and E2p-BFP. Upon
incubating cells with 600 pM azide 7 for -12 hours, excess azide 7 was removed via incubation
cy5
Nucleus-targeted
LAP2-
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cells with fresh growth medium for 1 hour. Thereafter, cells were fixed, blocked, and labeled
with CuAAC and cy5-alkyne. We were delighted to observe strong cy5 labeling signal in only
BFP- and mCherry-expressing cells, suggesting that intracellular azide ligation and subsequent
CuAAC were successful, and the azide ligation is dependent on both the presence of E2p and
LpIA (Figure 4-8, top panel). A negative control in which the lysine conjugation site on E2p was
mutated to alanine completely eliminated cy5 labeling (middle panel). However, when we co-
expressed the same mCherry-LplA with BFP fused to a Lys--+Ala mutant of the 22-amino acid
LAPI sequence, which should serve as an additional negative control, we instead saw strong cy5
labeling signal that was also specific to transfected cells (Figure 4-8. bottom panel). A further
negative control with expression of mCherry-LpIA alone in cells, without any E2p, LAP, or their
alanine mutants, showed the same transfection-dependent cy5 labeling and clearly pointed to
LplA as the culprit for such substrate-independent labeling (data not shown).
cy5 mCherry-LpLA BFP DIC
E2p-BFP
E2p(Lys-Ala)-
BFP
LAP1(Lys-Ala)-
BFP
Figure 4-8. Enzyme-dependent labeling background of intracellular azide 7 ligation. HeLa cells co-
expressing mCherry-tagged wild-type LpIA and E2p-BFP were incubated with azide 7 for 12 hours,
followed by a 1-hour washout period to remove excess azide 7 from cells. Thereafter, cells were fixed and
derivatized via CuAAC with cy5-alkyne. Controls are shown with an alanine mutant of E2p, as well as an
alanine mutant of LAP I, a very inefficient substrate/binder of LplA. While no azide/CuAAC labeling was
observed on E2p(Lys-*Ala), labeling background can be seen on transfected cells of the
LAP I (Lys-+Ala) sample.
As we have encountered with coumarin ligase, LplA has tendency to either trap the
activate probe-AMP (in this case, azide 7-AMP) in its active site, or even react covalently with
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the probe-AMP (the postulated interaction site is Lys 133, which is the active site lysine, but we
have not confirmed this). Unlike the fixed-cell azide 7 ligation, we have not seen evidence of
azide 7-AMP release into the environment and subsequent promiscuous labeling on other
proteins.
We attempted to remedy enzyme-dependent background labeling by reducing the cellular
expression of LplA. Dr. Marta Fernindez-Suairez demonstrated through Western blotting that
non codon-optimized LplA (which retains its original codons from E. coli) expresses at a lower
level than humanized LplA inside mammalian cells. The expression of non codon-optimized
LplA can be decreased further through its fusion to the FKBP-rapamycin binding domain of the
mTOR protein (FRB), which increases protein turnover/degradation. Removal of the N-terminal
mCherry tag also decreases LplA expression. Among the several constructs tested and labeling
conditions tried, the best results were obtained with FRB fusion to the non codon-optimized
LplA. Transfection of HEK cells with expression plasmids for E2p-BFP and FRB-E.coli LplA
(at 1:2 plasmid ratio, both plasmids are under the CMV promoter), followed by a prolonged
incubation with azide 7 of -35 hours, produced the eventual cy5 labeling that was specific to
E2p, with very minimal labeling background when E2p was absent (Figure 4-9). Under this
experimental condition, the FRB-E. coli LplA expression presumably remained low and produced
little background, while the labeling time was long enough to allow efficient azide ligation to
occur despite the low enzyme concentration. Moreover, under this condition, weak but specific
labeling signal could be observed on LAPI, a much inferior substrate of LpIA compared to E2p
(20,28).
Nevertheless, we realized that this approach of optimization would not lead to robustly
reproducible results, and LplA expression levels along with labeling would have to be re-
optimized when we performed labeling in other cell types or onto different E2p protein
constructs. Moreover, cy5 labeling intensity did not correlate well with E2p-BFP expression
levels, suggesting that the labeling yields on E2p were poor and that non-specific labeling on
LplA might still remain. Data obtained from both live-cell and fixed-cell azide 7 ligation by
LplA informed us that while low LplA concentration is key to minimize background labeling,
high LplA concentration is needed to maximize signal within appreciable labeling time. These
conflicting requirements prompted us to investigate other means to control LplA-dependent
labeling background other than expression level control.
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Figire 4-9. Specific intracellular azide 7 ligation could be observed when the ligase expression is
suppressed. HEK cells co-expressing LplA fused to FKBP-rapamycin binding domain of the mTOR
protein (FRB) and the indicated LplA substrate fused to BFP were incubated with azide 7 for 35 hours.
After a 1-hour washout period to remove excess azide 7, cells were fixed, and azide-modified proteins
detected via CuAAC with cy5-alkyne. LAPI(Lys--+Ala) was used here to represent the condition where
an LplA substrate is absent from the labeling system.
Co-expression of an alanine mutant of E2p suppresses LplA-dependent labeling
background
We have always observed LpIA-dependent labeling background when LplA is expressed
at high levels inside cells without a suitable protein (E2p) or peptide (LAP2) substrates present.
One peculiar exception to this generalization is when we co-expressed LpIA with an E2p mutant
in which its key lysine residue for lipoylation, Lys4l, is mutated to alanine (E2p-ala). We even
observed co-localization of LpIA and E2p-ala when they were both tagged with fluorescent
proteins, suggesting that E2p-ala can bind to LplA quite efficiently (data not shown). We
hypothesized that upon binding to LpIA, E2p-ala simply prevents azide 7 from accessing the
lipoate binding pocket to form the reactive intermdiate, or induces conformational changes to
LpIA such that the enzyme cannot bind to azide 7. We also thought that if E2p, the natural
substrate of LplA, is present among LplA and E2p-ala, E2p should have similar or even higher
affinity for LplA and should be able to compete with E2p-ala for LpIA binding. As E2p replaces
E2p-ala, E2p should allow azide 7 ligation onto itself. Thus, co-expression of LpIA + E2p + E2p-
ala inside cells should increase labeling specificity because background labeling would be
E2p-BFP
LAP1(Lys-Ala)-
BFP
LAP1-BFP
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actively blocked by E2p-ala, while specific labeling on E2p is still allowed. It should also
increase labeling sensitivity given that sufficient labeling time was provided, given there should
be little or no competition from non-specific signal.
To test this hypothesis, we co-expressed humanized LplA, E2p, and E2p-ala and allowed
azide 7 ligation to occur inside living HEK cells. Simple control of plasmid ratio upon
transfection was used to ensure that E2p-ala was expressed at higher level than LplA and to
ensure complete background suppression. As an additional control of labeling specificity, we
used a nucleus-targeted E2p as a substrate for LplA that is expressed throughout the whole cell.
The labeling signal in the cell nuclei would be indicative of specific azide 7 ligation onto E2p,
whereas a whole-cell labeling pattern would point to substrate-independent (but enzyme-
dependent) labeling background.
Upon cell fixation and derivatization with cy5-alkyne, we indeed observed specific cy5
labeling on the nuclei of transfected cells, which could be contrasted to the whole-cell expression
pattern of mCherry-tagged LplA (Figure 4-10 A). Removal of active E2p or LplA resulted in no
labeling. The labeling signal on E2p obtained from E2p-ala co-expression was shown to be much
higher, and more consistent, than when LpIA expression level was suppressed via using non-
optimized LplA, FRB, or tetracycline repressor (Figure 4-1 0B). And, most fortunately, E2p-ala
co-expression strategy allowed specific two-step labeling on the evolved LAP2 peptide. Specific,
localized labeling of cy5-alkyne could be observed when LAP2 peptide was targeted to the cell
nuclei, with signal-to-noise of labeling comparable to that obtained when using E2p (Figure 4-
11l).
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Figure 4-10. Improving LplA labeling specificity via co-expression of an alanine mutant of E2p. A)
Specific labeling on nucleus-targeted E2p using E2p-ala co-expression. HEK cells expressing whole-cell
mCherry-LplA, nucleus-targeted E2p-BFP and E2p-ala were incubated with 500 pM azide 7 for 12 hours.
Azide-modified proteins were detected post-cell fixation via CuAAC with cy5-alkyne. B) Comparison of
specific labeling signal obtained from E2p-ala co-expression (concomitant with high LplA expression
levels) versus low LplA expression conditions. For E2p-ala condition, TREx-HEK cells were transfected
with constitutive expression plasmids for mCherry-LplA, nucleus-targeted E2p-BFP, and E2p-ala. For
LplA expression control condition, TREx-HEK cells were transfected the same nucleus-targeted E2p-BFP
plasmid and pcDNA4-mCherry-hLplA, for tetracycline-inducible expression of mCherry-LpIA. In the
latter case, mCherry-LpIA expression was induced by adding 0.03ug/mL tetracycline 24h after
transfection. Otherwise, Azide and CuAAC labeling was performed as in A).
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Figure 4-11. Specific LpIA-mediated azide 7 ligation onto E2p and LAP2, with E2p-ala co-expression.
HEK cells expressing mCherry-LplA, E2p-ala, and either E2p-YFP or LAP2-YFP were incubated with
250 pM azide 7 for 12 hours. CuAAC with cy5-alkyne was performed post-cell fixation to detect azide-
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modified proteins. Negative controls are shown with an inactive LpIA substrate (an alanine mutant in E2p
or LAP, second row) or with an inactive LplA (K133R mutant, third row). Fourth row, specific cy5
labeling on to nucleus-targeted E2p- and LAP2-YFP via azide 7 ligation and CuAAC.
Optimization of cellular loading and washout of a membrane-permeable cyclooctyne-
fluorescein conjugate
We next evaluated the cyclooctyne-fluorophore reagents to be used for live-cell
derivatization of azide-ligated proteins. Several membrane-permeable cyclooctyne-fluorophore
conjugates were synthesized by Dr. Hemanta Baruah and evaluated for cellular entry by Dr.
Marta Fermandez-Suairez. It was found that carboxyfluorescein diacetate (CFDA) conjugated to
monofluorinated cyclooctyne via a NN'-dimethyl-1,6-diaminohexyl (HDDA) linker (MOFO-
HDDA-CFDA, structure in Figure 4-12A) performed best in entering cells and producing diffuse
whole-cell staining, suggesting that it does not stick to any intracellular organelles or
membranes. We further optimized the loading and washout of MOFO-HDDA-CFDA by varying
loading concentration (6.25-50 ptM) and loading time (5-120 min), hoping to maximize the
loading concentration of MOFO-CFDA that still gives clean washout from cells within
reasonable time. Figure 4-12B shows that low loading concentration of MOFO-CFDA (6.25-12.5
jiM) and short loading time (5-15 min) are required for us to obtain clean washout of excess
probe from HEK cells within 60 min. Based on this information, we decided to proceed with the
MOFO-CFDA loading condition of 10 ptM loading concentration and 10 min loading time for
subsequent studies.
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Figure 4-12. A) Structure of monofluorinated cyclooctyne-fluorescein conjugate (MOFO-HDDA-CFDA).
B) Cellular loading and washout studies of MOFO-HDDA-CFDA in HEK cells. Four loading times and
probe concentrations were tested. Loading was performed at 32 0C in the presence of 0.1 mg/mL pluronic
acid F-127. Cells were imaged right after loading (and quick washes), and every hour after.
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Live-cell intracellular protein labeling with azide 7 ligation and strain-promoted
cycloaddition
We combined the optimized protocols for LplA-mediated azide 7 ligation and loading of
cyclooctyne-fluorescein, and tested for live-cell two-step labeling. HEK cells expressing codon-
optimized LpIA, nucleus-targeted E2p-BFP, and E2p-ala were labeled with azide 7 for 12 hours.
Thereafter, excess azide probe was removed, and cells were further incubated with 10 PM
MOFO-HDDA-CFDA for 10 min. After MOFO-CFDA incubation, cells were washed for
additional 2 hours before live-cell imaging. We were able to observe specific fluorescein labeling
within the nuclei of transfected cells, suggesting that both azide 7 ligation and strain-promoted
cycloaddition labeling steps worked to selectively derivatize E2p-BFP inside the cell nuclei
(Figure 4-13). A control labeling experiment without E2p-ala co-expression showed that
fluorescein labeling was cytosolic, which is indicative of LpIA-dependent labeling background
since the pattern follows LpIA expression, not E2p expression.
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Figure 4-13. Live-cell, two-step labeling of proteins via enzymatic azide ligation and strain-promoted
cycloaddition. HEK cells were transfected with expression plasmids for wild-type LpIA (codon-
optimized), nucleus-targeted E2p-BFP, and without (top row) or with (middle row) E2p-ala. After 12
hours of 250 pM azide 7 incubation and a two-hour washout period, cells were cooled down to 32 'C, and
Dulbecco's modified eagle medium (DMEM) containing 10 pM MOFO-CFDA and 0.1% w/v pluronic F-
127 was added to cells for 10 min. Cells were imaged after another two-hour washout period to remove
excess MOFO-CFDA.
However, even with E2p-ala co-expression, we did not observe nucleus-specific labeling
in all transfected cells. It is possible that co-expression of three plasmids with the cell allows for
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variations in the expression levels of each recombinant protein, and labeling background can still
persist in cells that express more LplA than E2p-ala. While we could further control for
stoichiometric expression of LplA and E2p-ala by generating a construct for bicistronic
expression (via use of internal ribosome entry site (29) or virus 2A sequence (30) in expression
vectors), our optimized labeling protocol still involves long reaction time for the azide ligation
step, due to inefficient ligation of azide 7 by wild-type LplA (kcat = 0.11 s-1, Km = 127 tM for
azide 7 ligation onto E2p (20)). To further increase labeling efficiency and specificity, a better
azide ligase is also required.
Improved azide ligation kinetics allows for more specific two-step intracellular labeling
To identify a better ligase/azide pair, Jen Yao screened a panel of LplA Trp37 mutants
against 4 azidoalkanoic acids for ligation activity, and assessed the top enzyme/probe pairs for
intracellular ligation. She found the pair of LplAW371 and 10-azidodecanoic acid ("azide 9") to
the best, giving 2-fold improvement in kcat/Km (kcat = 0.06 s-, Km = 35 ptM (21)) even when she
performed kinetic characterizations using LAP2 peptide, a slightly worse substrate for LplA
compared to E2p. Most importantly, the improved ligation kinetics and perhaps improved
membrane permeability of azide 9 allowed Jen to perform intracellular azide 9 ligation
efficiently, achieving quantitative ligation yields inside cells within only 30-60 min of azide 9
incubation (21). The intracellular azide ligation specificity was also shown to be better upon
using LplAW371/azide 9 pair compared to wild-type LplA/azide 7 pair, partly because LplAW371
does not have to be expressed at high levels in cells to effect efficient labeling, and enzyme-
dependent labeling background can be much reduced. With Jen's optimized labeling protocol,
we were able to perform specific, efficient two-step azide-cyclooctyne labeling in living cells
with diverse fluorophores, including fluorescein, Oregon Green, and tetramethylrhodamine
(TMR). Figure 4-14 shows an example of specific labeling on nucleus-targeted LAP2-tagged
BFP by co-expressed LplAW371, with a monofluorinated cyclooctyne-TMR conjugate.
TMR LAP2-BFP TMR LAP2-BFP
Field of view 2
Figure 4-14. Live-cell, two-step site-specific labeling with an improved azide ligase and strain-promoted
cycloaddition. COS-7 cells expressing LplAw3 71 and nucleus-targeted LAP2-BFP were incubated with
200 ptM 10-azidodecanoic acid (azide 9) for 2 hours. After excess azide was removed during a 1-hour
washout period, cells were further treated with 10 pM monofluorinated cyclooctyne (MOFO)-
tetramethylrhodamine (TMR) conjugate in serum-free DMEM. Cells were imaged after a 2-hour washout
period to remove excess MOFO-TMR.
Suppression of mitochondrial background labeling using a mitochondria-localized
fluorescence quencher
While most membrane-permeable cyclooctyne-fluorophore conjugates can be used to
produce specific protein labeling with our two-step labeling protocol, we found that ATTO647N
(structure in Figure 4-1), an excellent red fluorophore preferred for many super-resolution
imaging applications (31,32), produced a high level of non-specific binding inside cells. The
non-specific staining of ATTO647N localizes primarily to the mitochondria, as confirmed by co-
staining with MitoTracker Red (Figure 4-15A), and is independent of conjugation of MOFO or
the HDDA linker to ATTO647N.
In order to combat the fluorophore's tendency to accumulate in the mitochondria, we
looked for a fluorescence quencher with similar electronic and hydrophobic properties as
ATTO647N. We imagined that, if added to cells, the quencher too would accumulate in the
mitochondria, selectively suppressing the fluorescence of dyes trapped there. We identified
QSY21 (structure in Figure 4-15B), a commercially available quencher of red fluorophores with
maximal absorption at 661 nm (c = 90,000 M- cm-), as a potential fluorescence quencher of
ATTO647N, which has the emission maximum at 669 nm. We synthesized a membrane-
permeable, unreactive derivative of QSY2I by reacting its succinimidyl ester with ethanolamine.
To test for selective quenching of ATTO647N in the mitochondria by QSY21 -ethanolamine, we
loaded 2 iM ATTO647N into HeLa cells for 10 min, then added 10 PM QSY21-ethanolamine
for 10 min before imaging. We found that the mitochondrial staining intensity of ATTO647N
decreased by -nine-fold upon addition of QSY21-ethanolamine, indicating that the quencher
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accumulated in the mitochondria and functioned as we had expected (Figure 4-15C and D). A
control showed that I 0-min is not sufficient for ATTO647N to be washed out of cells, and that
the reduced fluorescence of ATTO647N upon QSY21 addition is solely due to mitochondria-
localized fluorescence quenching by QSY21.
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Fig'ure 4-15. A red fluorescence quencher QSY21 can be used to suppress mitochondrial fluorescence
background of ATTO647N. A) Mitochondrial localization of ATTO647N-ethanolamine, as assessed from
co-staining with a mitochondrial fluorescence stain, MitoTracker Red. B) Structure of QSY21-
ethanolamine. Note that overall positive charge and hydrophobicity of the molecule. C) Quenching of
mitochondrial ATTO647N fluorescence by loading of QSY21. HeLa cells were incubated with 2 IM
A TTO647N-ethanolamine for 10 min (condition 1) before 10 pM QSY21-ethanolamine was added for 10
min (condition 2). A control in which ATTO647N was allowed to washout over 10-min period is shown
(condition 3). D) Quantitation of ATTO647N fluorescence intensities from C).
We then tested if QSY21 quenching strategy can be used to improve signal-to-noise of
labeling when the two-step protein labeling is performed with ATTO647N. We co-expressed
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LpIA W371 and nucleus-targeted LAP2-BFP inside HeLa cells and performed azide 9 ligation. For
the cycloaddition step, we added I pM of MOFO-HDDA-ATTO647N for 10 min, followed by
washout for 2 hours. Imaging revealed that the mitochondrial accumulation of MOFO-HDDA-
ATTO647N was still very high after two-hour washout, completely overpowering any specific
labeling signal in the cell nuclei. We then incubated cells with 10 pLM QSY21 for 10 min, and
were glad to observe that mitochondrial background was largely eliminated, leaving only
specific fluorescence signal in the nuclei of transfected HeLa cells (Figure 4-16). It seems that
QSY21 is strictly localized to the mitochondria, and does not exert its quenching effect on
labeled cellular proteins outside of the mitochondria.
ATTO647N LAP2-BFP
Field of view 1
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Figure 4-16. Improving signal-to-noise of labeling with ATTO647N, using mitochondrial fluorescence
quenching by QSY21. HeLa cells expressing LplAW3 7' and nucleus-targeted LAP2-BFP were incubated
with azide 9 for 1 hour, followed by a washout period of 1 hour. 1 tM MOFO-HDDA-ATTO647N was
then incubated with cells for 10 min. After another 2-hour washout period, cells were imaged, incubated
10 ptM QSY21-ethanolamine for 10 min, then imaged again.
For difficult labeling experiments in which mitochondrial staining background cannot be
eliminated by extensive cell washing, or in which extended cell washing is not an option, this
QSY21 quenching approach may be used to improve relative labeling signal.
Microinjection to deliver a membrane-impermeable fluorophore for two-step intracellular
protein labeling
Many excellent membrane-impermeable fluorophores are sulfonated, and therefore,
cannot be chemically derivatized easily to allow for cellular delivery. Various mechanical and
-1
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chemical methods exist to temporarily disrupt the plasma membrane, and permit cellular entry of
otherwise impermeable molecules. We experimented with a pore-forming toxin streptolysin 0
(33) as well as delivery via pinocytic vesicular loading and subsequent osmotic lysis (34). We
found that both methods can be used to deliver membrane-impermeable dyes such as cy3 and
cy5 into cells, but the accumulated levels of the dyes inside cells are not sufficient for a
concentration-dependent reaction like strain-promoted cycloaddition to proceed efficiently (data
not shown). We then turned to a more physical method-microinjection-to deliver the dyes.
Figure 4-17 shows that MOFO-HDDA-cy5 could be delivered into cells efficiently by
microinjection, and specific targeting to azide-labeled nucleus-targeted LAP2-YFP could be
achieved. However, microinjection is very low-throughput and causes severe damage to injected
cells. While we sometimes employ microinjection in cell labeling experiments as a tool for
proof-of-principle experiments and for troubleshooting, routine labeling and imaging with
membrane-impermeable sulfonated fluorophores would require a more gentle delivery method
that is easy to perform. We later describe such a method for efficient chemical derivatization of
sulfonated fluorophores for cellular delivery in Chapter 6.
cy5 LAP2-YFP + DIC
Figure 4-17. Cellular delivery of MOFO-HDDA-cy5 via microinjection for site-specific protein labeling.
COS7-cells expressing LplA W37 and nucleus-targeted LAP2-YFP were incubated with azide 9 for 1 hour,
followed by a washout period of 1 hour. 100 nM MOFO-HDDA-cy5 in PBS was then microinjected into
cells (injected cells indicated with white arrows) using FemtoJet microinjector. Out of three injected YFP-
expressing cells in this field of view, two showed specific cy5 labeling in the cell nuclei after excess cy5
was allowed to washout for 20 min.
134
Conclusion
In summary, we have extended LplA-mediated protein labeling to diverse fluorophores
beyond coumarins. This was accomplished via a two-step labeling approach of enzymatic azide
ligation, followed by cycloaddition with fluorophores linked to strained alkynes. We optimized
enzymatic azide ligation and two azide derivatization chemistries, in both fixed and living cells,
and developed a unique strategy to alleviate a common problem of mitochondrial accumulation
of many fluorescent dyes.
In this chapter, we focus on the use of strain-promoted cycloaddition to accomplish live-
cell targeting of fluorophores. In recent years, we also saw the development of even more
kinetically efficient bioorthogonal chemistries that are compatible with the living cell interior.
The new gold standard for such cell-compatible derivatization chemistry is reverse-electron-
demand Diels-Alder cycloaddition between trans-cyclooctenes and tetrazines, whose second-
order reaction rate constants can be as high as 104 M-1 S~1 (35). Daniel Liu and Anupong
Tangpeerachaikul in our lab have successfully adapted the Diels-Alder reaction for site-specific
protein labeling (36), and its utility is illustrated in Chapter 6.
For protein labeling in fixed cells, the two-step approach with azide ligation followed by
CuAAC described in this chapter is still the preferred labeling method, due to high azide ligation
and CuAAC labeling efficiencies that can be achieved under fixed-cell conditions. In Chapter 7,
we describe how the two-step azide/CuAAC labeling can be used to efficiently target cy5 to
cytoskeletal protein structures for STORM super-resolution imaging. The high labeling
efficiencies of LpIA and CuAAC, coupled with the small label size of LAP, allow us to improve
the spatial resolution of STORM upon imaging biological structures.
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Experimental methods
General synthetic methods
Chemicals were purchased from Sigma-Aldrich, Alfa Aesar, or TCI America unless specified
otherwise. Analytical thin layer chromatography was performed using 0.25 mm silica gel 60 F25 4
plates and visualized with p-anisaldehyde, bromocresol green, or short and long-wavelength UV
light. Flash column chromatography was performed using silica gel (ICN SiliTech 32-63D).
Mass spectra were recorded using electrospray ionization (ESI) on an Applied Biosystems 200
QTRAP Mass Spectrometer.
Chemicals. THPTA and BTTAA Cu' ligands were synthesized in-house as previously described
(26,12). Prof. M.G. Finn (Scripps) provided an initial batch of THPTA as well as coumarin
azide. TBTA is commercially available through Sigma-Aldrich. Monofluorinated cyclooctyne
(15) (MOFO) was a gift from Prof. Carolyn Bertozzi (Berkeley). Jen Yao and Dr. Hemanta
Baruah synthesized 8-azidooctanoic acid (azide 7), 10-azidodecanoic acid (azide 9), MOFO
conjugate to N,N'-dimethyl-1,6-hexanediamine (MOFO-HDDA), MOFO-HDDA conjugate to
carboxyfluorescein diacetate (MOFO-HDDA-CFDA), MOFO-HDDA conjugated to
tetramethylrhodamine (MOFO-HDDA-TMR), and MOFO-HDDA conjugated to cy5 as
described (21). Dr. Marta Femindez-Suirez synthesized cy3-alkyne in a similar way as the
synthesis of cy5-alkyne, described below.
Synthesis of cy5-alkyne
To a solution of cy5-succinimidyl ester (GE-Healthcare, 1 mg, 1.3 tmol) in anhydrous DMF
(100 pL) was added propargylamine (1 ptL, 18 pmol). The reaction was allowed to proceed for 3-
5 hr at room temperature. DMF was removed in vacuo, and the resulting residue was dissolved in
water and subjected to purification by HPLC. For this purification, we used a Varian Prostar 210
HPLC equipped with a photo-diode-array detector, and an analytical Microsorb C18 column
(Varian, 5 ptm particle size, 4.6mm x 250 mm dimension). The gradient used was 0-50%
acetonitrile in water at a ImL/min flow rate over 30 min. cy5-alkyne eluted at 19-20 minutes.
After collecting desired fractions, acetonitrile was removed in vacuo, and the resulting solution
was flash-frozen and lyophilized to yield the final product as dark blue powder. ESI-MS for cy5-
alkyne: calculated [M-H]-: 692.25; observed 692.34.
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Synthesis of MOFO-HDDA conjugates to ATTO647N
Synthesis of MOFO-HDDA (performed by Jen Yao). To a solution of MOFO cyclooctyne acid (5
mg, 19 pmol) in 500 gL anhydrous dichloromethane was added pentafluorophenyl
trifluoroacetate (PFP-TFA, 9.8 ptL, 57 pmol) and Et3N (8 pL, 57 pmol). The reaction was
allowed to proceed for 2 hr at room temperature. N, N'-dimethyl-1,6-hexanediamine (HDDA,
114 jmol) was then added to the reaction mixture, which was allowed to stir for 5 hr at room
temperature. Solvent was removed under reduced pressure. The reaction mixture was purified by
silica gel chromatography (10-15% methanol in dichloromethane) to afford MOFO-NN'-
dimethyl-1,6-hexanediamine (MOFO-HDDA).
Synthesis of MOFO-HDDA-ATTO647N. MOFO-HDDA was dissolved in anhydrous DMF (100
ptL), and ATTO647N-succinimidyl ester (Sigma-Aldrich, 1 mg, 1.2 pmol, Sigma-Aldrich) and
triethylamine (TEA; 2 pL, 14 [tmol) were added to the mixture, which was allowed to stir for 12
hours at room temperature in the dark. DMF was removed in vacuo, and the residue was purified
by silica gel chromatography using 0-2% methanol in dichloromethane. ESI-MS for MOFO-
HDDA-ATTO647N: calculated [M+H]f: 1014.66; observed 1014.42.
Synthesis of QSY21-ethanolamine conjugate
To a solution of QSY21-succinimidyl ester (1 mg, 1.3 pmol) in anhydrous DMF (50 ptL) was
added ethanolamine (0.5 pL, 8 gmol). The reaction was allowed to proceed for 12 hr at room
temperature. DMF was removed in vacuo, and the resulting residue was redissolved in DMSO
and used directly in subsequent cellular experiments without further purification.
Genetic constructs used are summarized in Table 2.
Optimized protocol for protein labeling via azide 7 ligation and copper-catalyzed click
derivatization on fixed cells (Figure 4-5)
Cells transfected with an expression plasmid for a desired LAP-tagged protein were fixed 16-24
hours after transfection. A blocking solution (0.5% casein and 0.5% Triton X-100 in Dulbecco's
phosphate buffered saline (DPBS) was then applied for at least I hour at room temperature.
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For LplA-mediated azide 7 ligation step, a reaction mixture was assembled as follows: 10
pM purified wild-type LplA, 250-500 pM azide 7, 1 mM ATP, and 5 mM Mg(OAc) 2 in 0.5%
casein in DPBS. For labeling on a 0.95 cm 2 dish (a 48-well plate well), 150 pL of the reaction
mixture was incubated with cells for 20 min at 30 'C. Thereafter, cells were washed three times
in a wash buffer containing 0.1% casein and 0.2% Triton X-100 in DPBS.
For CuAAC derivatization step, a reaction mixture was assembled as follows: 1 mM
CuSO 4, 100 pM TBTA, and 2.5 mM freshly prepared sodium ascorbate were first combined and
incubated for 5-10 min at room temperature. A reaction buffer of 0.5% casein in DPBS was then
added, followed by 3-5 pLM cy3- or cy5-alkyne. For labeling on a 0.95 cm2 dish (a 48-well plate
well), 150 pL of the reaction mixture was incubated with cells for 1 hour at room temperature, in
the dark and shaking. Thereafter, cells were washed 3 times in a wash buffer containing 0.1%
casein and 0.2% Triton X-100 in DPBS before proceeding to imaging.
Specific intracellular azide 7 ligation with FRB-LpIA (Figure 4-9)
HEK cells were transfected with pcDNA3-FRB-LplA (non-codon optimized; 800 ng per 0.95
cm2 dish) and pcDNA3-E2p-BFP (400 ng) using lipofectamine 2000. Twelve hours after
transfection, cells were incubated with 250 pM azide 7 in full growth media for 35 hours. After a
1-hour washout period to remove excess azide, cells were fixed using 3.7% formaldehyde in PBS
pH 7.4 for 10 min, followed by cold methanol treatment for 6 min at -20 'C. CuAAC detection
with cy5-alkyne was performed as described above.
Specific intracellular azide 7 ligation with E2p-ala co-expression (Figures 4-10 and 4-1 1)
HEK cells were transfected with pcDNA3-mCherry-LplA (humanized codons for LpIA gene,
200 ng per 0.95 cm 2 dish), pcDNA3-E2p(Lys41--Ala)-CFP(Trp66--+Ala) (600 ng), and an E2p
or LAP2 substrate construct (400 ng) using lipofectamine 2000. The Trp66--Ala mutation in
CFP silenced its fluorescence. 6-12 hours after transfection, cells were incubated with 250 pM
azide 7 in full growth media for 12 hours. After a 1-hour washout period to remove excess azide,
cells were fixed using 3.7% formaldehyde in PBS pH 7.4 for 10 min, followed by cold methanol
treatment for 6 min at -20 'C. CuAAC detection with cy5-alkyne was performed as described
above.
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Live-cell detection of azide-modified proteins via cycloaddition with MOFO-HDDA-CFDA
(Figure 4-12)
HEK cells were transfected with pcDNA3-FLAG-LplA (humanized codons for LplA gene, 200
ng per 0.95 cm 2 dish), pcDNA3-E2p(Lys41--Ala)-CFP(Trp66-+Ala) (600 ng), and pcDNA3-
E2p-BFP-NLS (400 ng) using lipofectamine 2000. 6-12 hours after transfection, cells were
incubated with 250 iM azide 7 in full growth media for 12 hours. After a 2-hour washout period
to remove excess azide, cycloaddition was performed by adding serum-free media containing 10
pM MOFO-HDDA-CFDA and 0.1% w/v pluronic F-127 for 10 min at 32 *C. Cells were washed
by changing method 3-4 times over 2 hours before imaging.
Live-cell detection of azide-modified proteins via cycloaddition with MOFO-HDDA-TMR
(Figure 4-13)
COS-7 cells were transfected with pcDNA3-FLAG-LplAW3 71 (humanized codons, 200 ng per
0.95 cm2 dish) and pcDNA3-LAP2-BFP-NLS (400 ng). 16-24 hours after transfection, cells were
incubated with 200 ptM azide 9 in full growth media for 2 hours. After a 1-hour washout period
to remove excess azide, cycloaddition was performed by adding serum-free media containing 10
pM MOFO-HDDA-TMR for 10 min at room temperature. Cells were washed by changing
method 3-4 times over 2 hours at 37 *C before imaging.
Suppression of mitochondrial labeling background using QSY21-ethanolamine (Figure 4-
16)
HeLa cells were transfected with pcDNA3-FLAG-LplAw3 7I (humanized codons, 200 ng per 0.95
cm2 dish) and pcDNA3-LAP2-BFP-NLS (400 ng). 16-24 hours after transfection, cells were
incubated with 200 ptM azide 9 in full growth media for 1 hour. After a 1-hour washout period to
remove excess azide, cycloaddition was performed by adding serum-free media containing 1 PM
MOFO-HDDA-ATTO647N for 10 min at room temperature. After labeling, cells were further
washed by changing method 3-4 times over 2 hours at 37 'C to remove as much MOFO-
ATTO647N as possible, then treated with 10 pM QSY21-ethanolamine in full growth media for
10 min at 37 'C. Cells were imaged after 2-3 quick washes to remove the QSY21 solution.
Microinjection of MOFO-HDDA-cy5 for intracellular protein labeling (Figure 4-17)
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COS-7 cells were plated directly on a 35-mm imaging dish and transfected with pcDNA3-
W37 2FLAG-LplA (humanized codons, 200 ng per 0.95 cm dish) and pcDNA3-LAP2-YFP-NLS
(400 ng). 16-24 hours after transfection, cells were incubated with 200 ptM azide 9 in full growth
media for 1 hour, followed by a 1-hour washout period to remove excess azide.
For microinjection, we used FemtoJet microinjector (Eppendorf) equipped with an
InjectMan N12 micromanipulator (Eppendorf). Injection was performed with Femtotip I
(Eppendorf, 0.5 im inner diameter/i ptm outer diameter) under manual injection mode. Injection
pressure and compensation pressure were set to be 180 hPa and 60 hPa respectively, while the
injection time varied from 2-5 seconds. The injected solution was 100 nM MOFO-HDDA-cy5 in
PBS pH 7.4, which was clarified before injection through centrifugation.
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Chapter 5
Fast, cell-compatible click chemistry with copper-chelating azides
for specific labeling of cell-surface proteins
The work discussed in this chapter has been published in part in: C. Uttamapinant, A.
Tangpeerachaikul, S. Grecian, S. Clarke, U. Singh, P. Slade, K. R. Gee, and A. Y. Ting, "Fast,
cell-compatible click chemistry with copper-chelating azides for biomolecular labeling," Angew
Chem Int Ed EngI 2012(51), 5852-5856.
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Introduction
We are interested in developing methods for efficient targeting of diverse fluorophores to
cell-surface proteins for many biological studies, such as single-molecule tracking of receptors or
assays that monitor the fate or properties of only the surface subpopulation of proteins, as well as
super-resolution imaging of proteins at the neuronal synapses. Such methods would also benefit
in vitro experiments-such as Fbrster resonance energy transfer (FRET) studies of a protein's
conformational dynamics-where tagging of fluorophores to a desired location within a protein
in vitro still presents a challenge (1). The new labeling method should be capable of producing
high labeling signal-to-noise ratio within a short labeling period, to minimize endocytosis from
the cell surface or protein denaturation. Ideally, the method should utilize a small peptide-
directing sequence, to minimize functional perturbation on the target protein (e.g. folding and
stability, surface trafficking); and only small-molecule labeling reagents, to eliminate potential
protein crosslinking that could arise from using antibodies or protein reagents, and to have better
accessibility to certain macromolecularly crowded environments of interest at the cell surface,
such as at the synaptic cleft of contacting neurons. Current state-of-the-art labeling methods for
cell-surface proteins are based on peptide-directed labeling mediated by enzyme ligases,
including phosphopantethienyl transferases (2), sortase (3), and biotin ligase with monovalent
streptavidin detection (4). We wished to extend our labeling methodology based on E. coli lipoic
acid ligase to similar or even better capacities.
We described in Chapter 4 a two-step labeling approach for fluorophore targeting to
intracellular proteins, using enzymatic azide ligation and strain-promoted [3+2] cycloaddition.
However, while strain-promoted cycloaddition is compatible with the living cell interior, even
the fastest of the strained cyclooctynes (5) react with azides more than ten-fold slower than
terminal alkynes in the presence of Cu' (second-order rate constant of -1 M's' for (aza)dibenzo
cyclooctyne (5) compared to 10-100 M-1s-' per 10-100 pM Cu"" for copper-catalyzed azide-
alkyne cycloaddition (CuAAC) (6). The sluggish kinetics of strain-promoted cycloaddition has
particularly detrimental effects towards labeling on the cell surface and in vitro, as high
concentrations of cycloaddition reaction partners would have to be supplied to achieve sufficient
labeling yields (7). Intracellular labeling, on the other hand, can have accumulation of labeling
probes within the cell due to inefficient efflux, especially if the probes are charged. For instance,
we found that coumarin trapped within cells can be twenty-fold more concentrated than its initial
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loading concentration of the probe's membrane-permeable form (8). The effective probe
concentration available for intracellular labeling reactions thus could be much higher than the
loading concentration, and can expedite concentration-dependent reactions like strain-promoted
cycloaddition, therefore partly compensating for its intrinsically slow kinetics.
In searching for efficient bioorthogonal reactions that can be combined with LplA-
mediated ligation for protein labeling, we were struck by the new developments in biocompatible
CuAAC. CuAAC has been used extensively in vitro for the conjugation, immobilization, and
purification of biomolecules (9). However, its use on biological samples has to be done with
caution, as the best Cul-stabilizing ligand, tris-(benzyltriazolylmethyl)amine or TBTA (10), has
poor water solubility, which necessitates the use of high Cu' loading (~1mM) to achieve
reasonable reaction rates. Free Cu' ions that are not coordinated by TBTA can mediate
generation of reactive oxygen species (ROS) in the presence of molecular oxygen (11) (Figure 5-
1). ROS, most particularly hydroxyl radicals, can then inactivate biomolecules and cause severe
cytotoxicity if CuAAC is performed in cellular or in vivo context. To improve biocompatibility
of CuAAC, a series of water-soluble tris-triazole ligands that can be supplied in molar excess to
CueL" have been developed-most notably tris(hydroxypropyltriazlylmethyl) amine (THPTA)
(12), bis[(tert-butyltriazoyl)methyl]-[(sulfoxyethyltriazoyl)methyl]-amine (BTTES) (13), and
bis[(tert-butyltriazoyl)methyl]-[2-carboxymethyltriazoyl)methyl]-amine (BTTAA) (14).
Structures of tris-triazole ligands most often used in cellular applications are assembled in Figure
5-2. These multifunctional ligands serve to accelerate the cycloaddition reaction, keep Cu' bound
to prevent Cu' ions from generating ROS, and act as sacrificial reductants to quench ROS from
harming biomolecules and cells. With the use of BTTAA, for example, CuAAC can be
performed in live zebrafish embryos to derivatize cell surface glycans, without obvious signs of
toxicity (14).
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Figure 5-1. Copper-mediated generation of reactive
Kennedy et al JAm Chem Soc 2011 (133), 17993 (15).
OH
HO 0 0
Cu(I)Ln + O
0 OH
Cu(Il)L,
-- + H2 0 2
Cu(ll)L,
+
+
+
02
02
OH
oxygen species. The equations are taken from
\N-N
N
N
N
HO
N-N
N OH
N N
N
NN
N SO3'
NN'
N NzN'
N
N
N-N
N
COOHN N-
N ) N.-N'
NN T
N-
OH
TBTA THPTA BTTES BTTAA
Figure 5-2. Structures of tris-triazole-based Cu' ligands. TBTA (10): tris-(benzyltriazolylmethyl)amine.
THPTA (12): tris(hydroxypropyltriazlylmethyl) amine. BTTES (13): bis[(tert-butyltriazoyl)methyl]-
[(sulfoxy ethyltriazoyl)methyl]-amine. BTTAA (14): bis[(tert-butyltriazoyl)methyl]-[2-
carboxymethyltriazoyl) methyl]-amine.
Despite developments of new CuAAC ligands, the utility scope of the CuAAC reaction is
still quite limited, as the requirement for fast reaction speed and good biocompatibility is in
direct conflict: higher concentrations of Cul accelerates the reaction, but also produces more
harmful ROS. For cellular applications, supplied concentrations of Cul" for CuAAC has thus
been capped at -50 ptM to provide compromise between adequate labeling efficiency and
minimal toxicity. Unfortunately, this copper concentration is only sufficient for CuAAC to detect
abundant metabolically labeled glycans at the cell surface, but does not allow for labeling on less
abundantly present cell-surface proteins with high sensitivity (vide intra).
In the work present in this chapter, we explored an alternative approach to improve the
cell-compatibility and speed of CuAAC, by modifying the CuAAC reaction partner itself.
Because ROS are generated in proportion to the concentration of Cu', it is beneficial to reduce
Cuvr levels. We reasoned that it might be possible to do so without sacrificing reaction rate, by
introducing an internal copper chelating moiety into the azide or alkyne reaction partner (Figure
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5-3). Indeed, this concept has been explored in previous studies (16,17), but for azide-alkyne
cycloadditions in the presence of Cu" rather than Cu', in organic solvents rather aqueous
conditions, and with very high reactant (200-400 mM) and copper (10 mM) concentrations. The
goal of our study was to extend this concept to the aqueous environment and to conditions
relevant for biomolecular labeling on cells.
We synthesized and tested a panel of potentially copper-chelating azides, and discovered
a >38-fold rate enhancement under aqueous conditions, for reaction of 2-picolyl azide containing
a copper-chelating pyridyl nitrogen with an alkyne fluorophore, compared to its non-chelating
benzyl azide counterpart. Next, the picolyl azide structure was converted into a substrate for
LplA, and a Trp37--*Val mutant of LplA was found to efficiently catalyze picolyl azide ligation
onto LAP-tagged proteins expressed on the surface of living mammalian cells, including
neurons. The ligated picolyl azide could then be chemoselectively derivatized with alkyne-
fluorophores, under mild CuAAC conditions (down to 10 pM Cu""). A side-by-side comparison
showed that our chelation-assisted CuAAC protocol provides much higher labeling sensitivity
for cell-surface proteins, compared to traditional CuAAC with alkyl azides as well as strain-
promoted cycloaddition.
R R'
N rN ::N
Cu(I) -cu- -N, +
click ligand(L) 'N N
R'
Figure 5-3. Generic reaction scheme for Cul-catalyzed, picolyl azide-alkyne cycloaddition (chelation-
assisted CuAAC).
Comparison of CuAAC rates with various copper-chelating azide structures
The rate-determining step of CuAAC is postulated to be the formation of the metallacycle
between the Cu'-acetylide and the organic azide (18). We hypothesized that an organic azide
with intrinsic affinity for Cu"", such as one that contains an internal Cu chelator, would
accelerate metallacycle formation and hence the overall reaction rate. We prepared two azides
with proximal pyridyl nitrogen atoms to chelate to Cu ions (picolyl azides 2 and 4), as well as
their non-chelating carbocyclic analogues, 1 and 3 (Figure 5-4). We also appended electron
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donating and withdrawing groups to modulate the chelating strength of the pyridyl nitrogen
(structures 5-7). To measure the relative CuAAC rates of our azide panel, we employed a
fluorogenic CuAAC assay using 7-ethynylcoumarin, which undergoes a large increase in
fluorescence quantum yield from 1% to 25% upon reaction with an azide to form the triazole
adduct (19). The assays were performed in 100 mM sodium phosphate buffer at pH 7.4 at 25 'C,
with 20 ptM azide, 40 ptM 7-ethylnyl coumarin, 10 [tM CuSO 4 , 4 mM sodium ascorbate, and 100
[tM Tempol. In initial runs, we observed Cu-dependent fluorescence quenching of 7-ethynyl
coumarin and coumarin-triazoles, but fortunately found that the problem could be alleviated via
addition of Tempol, which functions as a radical scavenger and helps destroy ROS (data not
shown). Ligands such as THPTA were not added at this stage, to assess the effects of the
chelating moieties alone. Coumarin fluorescence turn-on was converted to the quantity of
coumarin triazole product by comparison to standard curves, individually generated for each
azide-coumarin alkyne adduct.
A)
R N3 , Cu(I) RO
7-ethynyl coumarin OH triaZole adductOH
weakly fluorescent strongly fluorescent
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azide structure after 10 min after 30 min azide structure after 10 min after 30 min
0
1 N3 5 * N 13 ±1 43±1
2 43±3 81±3 OMe
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Figure 5-4. Analysis of CuAAC rates with chelating azides in vitro. A) A fluorogenic click reaction with
7-ethynyl coumarin (19) was used to measure CuAAC reaction progress. B) CuAAC reaction time
courses for azide structures shown in Figure 5-4C. Reactions were performed with 20 tM azide, 40 ptM
7-ethynyl coumarin, 10 pM CuSO4 , 4 mM ascorbate, and 100 pM Tempol in phosphate buffered saline,
pH 7.4. Fluorescence was converted to coumarin triazole product quantity by comparison to standard
curves, individually generated for each azide-coumarin alkyne adduct. Entries with less than 1% reaction
yield at 30 min (azides 1 and 3) are omitted from the plot. Measurements were performed in triplicate.
Error bars, ± s.d. C) Tabulated CuAAC reaction yields after 10 min and 30 min of various chelating azide
structures.
Figure 5-4B shows the CuAAC reaction time courses upon using different azides (entries
with less than 1% reaction yield are omitted from the plot), while Figure 5-4C tabulates the
values for percent conversion into product after 10 and 30-min reaction times. Whereas the
conventional azides 1 and 3 gave no detectable product after 30 minutes, likely due to the low
amount of Cu used, the picolyl azides 2 and 4 gave 81% and 38% product yields, respectively,
after 30 minutes. The picolyl azide methyl ester 5 gave similar results to the acid form 4.
Substitution of the aromatic ring with an electron-donating methoxy group (azide 6) further
accelerates the CuAAC reaction, while an electron-withdrawing chloride substituent (azide 7)
reacts slower than other picolyl azide derivatives. These observations are consistent with a
mechanism in which rate acceleration is caused by coordination of the pyridyl nitrogen atom to
CuI or Cu'-acetylide, since an electron-donating group will increase the electron density on this
nitrogen atom, improving coordination.
Effect of the THPTA ligand on chelation-assisted CuAAC rates
We further investigated picolyl azide 4, because it is the synthetic precursor of the ligase
substrate and fluorophore conjugates described later in this chapter. We repeated the CuAAC
reaction, but this time at three different copper concentrations (10, 40, and 100 pM), either in the
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absence or the presence of Cu'-stabilizing ligand THPTA (4 molar equivalents relative to
copper). While the presence of THPTA or other tris-triazole ligands is necessary to maintain the
reaction's biocompatibility, we were not sure whether we would see additional rate enhancement
from THPTA upon using picolyl azides, as THPTA and picolyl azides can compete in Cu
binding and together, might not be able to form productive Cu-coordinating complexes that
facilitate [3+2] cycloaddition. Figure 5-5 shows that time courses of these six reactions, as well
as control reactions using the non-chelating analogue of 4, azide 3. Gratifyingly, we found that
the additional of THPTA further increases the CuAAC reaction rate, even when picolyl azide 4 is
used as a reaction partner. For the conventional azide 3, product was undetectable after 30
minutes in the absence of THPTA (consistent with Figure 5-4), whereas the reactions at 40 and
100 pM cooper proceeded to completion within 30 minutes when THPTA was added.
100pM CuSO4 40M CuSO4
I
t
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I
I
5 10 15 20 25 30
reaction time (min)
10pM CuSO4
-- - - - - - - - - - -
120
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0
o 20
0
-20
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- - 4-azidomethylbenzoic acid 3, - THPTA
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- - 6-azidomethylnicotinic acid 4, - THPTA
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reaction time (min)
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Figure 5-5. Kinetic comparison of chelating azide 4 and its non-chelating benzyl counterpart 3 at different
copper concentrations. CuAAC product was detected using the assay in Figure 5-4A. Solid lines indicate
reactions in which the Cu(I) ligand THPTA was added (at 4 molar equivalents over the copper
concentration). Measurements were performed in triplicate. Error bars, ± s.d.
Striking rate enhancements are observed for all six conditions when azide 3 is substituted
by the chelation-competent azide 4. Without THPTA, reactions were still able to proceed to
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completion within 30 minutes for the two higher copper concentrations (40 and 100 pM), in
striking contrast to azide 3. When THPTA was added, azide 4 reacted to completion within 5
minutes at all three copper concentrations. In other words, the use of copper-chelating azide 4 far
offsets the decrease in the CuAAC reaction rate caused by lowering the copper concentration.
The effect is very strong such that the reaction rate of chelating azide 4 at the lowest Cu
concentration (10 pM) exceeded the reaction rate of the non-chelating azide 3 at the highest Cu
concentration (100 pM). It is also noteworthy that the use of picolyl azide 4 instead of the
conventional azide 3 can more than offset the effect of omitting the accelerating ligand THPTA.
Figure 5-5 shows that the reaction rates with picolyl azide 4 at all three Cu concentrations in the
absence of THPTA were at least as high as the reaction rates of the conventional azide 3 in the
presence of THPTA.
Screening for LpIA mutants to catalyze picolyl azide ligation and in vitro characterization
Based on the dramatic effects observed in vitro, we were interested in exploring whether
chelation-assisted CuAAC with picolyl azide could be used in conjunction with our lab's
methodology for site-specific protein labeling, based on E. coli lipoic acid ligase, as illustrated in
Figure 5-6. In such two-step labeling approach, LplA would ligate one click reaction partner, in
this case the picolyl azide, onto LAP-tagged cell-surface proteins. Picolyl azide-modified
proteins can then be chemoselectively derivatized with a terminal alkyne-probe conjugate via
chelation-assisted CuAAC.
0 0
0 0  NZA 0 '
NH3 O N3 O
-0~~}N j NH NH
Outside cell N N3  N
13-residue azijNe
LA P picolyl azide 8" N
POI P01 P01Lipoic acid ligase Cu(I), 0
Inside cell (w37vLplA) + ATP BTTAA or TH PTA
Figure 5-6. Site-specific probe targeting to cell surface proteins via lipoic acid ligase and chelation-
assisted CuAAC. An engineered lipoic acid ligase (Trp37-+Val LplA) first ligates a picolyl azide
derivative (picolyl azide 8) onto LplA Acceptor Peptide (LAP), which is genetically fused to a protein of
interest (POI). Picolyl azide-modified proteins are then derivatized with a terminal alkyne-probe
conjugate (red circle), via live cell-compatible chelation-assisted CuAAC. BTTAA and THPTA are Cu'
tris-triazole ligands.
In previous work, we showed that E. coli lipoic acid ligase (LplA) could be mutated at a
gatekeeper residue, Trp37, to allow it to catalyze covalent ligation of a variety of unnatural
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small-molecule substrates (20,21,22,8) onto a central lysine residue of LplA acceptor peptide, or
LAP. The principle requirement of the small molecule substrate is that it must have an aliphatic
appendage (3-4 methylenes) terminated by a carboxylic acid, which is activated by the ligase to
an adenylate ester. Therefore, to develop a picolyl azide enzymatic ligation, we first synthesized
such a variant of picolyl azide 4, which bears a close structural resemblance to an aryl azide
photocrosslinker derivative that our lab had previously engineered a specific ligase for (23).
Figure 5-7 shows the synthesis of the potential LplA substrate, picolyl azide 8, which was
accomplished in six steps in 21% overall yield from dimethyl pyridine-2,5-dicarboxylate.
0
N OMe NaBH 4/CaC12  OH 1) TsCl, TEA, CH 2Cl 2  N N3MeO .- MeO r MeO
O THF/MeOH O 2) NaN3, THF O0 0 0
40% 85% over two steps 5
NN
LiOH N3 1) DSC, TEA, DMF HO H N3HO HOS4 N
MeOH, H20, rt 2) HO NH2  4
96% 0 0
4 0 picolyl azide 8
TEA, DMF
64% yield over two steps 21% overall yield
Figure 5-7. Synthesis of picolyl azide 8, a picolyl azide derivative that can function as an LplA substrate.
TsCl: p-toluenesulfonyl chloride; TEA: triethylamine; DSC: disuccinimidyl carbonate.
We next tested picolyl azide 8 for ligation by a panel of LplA mutants. Each mutant
contained a modification at the gatekeeper residue Trp37 - to G, A, V, I, L, or S. w37vLplA was
found to be the most effective ligase (data not shown), based on an HPLC assay using synthetic
LAP peptide. Figure 5-8A shows the HPLC data for w37vLplA-catalyzed ligation of picolyl azide
8 onto a synthetic LAP2 peptide, alongside negative controls with ATP omitted or w37vLpIA
replaced by wild-type LpIA. The starred product peak was analyzed by mass spectrometry to
confirm its identity as the covalent adduct between LAP and picolyl azide 8 (Figure 5-8B).
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Figure 5-8. In vitro characterization of W37vLpA-catalyzed ligation of picolyl azide 8. A) Reverse-phase
HPLC traces showing LAP peptide conversion to LAP-picolyl azide 8 adduct, catalyzed by W37 vLplA. For
the red trace, the reaction was performed for 30 min with 1 mM ATP. In black are negative controls with
ATP omitted or W37vLplA replaced by wild-type LplA, which does not recognize picolyl azide 8. B)
Mass-spectrometric analysis of the starred peak in A). Calculated mass for the LAP-picolyl azide 8 adduct
is 1829.28 g/mol; 1829.20 g/mol was detected.
To test LplA-catalyzed picolyl azide targeting on cells, we prepared HEK cells
expressing LAP4.2-tagged cyan fluorescent protein fused to the transmembrane domain of the
platelet-derived growth factor receptor (LAP4.2-CFP-TM). LAP4.2-CFP is on the extracellular
side of the cell. Picolyl azide 8, LplAW37v, and ATP were added for 20 minutes to these
transfected cells. LAP-ligated picolyl azide was then detected by CuAAC with Alexa Fluor 647-
alkyne. Figure 5-9 shows that labeling was easily detectable and specific to transfected cells.
Picolyl azide 8 ligation is more efficient than 8-azidooctanoic acid ligation at the cell surface
In the next section, we wished to determine the contribution of picolyl azide's chelation
assistance to cellular labeling efficiencies, by comparing cell-surface labeling signal obtained
from using a chelation-competent picolyl azide 8 to signal from an azide that is incapable of
click chelation assistance, 8-azidooctanoic acid (21) (which is referred to as azide 7 in Chapter 4
but is referred to by its IUPAC name in this chapter, to avoid confusion with a chelating azide 7
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in Figure 5-4). However, we had to take into account the difference in ligation kinetics between
LpIA W37V-catalyzed picolyl azide 8 ligation and wild-type LpIA-catalyzed 8-azidooctanoic acid
ligation, which would ultimately affect the apparent CuAAC labeling efficiencies.
To estimate enzyme-mediated azide ligation efficiencies at the cell surface, we performed
the two azide ligations using 200 pM azide (picolyl azide 8 or 8-azidooctanoic acid), 20 pM
purified LplA (W37V mutant or wild-type), 2mM ATP, and 5mM Mg(OAc) 2 for 20 min. The
ligation conditions were the exact same conditions used in the next section. Thereafter, cells
were washed and any remaining unmodified LAP sites were labeled under forcing conditions
with lipoic acid (200 piM lipoic acid, 1 mM ATP, and 20 pM wild-type LplA for 20 min) (Figure
5-9A). Anti-lipoic acid antibody staining was used to quantify the extent of lipoylation. and
CuAAC was performed thereafter with 20 ptM Alexa Fluor 647-alkyne, 100 pM CuSO4 , and 500
pM BTTAA ligand for 5 min.
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Figure 5-9. Comparison of enzyme-catalyzed azide ligation efficiencies at the cell surface. A) Labeling
protocol. HEK cells expressing LAP-CFP-TM were labeled with picolyl azide 8 and W37vLplA, or 8-
azidooctanoic acid and wild-type LplA, using the same exact conditions as in Figure 5-10. Thereafter,
cells were washed and any remaining unmodified LAP sites were labeled under forcing conditions with
lipoic acid (200 pM lipoic acid, 1 mM ATP, and 20 piM wild-type LplA for 20 min). Anti-lipoic acid
antibody staining was used to quantify the extent of lipoylation, and CuAAC was performed thereafter
with 20 pM Alexa Fluor 647-alkyne, 100 siM CuSO 4, and 500 ptM BTTAA ligand for 5 min. Cells were
imaged live. B) Representative confocal images. Results obtained using picolyl azide 8 (condition 2) are
shown below results with 8-azidooctanoic acid (condition 1). A negative control with neither azide added
during the LpIA step is shown in the bottom row (condition 3). The Alexa Fluor* 647 channel reflects
CuAAC labeling. The Alexa Fluor 568 channel shows anti-lipoic acid antibody labeling. The CFP
channel showing LAP-CFP-TM expression is overlaid on DIC. Scale bars, 10 ptm. C) Quantitation of data
in B). The mean intensities in all three channels were collected for >90 single cells for each condition. To
compare the extents of lipoylation, the Alexa Fluor 568/CFP ratios were calculated (to normalize for
variations in LAP expression level), averaged, and plotted on the graph. CuAAC labeling extent was
quantified in a similar way. Error bars, ± s.e.m.
Figure 5-9B and Figure 5-9C show representative labeling images from CuAAC labeling
and anti-lipoic acid staining, and quantitation of labeling signal, respectively. Condition 3, a
control in which neither azide was added during the LplA step, was set to represent 100%
lipoylation of the cell surface LAP-CFP-TM population due to the forcing conditions of the
LplA-catalyzed lipoylation. By comparison, lipoylation after picolyl azide 8 labeling (condition
1) proceeded to 19% that of condition 3. Lipoylation after 8-azidooctanoic acid labeling
proceeded to 37% that of condition 3. Based on these, we could indirectly estimate that picolyl
azide 8 ligation proceeded to 81%, and 8-azidooctanoic acid ligation proceeded to 63%, under
the specified conditions.
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Assessing the contribution of picolyl azide's chelation assistance in the cellular context
To quantitatively examine the contribution of chelating assistance to labeling efficiency
in the context of cell-surface fluorescence experiments, we repeated the labeling under several
different conditions. We varied the copper concentration (10, 40, and 100 piM, same as in Figure
5-5) and added either THPTA ligand used in our in vitro experiments (Figure 5-5), or BTTAA
ligand, which was recently reported to be superior to THPTA and to give the fastest and most
cell-compatible CuAAC labeling to date (14). As a control, we compared LAP-expressing cells
labeled with wild-type LpIA and 8-azidooctanoic acid, an alkyl azide that is incapable of click
chelation assistance (7). Although picolyl azide 8 ligation was shown to be faster, the difference
in yields after 20 min of labeling is at most 1.5-fold over that of 8-azidooctanoic acid ligation by
wild-type LplA (see Figure 5-9). This correction factor can therefore be applied to the
multivariate comparison shown in Figure 5-10B (cell images) and Figure 5-1 OC (quantitation of
labeling intensities on the cells).
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FigLre 5-10. Comparison of protein labeling signals on live cells using lipoic acid ligase and CuAAC,
with and without chelation assistance. A) Two-step site-specific cell surface protein labeling protocol. In
the first step, HEK cells expressing LAP-CFP-TM (TM is the transmembrane helix of the PDGF
receptor) are labeled with picolyl azide 8 using wnvLplA and ATP added to the cell medium for 20 min.
Alternatively, for the purpose of comparison, LAP-CFP-TM is labeled with non-chelating azide 8-
azidooctanoic acid using wild-type LplA and ATP. In the second step, CuAAC is performed for 5 min
using Alexa Fluor 647-alkyne, various concentrations of CuSO 4 (10, 40, or 100 pM), and either THPTA
or BTTAA ligand added in 4-fold excess of the CuSO 4. B) Representative confocal cell images for twelve
different conditions (three CuSO4 concentrations, either THPTA or BTTAA ligand, and either alkyl azide
or picolyl azide on LAP). For each condition, the Alexa Fluor 647 labeling channel and the CFP channel,
overlaid on DIC, are shown. Insets show the Alexa Fluor 647 channel at higher contrast. Scale bars, 10
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pim. C) Quantitation of data in B). To quantify labeling signals, the mean Alexa Fluor 647 and mean CFP
intensities were calculated for >90 cells for each condition, ratioed to normalize for variations in LAP-
CFP-TM expression level, and averaged. Error bars, ± s.e.m.
Several trends are apparent from Figure 5-10. First, for the conventional azide, 8-
azidooctanoic acid, decreasing the copper concentration reduces the cell labeling signal, as
expected. Second, BTTAA does indeed give high signals than THPTA, but not as much as
previously reported (14) and not at the lowest copper concentration of 10 pM. Third,
replacement of 8-azidooctanoic acid on LAP with the chelation-competent picolyl azide 8 boosts
cell signal at all Cu concentrations 4- to 38-fold. When differences in picolyl azide vesus alkyl
azide enzymatic ligation efficiencies are taken into account, the difference is 2.7 to 25-fold
(Figure 5-10C). The signal enhancements are greatest at the higher copper concentrations of 40
and 100 pM. Similar to the in vitro data shown in Figure 5-5, the signal enhancement caused by
picolyl azide more than offsets the decrease in the CuAAC rate caused by lowering the copper
concentration. For example, the signal with picolyl azide at 10 pM Cu (+ THPTA) is still 1.6-
fold (corrected value) greater than the signal with alkyl azide at 100 pM (+ THPTA).
Comparisons in the presence of BTTAA ligand show that picolyl azide at 40 pM Cu gives a 3.9-
fold (corrected value) greater signal than alkyl azide at 100 pLM Cu. This experiment also shows
that the rate enhancement caused by picolyl azide (compared to the non-chelating alkyl azide) is
much greater than the rate enhancement due to switching from a previous-generation ligand
(THPTA) to the newest-generation ligand (BTTAA). Overall, the best cell-labeling results are
obtained using picolyl azide 8 in combination with BTTAA ligand and either 40 or 100 gM
CuSO4.
Specificity of cell-surface protein labeling with LplA-mediated picolyl azide ligation and
CuAAC
Using the optimized labeling conditions, we tested the site-specificity of cell-surface
protein labeling using LplA and CuAAC. In Figure 5-11, HEK cells expressing the
transmembrane construct LAP4.2-neurexin-1 P (LAP is extracellular) were labeled first with
LplAW37v and picolyl azide 8, then with Alexa Fluor 647-alkyne in the presence of 40 pM
CuSO 4 and 200 pM BTTAA ligand. Transfected cells (expressing a nuclear yellow fluorescent
protein (YFP) marker) were strongly labeled with a ring of Alexa Fluor 647 fluorescence,
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whereas neighboring untransfected cells were unlabeled. Negative controls with ATP omitted,
wild-type LplA in place of LpIA W37V, or an alanine mutation in LAP did not result in Alexa
Fluor 647 labeling. The use of picolyl azide ligase in combination with chelation-assisted
CuAAC thus seems to increase labeling signal without sacrificing labeling specificity.
Alexa Fluor 647
marker
+ DIC
orrutA TP wild type ligase (Lys -Ala) LAF
Figure 5-11. Site-specific labeling of cell surface proteins with an engineered picolyl azide ligase and
chelation-assisted CuAAC. Labeling of LAP-neurexin-1 on the surface of live HEK cells was performed
using lipoic acid ligase and CuAAC. First, picolyl azide 8 was ligated to LAP using 10 pM w37vLplA and
1 mM ATP for 20 min. Second, the cell media was replaced with 20 puM Alexa Fluor 647-alkyne, 40 piM
CuSO 4 , and 200 pM BTTAA for 5 min. Negative controls are shown with ATP omitted from the first
step, wild-type LpIA used in place of W37 vLpIA, and a Lys -> Ala mutation in LAP. Histone2B-YFP was
used as a transfection marker. Confocal images are shown. Scale bars, 10 tm.
Exploring a reverse-order labeling scheme with LpIA-mediated alkyne ligation and
CuAAC with picolyl azide-fluorophore conjugate
For maximum versatility, we also wished to develop an enzymatic alkyne ligation.
Alkyne-modified proteins can subsequently be derivatized using picolyl azide-probe conjugates
(IFigure 5-12A). Previously, we showed that wild-type LplA ligates several alkynoic acids to a
small extent (7). This degree of ligation is not adequate for cellular labeling experiments. We
repeated the screen with the same six LplA W37 mutants used for picolyl azide 8 ligase
screening, and two alkynoic acids-6-heptynoic acid and 10-undecynoic acid. The combination
of 10-undecynoic acid and w37vLplA gave the greatest product in a 30-minute assay. HPLC and
mass spectrometric characterizations of this alkyne enzymatic ligation are shown in Figure 5-
12B and 5-12C. An analogous two step labeling experiment with enzymatic ligation of 10-
undecynoic acid, followed by chelation-assisted CuAAC with Alexa Fluor 647-picolyl azide, is
shown in Figure 5-12D.
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Figure 5-12. Site-specific labeling of cell surface proteins with an alkyne ligase, followed by chelation-
assisted CuAAC with a picolyl azide-probe conjugate (the inverse reaction compared to Figures 5-3). We
screened six LpIA W37 mutants-G, A, V, I, L, S-for ligation activity with 6-heptynoic acid and 10-
undecynoic acid. The combination of 10-undecynoic acid and W37vLplA gave the greatest amount of
product in a 30-minute assay (data not shown). A) Labeling scheme. W37vLplA first ligates 10-undecynoic
acid onto a LAP-tagged fusion protein. Ligated alkynes are then derivatized with a picolyl azide-probe
conjugate via chelation-assisted CUAAC. B) HPLC analysis of W37vLplA-catalyzed ligation of 10-
undecynoic acid onto LAP peptide. A negative control with ATP omitted is shown. C) ESI-mass
spectrometric analysis of 10-undecynoic acid-LAP conjugate (starred peak in (B)). D) Fluorescent
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labeling of LAP-neurexin-1P on the surface of live HEK cells following the scheme in (A). The first step
was performed with 200 pM 10-undecynoic acid, 10 [tM purified W37vLplA, 1 mM ATP, and 5 mM
Mg(OAc) 2 for 20 min. The second step was performed with 20 pM Alexa Fluor* 647-picolyl azide, 50
IM CuSO 4 , 250 pM THPTA, and 2.5 mM sodium ascorbate in DPBS for 5 min. Negative controls are
shown with ATP omitted (second row) or wild-type LpIA in place of W37vLplA (third row). H2B-YFP
was used as a nuclear-localized transfection marker. Scale bars, 10 im.
The two labeling schemes involving picolyl azide were compared side by side in Figure
5-13. Picolyl azide ligation, followed by fluorophore-alkyne, gave -2.4-fold greater signal on
average than alkyne ligation followed by fluorophore-picolyl azide. This may be due to enhanced
chelation effect in one orientation compared to the other, or it may also reflect higher efficiency
for the enzymatic ligation of picolyl azide 8 versus enzymatic ligation of the alkyne 10-
undecynoic acid. To help separate these contributions, we also performed the second labeling
scheme (alkyne ligation followed by fluorophore-azide) using a fluorophore-alkyl azide rather
than a fluorophore-picolyl azide. In this case, the resulting signal on cells dropped by -1.5-fold,
illustrating the contribution of chelation-assistance to CuAAC yield in the presence of 100 pM
copper. Finally, Figure 5-13 compares the labeling signal for ligation of 8-azidooctanoic acid
followed by a fluorophore-alkyne, which gives the poorest result, probably due to a combined
effect of no chelation assistance and low enzymatic ligation efficiency for 8-azidooctanoic acid.
We concluded that the optimal way to use LpIA-catalyzed labeling and chelation-assisted
CuAAC in combination, is to use LplA to ligate the picolyl azide substrate, and then derivatize
with a fluorophore-alkyne.
Comparison of chelation-assisted CuAAC and strain-promoted cycloaddition
Since strain-promoted cycloaddition is frequently used as an alternative to CuAAC in the
cellular context, including by us (20), we compared this approach to our newly optimized
CuAAC in terms of both labeling signal and cytotoxicity. Figure 5-14A shows that picolyl azide
8 ligation to LAP4.2-neurexin-1P at the cell surface, followed by CuAAC at 50 gM CuSO4 and
25 pM Alexa Fluor 647-alkyne, gave far greater Alexa Fluor 647 labeling signal than if the azide
were derivatized by dibenzocyclooctyne (24)-Alexa Fluor 647 conjugate, supplied at the same
concentration as the alkyne. We also compared the toxicity of these labeling conditions using the
CellTiter-Glo assay, which measures cellular ATP levels. Figure 5-14B shows that the assay did
not distinguish the levels of toxicity of our CuAAC conditions and strain-promoted
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cycloadditions, even when CuAAC was performed at high Cu concentration of 300 IM. A
control of toxic treatment via incubation of cells with CuSO 4 in the absence of a CuI-stabilizing
ligand shows that THPTA or BTTAA ligand is required for cell-compatible CuAAC labeling, as
previously reported.
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Figure 5-13. Comparison of cell-surface labeling signals for four different LpIA-CuAAC labeling
schemes. LplA labeling was performed with picolyl azide 8, 8-azidooctanoic acid, or 1 0-undecynoic acid.
CuAAC was performed with either alkyne, picolyl azide, or alkyl azide conjugates to Alexa Fluor 647. A)
Representative images showing labeling of LAP-CFP-TM on the surface of live HEK cells under four
different conditions. CFP channels are shown, along with Alexa Fluor 647 labeling channels normalized
to the same intensity range (bottom) or not normalized (middle). LpIA labeling protocol for all four
conditions: 200 pM azide or alkyne substrate, 10 pM LpIA (wild-type or mutant), 1 mM ATP, and 5 mM
Mg(OAc) 2 in cell culture medium for 20 min. CuAAC labeling protocol for all four conditions: 20 pM
click probe, 100 IM CuSO 4 , 500 IM THPTA, and 2.5 mM sodium ascorbate in DPBS for 5 min. B)
Quantitation of data in (A). Average Alexa Fluor 647/CFP intensity ratios were calculated for -50 single
cells from each condition. Error bars, ± s.d.
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Untransfected, unlabeled 100 ± 4
Transfected, unlabeled 95 ± 6
Transfected, labeled with 40pM Cu2+, 200pM THPTA, and 25pM Alexa Fluor 647-alkyne 113 ± 4
Transfected, labeled with 300pM Cu2+, 1.5mM THPTA, and 25pM Alexa Fluor 647-alkyne 98 ± 0
Transfected, labeled with 40pM Cu2+, 200pM BTTAA, and 25pM Alexa Fluor 647-alkyne 115 ± 7
Transfected, labeled with 300pM Cu2+, 1.5mM BTTAA, and 25pM Alexa Fluor 647-alkyne 106 ± 15
Transfected, labeled with 25pM Alexa Fluor 647-DIBO 117 ± 1
Transfected, treated with 600pM Cu2. 19 ± 2
Fig1Yure 5-14. Comparison of chelation-assisted CuAAC and strain-promoted azide-alkyne cycloaddition.
A) HEK cells expressing LAP-tagged neurexin-l IP were labeled by W37vLplA with picolyl azide 8, then
derivatized with either Alexa Fluor 647-alkyne via chelation-assisted CuAAC (top row), or Alexa Fluor
647-dibenzocyclooctyne (DIBO; bottom row) via strain-promoted cycloaddition. Live-cell anti-c-myc
immunostaining, with a secondary antibody conjugated to Alexa Fluor 568, shows c-myc-tagged LAP-
neurexin expression on the cell surface. LplA labeling conditions: 200 piM picolyl azide 8, 10 [tM
W37vLplA, 1 mM ATP, and 5 mM Mg(OAc) 2 in cell culture medium for 20 min. CuAAC labeling
conditions: 25 ptM Alexa Fluor 647-alkyne, 50 PM CuSO 4 , 250 PM THPTA, 2.5 mM sodium ascorbate in
DPBS for 5 min. Strain-promoted cycloaddition labeling conditions: 25 ptM Alexa Fluor 647-DIBO in 3%
w/v bovine serum albumin in DPBS for 5 min. Confocal images are shown. Scale bars, 10 Pm. B)
CellTiter-Glo cell viability assay to test the cytotoxicity of various labeling conditions. HeLa cells
transfected with LAP-neuroligin-1 plasmid were labeled using CuAAC or strain-promoted cycloaddition
as indicated for 5 min. In the last row, cells were subjected to toxic treatment with 600 pM CuSO 4 for 10
min. Values are normalized to that of untransfected, unlabeled cells (first entry), which is set to 100% cell
viability. Measurements were performed in triplicate. Errors, ± s.d.
Optimizations of chelation-assisted CuAAC labeling on cultured neurons
A demanding test of the biocompatibility of our new CuAAC with a copper-chelating
azide is to perform it on neuron cultures. These delicate cells show morphological changes in the
presence of even low concentrations of toxic substances. Initial attempts to perform LpIA-
mediated picolyl azide ligation and subsequent CuAAC in neurons produced strong labeling
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signal that was specific to transfected cells, but also a lot of focal swelling of neurons, which is a
sign of cytotoxicity. We performed several empirical optimizations to ensure that the labeling,
especially the CuAAC step, is as non-toxic as possible. The modified labeling protocol to
maximally protected neurons is: 1) we added a radical scavenger Tempol, which has been shown
to have neuroprotective effects (25) and should be able to aid in protecting neurons from ROS; 2)
to immediately sequester ROS-generating Cu' species after CuAAC labeling (13), a
biocompatible Cu' chelator, bathocuproin sulfonate, was applied during the first post-CuAAC
rinse; 3) DMSO used in labeling stocks was minimized. All labeling reagents, including picolyl
azide 8, Tempol and bathocuproine sulfonate, are water-soluble and are supplied to labeling
solutions from aqueous stocks. The only labeling reagent that we kept as DMSO stock is Alexa
Fluor 647-alkyne: its 100mM DMSO stock was diluted immediately prior to use to make 5mM
aqueous stock, which is then used to add to the final labeling solution. Sodium ascorbate
concentration can also be reduced from 2.5 mM to 750 pM without an obvious reduction in
labeling signal intensity (data not shown). Aminoguanidine, which can capture dehydroascorbate
and its decomposition product before they can react with protein sidechains (12), did not seem to
help improve neuron viability (data not shown).
With a more optimized labeling protocol tailored for neurons in hand, we transfected 5-
day old hippocampal rat neuron cultures with plasmids for Homerlb-GFP (a postsynaptic
marker) and LAP4.2-neuroligin-I (a postsynaptic transmembrane adhesion protein with an
extracellular LAP tag). On day 11, picolyl azide 8 was ligated to LAP for 20 minutes, then
CuAAC was performed with THPTA and either 50 pM or 300 pM CuSO4 . Figure 5-15 shows
that both conditions produced specific labeling, with Alexa Fluor 647 on neuroligin-1 co-
localized with Homerlb-GFP marker. However, the high copper concentration causes focal
swelling in the neurons (white arrows). Alexa Fluor 647 labeling on LAP-neuroligin-1 also co-
localized well with antibody staining against the GluRi subunit of the AMPA glutamate receptor
(Figure 5-16), further confirming the specificity of neuroligin-1 labeling at the synapses. The use
of chelation-assisted CuAAC thus allows the concentration of Cu to be decreased to levels
minimally toxic to neurons, with little sacrifice to the signal intensity.
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Figure 5-15. Labeling of LAP-neuroligin-1 on the surface of living hippocampal rat neurons. I1 day-old
rat hippocampal neuron cultures expressing LAP4.2-neuroligin-1 and GFP-Homerlb were labeled with
picolyl azide 8 as described in Figure 5-11, then with Alexa Fluor 647-alkyne via chelation-assisted
CuAAC. Cells were imaged live after brief rinsing. CuAAC labeling was performed with two Cu
concentrations indicated, in the presence of 5:1 THPTA:Cu molar ratio and 50 pM Tempol. Alexa Fluor
647 images in the second column correspond to the boxed regions 1 and 2, shown at higher zoom. White
arrows denote regions of focal swelling when 300 pM CuSO 4 is used. All scale bars, 10 ptm.
Alexa Fluor 647
(LAP-neuroligin-1) Anti-GluR1 Anti-GluR1 + DIC
Figure 5-16. 7 day-old rat cortical neuron cultures expressing LAP4.2-neuroligin-1 and Venus fluorescent
protein marker were labeled with picolyl azide 8 and Alexa Fluor 647-alkyne using protocols described in
Figure 5-15. After cell fixation, endogenous GluRI subunit of the AMPA receptor was detected via
immunofluorescence staining
Intracellular protein labeling with picolyl azide ligase in fixed and living cells
Due to the superior ligation kinetics of LplAw 37 v-mediated picolyl azide 8 ligation over
wild-type LplA-mediated 8-azidooctanoic acid ligation, we explored whether picolyl azide ligase
can improve sensitivity in intracellular protein labeling applications in which we previously
employed 8-azidooctanoic acid (Chapter 4). Figure 5-17 shows that detection of intracellular
picolyl azide 8 ligation on LAP2-BFP, either in fixed cells via CuAAC with cy5-alkyne or in
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living cells via strain-promoted cycloaddition with monofluorinated cyclooctyne-fluorescein
diacetate (MOFO-CFDA), produced stronger signal-to-noise of labeling than when 8-
azidooctanoic acid ligation was used, consistent with the better ligation kinetics of picolyl azide
ligation. In the case of live-cell labeling, labeling background also seemed to be lower upon
using picolyl azide 8 compared to the alkyl azide, possibly because picolyl azide is more
hydrophilic and less prone to stick non-specifically to the cellular interior.
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Figure 5-17. Intracellular protein labeling with picolyl azide 8 ligase. A) Detection of picolyl azide-
labeled proteins in fixed cells via CuAAC. HEK cells expressing LplAw'7 (which can also ligate picolyl
azide 8 efficiently) and nucleus-targeted LAP2-BFP were labeled with picolyl azide 8 for 1 hour, then
fixed. CuAAC with cy5-alkyne and TBTA was performed on cells as described in Chapter 4. A control
with a non-chelating azide 8-azidooctanoic acid used as an LplA substrate is shown. B) Detection of
picolyl azide-labeled proteins in living cells via strain-promoted cycloaddition. After the azide labeling
step as described in A), monofluorinated cyclooctyne-fluorescein diacetate conjugate was added to cells,
as described in Chapter 4.
LAP2-BFP
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Labeling of proteins in the cell's secretory pathway using picolyl azide ligase
While we can efficiently perform cell-surface protein labeling using exogenously
supplied LplA protein, it is very desirable to have a labeling procedure where the desired LAP-
tagged cell-surface protein is labeled within the secretory pathway as it matures and traffics to
the cell surface, to eliminate the need to express and purify proteins (LplA) and simplify the
overall operation. Performing LplA-mediated ligation within the secretory pathway would also
eliminate the need to add ATP during labeling, which is a preferred practice for neuron cultures
as ATP can activate purinergic receptors in neurons and cause excitotoxicity (26). Moreover,
certain biological imaging venues where reagent accessibility is a problem-such as imaging in
tissue slices-will benefit from a labeling method that is based solely on small-molecule
reagents.
We have discussed in Chapter 3 that the environment within the endoplasmic reticulum
(ER) and the Golgi apparatus, most likely the presence of high concentrations of Ca+, seems to
inhibit LplA ligation activity, and that only the ligation reactions with efficient catalytic
efficiencies (e.g. the natural lipoylation reaction) can proceed within these compartments.
Encouraged by our observation that picolyl azide 8 ligation seems to have excellent kinetics,
Katie White of our lab has characterized the turnover of LplAw3v-mediated picolyl azide 8
ligation on LAP2 and found it to be comparable to kat of wild-type LplA-mediated lipoylation
(both kcat values -0.2 s-1, Katie White, unpublished results). Moreover, Katie used an in vitro
evolution scheme based on co-display of LAP2 and LplA mutant library on the yeast cell
surface, with picolyl azide 8 ligation and subsequent CuAAC as readout, to select for a more
kinetically efficient picolyl azide ligase. The evolved picolyl azide ligase,
LplA W37A,T571,F147L,H267R, has a catalytic turnover of -0.3 s1 for picolyl azide 8 ligation onto
LAP2, even better than that of lipoylation catalyzed by wild-type LplA (Katie White,
unpublished results).
With a very kinetically superior picolyl azide 8 ligase in hand, we proceeded to test
whether picolyl azide ligation can occur inside the ER. To maximize ligation efficiency, we
synthesized a more membrane-permeable form of picolyl azide 8 through derivatization of its
carboxylic acid group as acetoxymethyl (AM) ester. HEK cells co-expressing LAP4.2-neurexin-
1p and ER-retained LplAW37AT57,FI47LH267R (through fusion to a KDEL sequence (27)), were
incubated with 100 ptM picolyl azide 8-AM for 1 hour, and following a brief washout period,
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labeled with Alexa Fluor 647-alkyne via CuAAC. Figure 5-18 shows that the cell-surface ring of
Alexa Fluor 647 fluorescence could be observed on transfected cells (expressing a nuclear YFP
marker), indicating successful picolyl azide ligation within the ER. The average labeling
intensity obtained from ER-retained picolyl azide ligase is currently around a third of what can
be obtained when the labeling is performed exogenously supplied LplAwny, likely because the
one-hour labeling time window can only allow so much protein to traffic through the ER and
receive picolyl azide labeling.
Alexa Fluor 647
1+ DIG
LpIAW3 V LpIAW37A.T571 F147L.H267R
(exogenous) (ER)
Eur
LplAw37A
(ER)
UA
Figure 5-18. Site-specifically labeling of cell-surface proteins via ER-retained picolyl azide 8 ligase. HEK
cells expressing KDEL-LplAW7 A1,T5 71.1l 4 7 LH267R and LAP4.2-neurexin- P (middle column) were labeled
with 100 iM picolyl azide 8-AM for I hour at 37 'C. After quick rinses, the cell media was replaced with
20 pM Alexa Fluor 647-alkyne, 50 PM CuSO4 , and 300 jaM BTTAA for 5 min. Controls are shown with
exogenous picolyl azide 8 labeling by purified LpIAW3 7 (left column) and labeling inside the ER with an
inefficient ligase for picolyl azide 8, LpIAW3 7A (right column).
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Conclusion
In summary, the use of copper-chelating azides dramatically accelerates the CuAAC
reaction under conditions relevant to biomolecular labeling. We see this advance as
complementary to advances in ligand design, which have also led to CuAAC rate acceleration
and reduced cytotoxicity (11,14). Our in vitro data show that the picolyl azide effect is so strong
that it more than compensates for the effect of omitting THPTA ligand, or decreasing the copper
concentration from 100 ptM to 10 piM. Our experiments on living cells show that the use of
picolyl azide, instead of a conventional non-chelating azide, increases the specific protein
labeling signal by as much as 25-fold. By engineering a lipoic acid ligase mutant capable of
conjugating picolyl azide 8 onto LAP fusion proteins, we have made it straightforward to use
chelation-assisted CuAAC to tag specific cell-surface proteins with bright and photostable
fluorophores. We think that the CuAAC protocol reported here, in which a copper-chelating
organic azide, a newest-generation Cul-stabilizing ligand (BTTAA), and low copper
concentrations (10-100 ptM) are utilized, may represent the fastest biocompatible version of
CuAAC to date.
We are starting to employ the two-step labeling approach with picolyl azide ligation and
CuAAC for biological studies of cell-surface proteins, an example of which is described in
Chapter 7. In addition, we are collaborating with Sijia Wu and Dr. Haley Melikian at University
of Massachusetts Medical School on the study of dopamine transporter dynamics at the cell
surface. The neuronal dopamine transporter (DAT) is responsible for the termination of
dopamine-dependent neurotransmission, but its surface dynamics has never been directly studied
due to the lack of methods to efficiently tag the protein. Through examination of many LAP-
tagged DAT designs, Sijia and Dr. Melikian discovered a functional LAP-DAT construct, in
which LAP is grafted in an internal loop of DAT. The construct can be labeled successfully
using picolyl azide ligation and CuAAC, and exhibit similar functional properties as wild-type
DAT (unpublished results).
Beyond fluorophore targeting to specific cell-surface proteins, our collaborators Dr. Scott
Clarke and Dr. Kyle Gee at Life Technologies have demonstrated the utility of picolyl azide for
sensitive detection of metabolically labeled proteins and RNAs in cells (Figure 5-19). Scott
showed that alkyne-tagged cellular RNAs and proteins, using 5-ethynyluridine (28) or L-
homopropargyiglycine (29) respectively, could be detected on fixed cells with a 1.8-2.7-fold
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improvement in average signal intensity with a picolyl azide-fluorophore conjugate, compared to
an alkyl-azide fluorophore. We envision chelation-assisted CuAAC to be universally useful for
detection of other classes of metabolically labeled biomolecules, such as lipids (30) and glycans
(13).
0
NH metabolic N3
HO N O incorporation N
Cu(I),
H H 0BTTAA or THPTA
OH OH ~1
5-ethynyl uridine
(EU) alkyne-labeled RNAs
rnetabolic
incorporation N
0- Cu(I),HN BTTAA or THPTA
L-homopropargylglycine
(Hpg) alkyne-labeled proteins
Figure 5-19. Examples of labeling of newly synthesized biomolecules via alkynyl metabolites and
chelation-assisted CuAAC. RNAs (top) and proteins (bottom) can be metabolically labeled with a uridine
surrogate 5-ethynyluridine (28), and with a methionine surrogate homopropargylglycine (29),
respectively. Alkyne-labeled RNAs and proteins are derivatized after cell fixation with picolyl azide-
fluorophore conjugates (red circle).
Fast, biocompatible CuAAC also benefits site-specific labeling of proteins in vitro. In
collaboration with Dr. Aathavan Karunakaran and Dr. Ron Vale at UCSF, we demonstrated that
picolyl azide ligation and chelation-assisted CuAAC can be used to label LAP-tagged motor
protein kinesin with high specificity and efficiency (unpublished results). It remains to be seen
whether in vitro-labeled proteins would remain functional, but we are optimistic as we know that
GFP, whose fluorescence is sensitive to the presence of ROS, is not destroyed under our CuAAC
conditions.
Efficient LpIA-mediated picolyl azide ligation, both in the cytosol and in the secretory
pathway, also paves way to the possibility of performing CuAAC within living cells. To achieve
CuAAC labeling in the cytosol, many challenges will have to be addressed. Cull would need to
be delivered across the cell membrane, perhaps with ionophores. Glutathione in the cytosol
would likely reduce Cu" to Cu' but then a major problem would be sequestration of the Cu' by
these same thiols. The ability of copper-chelating azides like picolyl azide to compete with
glutathione for copper binding thus is crucial for potentially allowing CuAAC to occur inside the
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cytosol. Another requirement is to deliver membrane-permeable forms of tris-triazole ligands
such as THPTA and BTTAA across the cell membrane. It might be less challenging to begin
attempts at intracellular CuAAC labeling within the secretory pathway, which lacks endogenous
thiols, though the main problem then would be to maintain the reduced, catalytic oxidation state
of copper.
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Experimental methods
General synthetic methods. Chemicals were purchased from Sigma-Aldrich, Alfa Aesar, TCI
America, Fisher Scientific, Adesis Inc, EMD, Avocado Research Chemicals, or Life
Technologies. Analytical thin-layer chromatography was performed using 0.25 mm silica gel 60
F2 54 plates and visualized with 254 nm UV light or with bromocresol green. IH NMR spectra
were recorded on a Bruker Avance 400 MHz or a Varian Inova 500 MHz spectrometer. All
samples were dissolved in CDCl 3, CD 30D, D20, or d6-DMSO and chemical shifts (6) are
expressed in parts per million relative to residual solvent peak as an internal standard.
Abbreviations are: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad. Coupling
constants (J) are reported in hertz (Hz).
High-resolution mass spectrometric data were obtained using a Waters SYNAPT-HDMS
mass spectrometer equipped with a Waters ACQUITY UPLC and a BEH C18 column (1.7 ptm
particle size, 2.1 x50 mm). For positive ion detection mode, the gradient used was 5-95%
acetonitrile in water with 0.1% formic acid, at a 0.3 mL/min flow rate over 10 minutes. The mass
spectrometry for each chromatogram was re-calibrated relative to the internal standards' accurate
mass: reduced glutathione (m/z 308.0916); oxidized glutathione (m/z 613.1598); and Leu-
enkephalin (m/z 556.2771-positive ion). Each compound's mass was centered and calculated
using Mass Lynx V4.1 software.
Synthesis of organic azides (All azide compounds in Figure 5-4 were synthesized by Dr. Scott
Grecian (Life Technologies)) and characterized by us)
H0 2C
N3  (' N3  H2 N3
1 2 3
Benzyl azide 1 is commercially available from Alfa Aesar. Azide 2 (2-azidomethylpyridine) was
prepared according to a published literature procedure (19). 'H NMR (400 MHz, CDCl 3): 8.57
(dd, 1H, J = 4.9, 1.8 Hz), 7.69 (dt, IH, J = 7.8, 1.8 Hz), 7.31 (d, 1H, J = 7.8 Hz), 7.22 (dd, I H, J
= 7.8, 4.9 Hz). 13 C NMR (100 MHz, CDCl 3): 115.8, 149.7, 137.1, 123.0, 122.0, 55.7. HR-ESI-
MS: [M+H]* m/z 135.0671 calculated, 135.0667 observed.
173
Azide 3 (4-azidomethylbenzoic acid) was prepared according to a published literature procedure
(16). 'H NMR (400 MHz, CD 30D): 8.03 (d, 2H, J = 8.4 Hz), 7.45 (d, 2H, J = 8.4 Hz), 4.91 (br,
I H), 4.46 (s, 2H). 13C NMR (100 MHz, CD 30D): 169.4, 142.4, 131.7, 131.2, 129.2, 55.0. HR-
ESI-MS: [M+H]* m/z 176.0460 calculated, 176.0467 observed.
0 0
MeO LiOH - HO
N3  MeOH, H20, rt N N3N 96% N
5 4
Azide 4 (6-Azidomethylnicotinic acid). Methyl 5-(azidomethyl)nicotinate (azide 5, 114 mg, 0.59
mmol) was dissolved in methanol (2.5 mL). A 1.0 M solution of LiOH in water (1.78 mL, 1.78
mmol) was then added and the mixture was stirred for 25 minutes, at which time acetic acid (60
tL) was added and the mixture was loaded directly onto a silica gel column equilibrated with
ethyl acetate + 1% acetic acid. Purification was performed with a gradient from 1% acetic acid in
ethyl acetate to 4% acetonitrile and 1% acetic acid in ethyl acetate to afford 101 mg (96%) of 4
as a yellow solid. Rf 0.35 (ethyl acetate + 1% acetic acid, 254 nm UV). 'H NMR (400 MHz,
CD 30D): 9.10 (dd, J 2.1, 0.8 Hz), 8.39 (dd, 1H, J = 8.1, 2.1 Hz), 7.57 (dd, 1H, J = 8.1, 0.8 Hz),
4.59 (s, 2H). "C NMR (100 MHz, CD 30D): 167.7, 161.3, 151.5, 139.9, 127.6, 123.3, 56.0. HR-
ESI-MS: [M+H]* m/z 179.0569 calculated, 179.0563 observed.
0 0 0
MeO NaBH 4, CaCl2 MeO 1) TsCI, TEA, DCM MeO
OeOH 'In N3N- OWe THF, MeOH N 2) NaN3, THE N
0 40% 85% over two steps 5
Azide 5 (Methyl 5-(azidomethyl)nicotinate). To synthesize 6-hydroxymethyl-nicotinic acid
methyl ester intermediate, NaBH 4 (264 mg, 6.98 mmol) was added in portions to a slurry of 2,5-
pyridinedicarboxylic acid dimethyl ester (500 mg, 2.79 mmol) and CaCl2 (1.2 g, 11.16 mmol) in
anhydrous tetrahydrofuran (THF; 5 mL) and anhydrous methanol (10 mL). The reaction was
stirred at 0 'C for ~ 3 hours. Excess NaBH 4 was then quenched by adding 10 mL of ice-cold
water to the reaction mixture. After extraction with chloroform (3 x 20 mL), the combined
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organic layer was dried with magnesium sulfate and concentrated in vacuo to provide 6-
hydroxymethyl-nicotinic acid methyl ester as white solid (186 mg; 40% yield). Rf = 0.27 (1:1
hexanes:ethyl acetate). 1H NMR (500 MHz, CDCl 3): 9.16, (d, I H, J = 2.0 Hz), 8.29 (dd, I H, J =
2.0, 8.5 Hz), 7.36 (d, IH, J = 8.5 Hz), 4.83 (s, 2H), 3.96 (s, 3H). 13 C NMR (75 MHz, CDCl 3):
165.7, 163.7, 149.9, 138.3, 125.2, 120.4, 64.4, 52.7.
To a solution of 6-hydroxymethyl-nicotinic acid methyl ester (15 mg, 0.09 mmol) in
dichloromethane (DCM, 2 mL) was added para-toluenesulfonyl chloride (TsCl, 26 mg, 0.135
mmol) and triethylamine (TEA, 62 pL, 0.45 mmol). The reaction was stirred for 2 hours, after
which dichloromethane was removed in vacuo. The residue was dissolved in THF (1 mL), and
sodium azide (58 mg, 0.90 mmol) was added. The reaction was further stirred at room
temperature for 24 hours, then diluted with ethyl acetate and water. The aqueous layer was
further extracted with ethyl acetate three times. The combined organic layers were washed with
brine, dried over sodium sulfate, and concentrated in vacuo. The residual mixture was purified
by silica chromatography (4:1 hexanes:ethyl acetate) to afford azide 5 as light yellow solid (14.6
mg, 85% yield). Rf = 0.79 (1:1 hexanes:ethyl acetate). Note that Rf of azide 5 is almost identical
to the tosylate intermediate, making reaction monitoring by TLC rather difficult. 'H NMR (500
MHz, CDCl 3): 9.18 (d, 1H, J = 2.0 Hz), 8.32 (dd, IH, J = 8.5, 2.0 Hz), 7.44 (d, IH, J = 8.5 Hz),
4.56 (s, 2H), 3.95 (s, 3H). 3C NMR (125 MHz, CDC 3): 165.7, 160.3, 151.6, 138.4, 125.5,
121.6, 55.7, 52.7. HR-ESI-MS: [M+H]f m/z 193.0726 calculated, 193.0733 observed.
OMe OMe OMe
KOH, p-TsCI NaN3 ,
- OH THF, 0-5 C - OTs DMF, rt N N3N N30% over two steps
6
Azide 6 (2-Azidomethyl-4-methoxypyridine). 2-Hydroxymethyl-4-methoxypyridine (278 mg,
2.0 mmol) was dissolved in tetrahydrofuran (15 mL) in a 50 mL round-bottomed flask under
argon. The flask was cooled to 0-5 0C with an ice/water bath for 10 minutes at which time,
powdered KOH (157 mg, 2.8 mmol) was added followed by para-toluenesulfonyl chloride (p-
TsCl). The reaction was stirred for 12 hours, at which time diethyl ether (30 mL) was added. The
mixture was transferred to a separatory funnel, and a saturated solution of NaHCO 3 (40 mL) was
added. The organic layer was dried with MgSO 4, filtered, and concentrated to a residue, which
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was chromatographed on a silica gel column with a 10% to 50% gradient of ethyl
acetate/hexanes. Rf= 0.69 (ethyl acetate, 254 nm UV). This material was then dissolved in N,N-
dimethylformamide (DMF, 5 mL), and sodium azide (266 mg, 4.09 mmol) was added and the
reaction was stirred at ambient temperature for 16 hours, at which time the reaction mixture was
diluted with diethyl ether (30 mL) and washed with a saturated solution of NaHCO 3 (3 x 30 mL),
then with brine (25 mL). The organic layer was dried with MgSO 4, filtered and concentrated in
vacuo. The resulting residue was chromatographed over silica gel with a 15% to 50% gradient of
ethyl acetate/hexanes to furnish 100 mg (30% yield) of 6 as a light yellow oil. Rf= 0.68 (ethyl
acetate, 254 nm UV). 'H NMR (400 MHz, CDCl 3): 8.38 (d, 1H, J = 5.8 Hz), 6.85 (d, 1H, J = 2.4
Hz), 6.74 (dd, IH, J = 5.8, 2.4 Hz), 4.42 (s, 2H), 3.85 (s, 3H). 1C NMR (100 MHz, CDCl 3):
166.6, 157.5, 151.0, 109.1, 108.1, 55.8, 55.3. HR-ESI-MS: [M+H]* m/z 165.0776 calculated,
165.0777 observed.
Cl
N3
7
Azide 7 (2-Azidomethyl-4-chloropyridine) was prepared according to a published patent
procedure (Jung, F.H. Cephalosporin derivatives. EP Patent 127991. December 12, 1984). 'H
NMR (400 MHz, CDCl 3): 8.44 (d, 1H, J = 5.3 Hz), 7.33 (d, IH, J = 2.0 Hz), 7.21 (dd, 1H, J =
5.3, 2.0 Hz), 4.46 (s, 2H), 4.44 (s, 2H). 13 C NMR (100 MHz, CDCl 3): 157.5, 150.5, 145.1, 123.3,
122.2, 55.1. HR-ESI-MS: [M+H]+ m/z 169.0281 calculated, 169.0279 observed.
HO N3 1) DSC, TEA, DMF 0 N3
2) HO NH2  4 )rN I '
4 0 8
TEA, DMF
64% over two steps
Picolyl azide 8 (5-(6-(Azidomethyl)nicotinamido)pentanoic acid). To a solution of 6-
azidomethylnicotinic acid (azide 4; 30 mg, 0.168 mmol) in anhydrous DMF (500 IL) was added
disuccinimidyl carbonate (DSC; 65 mg, 0.253 mmol) and triethylamine (TEA; 120 ptL, 0.840
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mmol). The reaction was allowed to proceed for 3 hours at ambient temperature. The reaction
mixture was diluted with chloroform and water. Layers were separated, and the aqueous layer
was extracted with chloroform three times. The combined organic layers were washed with
brine, dried over MgSO 4, and concentrated in vacuo. The residual mixture was purified by silica
chromatography (1:1 hexanes:ethyl acetate) to afford the succinimidyl ester of 6-
azidomethylnicotinic acid. Rf= 0.67 in 9:1 chloroform:methanol.
To a solution of 5-azidomethylnicotinic acid succinimidyl ester (15 mg, 0.055 mmol) in
anhydrous DMF (500 tL) was added 5-aminovaleric acid (32 mg, 0.273 mmol) and TEA (38
pL, 0.273 mmol). The reaction proceeded for 12 hours at ambient temperature. TEA and DMF
were then removed in vacuo, and the resulting residue was dissolved in water and subjected to
purification by preparative-scale HPLC. For this purification, we used a Varian Prostar 210
HPLC equipped with Agilent 325 UV/Vis dual-wavelength detector, Agilent 440-LC fraction
collector, and a Microsorb C18 column (Varian, 5 pm particle size, 21mm x 250 mm
dimension). The gradient used was 0-10% acetonitrile in water at a lOmL/min flow rate over 30
min. Picolyl azide 8 eluted at 29-30 minutes. After collecting desired fractions, acetonitrile was
removed in vacuo, and the resulting solution was flash-frozen and lyophilized to yield the final
product as white powder. Rf = 0.58 in 90: 5: 5 ethyl acetate: methanol: acetic acid. IH NMR (500
MHz, D20): 8.83 (s, IH), 8.18 (d, I H, J = 8.5 Hz), 7.59 (d, I H, J = 8 Hz), 4.62 (s, 2H), 3.42 (m,
2H), 2.32 (m, 2H), 1.65 (m, 4H). "C NMR (100 MHz, CD 30D): 177.7, 167.6, 160.0, 149.2,
137.7, 131.1, 123.3, 55.9, 40.7, 34.7, 29.8, 23.5. HR-ESI-MS: [M+H]* m/z 278. 1248 calculated,
278.1264 observed.
Picolyl azide 8-acetoxymethyl ester (Picolyl azide 8-AM). To a solution of picolyl azide 8 (5 mg,
0.0 18 mmol) in anhydrous DMF (100 tL) was added bromomethyl acetate (3.5 pL, 0.036 mmol)
and triethylamine (5 tL, 0.036 mmol). The reaction was stirred at room temperature for 1 hour,
at which time chloroform and water (10 mL each) were added. Layers were separated, and the
aqueous layer was extracted with chloroform three times. The combined organic layers were
washed with brine, dried over MgSO 4, and concentrated in vacuo. The residual mixture was
purified by silica chromatography (1:1 hexanes:ethyl acetate, then 1:3 hexanes:ethyl acetate, then
ethyl acetate). After concentration, the product was obtained as pale yellow oil. Rf = 0.37 in
90:5:5 ethyl acetate:methanol:acetic acid. 1H NMR (400 MHz, CDCl 3): 8.95 (d, IH, J 1.7 Hz),
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8.14 (dd, I H, J = 2.3, 8.1 Hz), 7.43 (d, IH, J = 8.4), 5.72 (s, 2H), 4.54 (s, 2H), 3.47 (m, 2H), 2.43
(t, 2H, J = 6.8), 2.09 (s, 3H), 1.70 (m, 4H).
Synthesis of Alexa Fluor* 647-picolyl azide conjugate.
0 0
HO O 1) NHS, EDC, DCM, rto e O O NABH 4, THF, MeOH O OI ____ 1 H 0 N____
N-OMe 0 N~ We15m > H I
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1) NaN3, PPh 3, CBr 4  O Alexa Fluor* 647 H O
DMF, rt CI- *H3N succinimidyl ester Alexa FluorR 64 7-_, N .N
2) HCI, MeOH H N N3  DIPEA, DMF, rt O N- N3
1,4-dioxane
D Alexa Fluor 647-picolyl azide
Methyl 5-(2-(tert-butoxycarbonylamino)ethyl) carbamoyl picolinate (compound B). Ester A (100
mg, 0.55 mmol) was dissolved in dichloromethane (DCM, 10 mL) at ambient temperature. N-
Hydroxysuccinimide (NHS; 95 mg, 0.83 mmol) was added, followed by 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide) hydrochloride (EDC, 133 mg, 0.69 mol) and the mixture
stirred at ambient temperature for 2 hours. The mixture was then diluted with chloroform (15
mL), followed by the addition of 2% HCl solution (15 mL). The organic layer was washed with
water (15 mL), dried with MgSO 4, and filtered. The crude succinimidyl ester product was used
directly in the next step without further purification. Rf = 0.53 (ethyl acetate, 254 nm UV).
The succinimidyl ester of A (155 mg, 0.55 mmol) was dissolved in dichloromethane (15
mL). NN,-diisopropylethylamine (DIPEA, 0.30 mL, 1.65 mmol) was added at ambient
temperature followed by tert-butyl (2-aminoethyl)carbamate hydrochloride (119 mg, 0.61
mmol). The reaction was stirred for 50 minutes, then diluted with dichloromethane (30 mL) and
2 M Na 2CO 3 solution (20 mL). The layers were separated and the organic layer was dried with
MgSO 4, filtered and concentrated in vacuo. The residue was dissolved in warm methanol (3 mL),
loaded onto a silica gel chromatography column and eluted with ethyl acetate then 95:5 ethyl
acetate:methanol to provide 104 mg (58%) of B as a white solid. Rf = 0.32 (ethyl acetate, 254 nm
UV). 'H NMR (400 MHz, CDCl 3): 9.15 (d, J= 2 Hz, IH), 8.30 (d, J= 1.6 Hz, 1H), 8.14
(complex, 2H), 5.32 (br s, IH), 4.00 (s, 3H), 3.56 (m, 2H), 3.41 (m, 2H), 1.39 (s, 9H).
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tert-Butyl (2-(6-(hydroxymethyl)nicotinamido)ethyl) carbamate (compound C). NaBH 4 (55 mg,
1.46 mmol) was added slowly to B (157 mg, 0.49 mmol) dissolved in methanol (3 mL). THF
(10 mL) was added and the reaction flask was placed in an oil bath preheated to 65 'C. The
reaction was stirred at 65 'C for 15 minutes, at which time 2 M Na 2CO 3 solution (6 mL) was
added over 10 minutes followed by water (6 mL). The mixture was then concentrated to 1/5 of
its original volume and chromatographed directly with 0.5% triethylamine and ethyl
acetate/methanol to provide C (132 mg, 91%) as a white solid. Rf = 0.10 (ethyl acetate, 254 nm
UV). 'H NMR (400 MHz, d6-DMSO): 8.89 (s, 1H), 8.61 (s, IH), 8.18 (d, J= 8.0 Hz, IH), 7.55
(d, J= 8.0 Hz, 1H), 6.93 (m, I H), 5.53 (br s, I H), 4.61 (s, 2H), 3.29 (m, 2H), 3.12 (d, J= 6.0 Hz,
2H), 2.51 (s, 2H), 1.7 (s, 9H).
tert-Butyl (2-(6-(azidomethyl)nicotinamido)ethyl) carbamate (compound D). C (132 mg, 0.45
mmol) was dissolved in DMF (5 mL). Sodium azide (218 mg, 3.36 mmol) was added, followed
by triphenylphosphine (129 mg, 0.492 mmol) and carbon tetrabromide (189 mg, 185 mg, 0.56
mmol). The reaction was stirred for 1 hour at ambient temperature, at which time 2 M Na2 CO 3
solution (10 mL) was added followed by ethyl acetate (30 mL). The organic layer was washed
with saturated NaHCO 3 solution (2 x 15 mL), dried with MgSO 4 , filtered, and concentrated in
vacuo. The resulting clear oil was purified by silica gel chromotagraphy using ethyl acetate as
eluent to furnish 6-azidomethyl derivative of C as a white solid. Rf= 0.30 (ethyl acetate, 254 nm
UV). 'H NMR (400 MHz, CDCl 3): 9.04 (d, J= 1.6 Hz, 1 H), 8.19 (dd, J= 8.1, 2.3 Hz, I H), 7.72
(br s, IH), 7.43 (d, J= 8.1 Hz, I H), 5.17 (t, J= 8.1 Hz, 5.8 Hz, IH), 4.55 (s, 2H), 3.58 (q, J= 4.9
Hz, 2H), 3.43 (q, J= 5.9 Hz, 2H), 1.43 (s, 9H). LCMS (ESI +): 296.50 (MH+, 100%), 240.38
(86%); TR = 8.8 min.
To a solution of 6-azidomethyl derivative of C (16.9 mg, 0.053 mmol) in methanol (0.5 mL)
was added a 4M HCl/dioxane solution (132 piL, 0.264 mmol hydrogen chloride). The reaction
mixture was stirred for 1 hour and 40 min under ambient temperature, at which time the mixture
was concentrated under a stream of nitrogen to provide 7.6 mg of D, which was used in the next
step without further purification.
Alexa Fluor* 647-picolyl azide conjugate. To a solution of D (5.5 mg) in DMF (0.95 mL) was
added NN,-diisopropylethylamine (DIPEA, 100 tL) and Alexa Fluor* 647 succinimidyl ester
179
(20 mg, 0.016 mmol, Life Technologies). After stirring at ambient temperature for 10 hours, the
reaction mixture was concentrated and directly purified by preparative-scale HPLC. For this
purification, we used Waters 600 HPLC equipped with Waters 996 diode array detector, Waters
717 plus autosampler, and a Luna C18 column (Phenomenex, 5 ptm particle size, 4.6mm x 250
mm dimension). The gradient used was 5-95% 10 mM NH 40Ac/MeOH at a I mL/min flow rate
over 30 min. Fractions containing the product were combined and concentrated in vacuo. The
residue was then dissolved in water (10 mL), flash-frozen, then lyophilized to yield 13.6 mg of
Alexa Fluor* 647-picolyl azide a bright blue powder (83%). T, = 20.8 min at 647 nm. MS (ESI
+): 1061.3 (M + H+; 2%), 531.2, 6%); (ESI -): 1060.3 (Zwitterion, 17%), 540.3 (52%), 529.3
(M2-, 100%). HPLC: >99% purity at 254 nm and 644 nm.
Characterization of triazole adducts (synthesized by Anupong Tangpeerachaikul). 7-
ethynylcoumarin was synthesized and characterized as previously reported (19).
,N N ,Nz:N
N 00 0 0 O
0 0
HOOC OOH HOOC O OH
0 0
7-ethynyl coumarin-azide 3 7-ethynyl coumarin-azide 4
triazole adduct triazole adduct
To prepare the triazole adduct between 7-ethynyl coumarin and 4-azidomethylbenzoic acid
(azide 3), 7-ethynyl coumarin (20 mg, 0.067 mmol) and 3 (20 mg, 0.11 mmol) were dissolved in
tetrahydrofuran (4 mL). Sodium ascorbate (0.5 M solution in water, 59 pL, 0.029 mmol) and
copper(II) sulfate (0.25 M solution in water, 30 pL, 0.007 mmol) were then added, and the
reaction was heated to reflux overnight. After the solvent was removed in vacuo, the resulting
residue was washed three times with methanol, and the remaining solid dried in vacuo. Pure
product was obtained as a white powder. IH NMR (400 MHz, DMSO-d6): 8.88 (s, 1H, 7.96 (br,
2H), 7.88 (m, 2H), 7.82 (m, 1H), 7.47 (br, 2H), 6.47 (s, IH), 5.78 (s, 2H). 5.43 (s, 2H), 2.71 (br,
2H), 2.57 (br, 2H). HR-ESI-MS: [M+H]+ m/z 478.1250 calculated, 478.1239 observed.
180
To prepare the triazole adduct between 7-ethynyl coumarin and 6-azidomethylnicotinic acid
(azide 4), 7-ethynyl coumarin (20 mg, 0.067 mmol) and 4 (20 mg, 0.11 mmol) were dissolved in
DMSO (4 mL). Sodium ascorbate (0.5 M solution in water, 59 pL, 0.029 mmol) and copper(II)
sulfate (0.25 M solution in water, 30 gL, 0.007 mmol) were then added, and the reaction was
stirred for 1 hour. After the solvent was removed in vacuo, the resulting residue was taken up in
methanol and loaded directly onto a preparative silica TLC plate (0.25 mm thickness) and the
plate was developed with 95:5 acetonitrile:H 20. The product-containing silica was collected and
sonicated in chloroform (30 mL) for 3 minutes and filtered. The filtrate was concentrated to
deliver the triazole adduct as a tan solid. 'H NMR (400 MHz, DMSO-d6): 8.91 (s, 1H), 8.77 (s,
1H), 8.17 (d, 1H, J = 8.0 Hz), 7.86-7.75 (m, 3H), 7.34 (d, 1H, J = 8.0 Hz), 6.41 (s, 1H), 5.76 (s,
1H), 5.35 (s, 2H), 2.64 (t, 1H, J = 6.2 Hz), 2.50- 2.45 (m, 2H), 1.86 (s, IH). 13 C NMR (100
MHz, DMSO-d6): 175.0, 173.7, 172.8, 160.4, 155.4, 153.88, 150.7, 150.6, 145.45, 138.4, 134.6,
125.9, 124.3, 122.1, 121.9, 116.7, 113.0, 112.4, 61.5, 54.9, 48.9, 30.0, 29.5, 21.9. HR-ESI-MS:
[M+H]* m/z 479.1203 calculated, 479.1210 observed.
Other chemicals. 8-azidooctanoic acid (21), tris(3-hydroxypropyltriazolylmethyl)amine
(THPTA) (12), and bis(tert-butyltriazoylmethyl)-2-carboxy methyltriazoylmethylamine
(BTTAA) (14) were synthesized and characterized according to published literature. 10-
undecynoic acid is commercially available from Avocado Research Chemicals. Alexa Fluor*
647-alkyne and Alexa Fluor* 647-alkyl azide are commercially available from Life
Technologies.
In vitro kinetic analysis of the CuAAC reaction (Figure 5-4B and 5-5). General reaction
conditions were: 20 ptM azide, 40 ptM 7-ethynyl coumarin, and 4 mM sodium ascorbate in 100
mM sodium phosphate buffer at pH 7.4 at 25 ± 1 'C. 100 ptM Tempol was added to each reaction
to minimize Cu-dependent fluorescence quenching of 7-ethynyl coumarin and coumarin-
triazoles. Reactions were initiated by the addition of CuSO 4: 10 ptM for Figure 5-4B, and 10, 40,
or 100 ptM for Figure 5-5. In Figure 5-5 when THPTA was included, the THPTA:copper ratio
was fixed at a 4:1 molar ratio. Coumarin fluorescence was recorded on a Tecan SAFIRE
microplate reader at 2-min intervals for 30 min with excitation at 320 nm and emission detected
at 430 nm. For each azide, the turn-on fluorescence of coumarin Was correlated to % conversion
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to product using a calibration curve made from a mixture of known concentrations of 7-ethynyl
coumarin and the coumarin-triazole adduct of each azide, as follows:
Coumarin-triazole standards for azides 1, 2, 5, 6, and 7 were generated by reacting 120 IM of
each azide with 100 pM 7-ethynyl coumarin until 7-ethynyl coumarin was fully converted to the
triazole adduct, using 100 IM CuSO 4, 400 ptM THPTA, and 4 mM sodium ascorbate. Complete
conversion of 7-ethynyl coumarin to coumarin-triazole was achieved in 30 min for all azides
under these conditions (which differ from conditions in Figure 5-4B), and was confirmed by
thin-layer chromatography, and by monitoring for saturation of turn-on fluorescence levels of
coumarin. These reaction mixtures, now representing coumarin-triazoles of known concentration
(100 pM), were then mixed with 7-ethynyl coumarin in defined ratios in the presence of 20-fold
molar excess of EDTA relative to CuSO 4, (which was carried over from the triazole generation
reaction), to generate the calibration curve above.
Coumarin-triazole standards for azides 3 and 4 were generated from purified coumarin-
triazole adducts (see synthetic methods below). We also generated calibration curves for azides 3
and 4 using coumarin-triazoles from crude reaction mixtures as described above, and found them
to be indistinguisable from calibration curves generated from purified triazoles.
In vitro LpIA-catalyzed picolyl azide and alkyne ligation (Figures 5-8A and 5-12B).
For picolyl azide 8 ligation (Figure 5-8A), the enzymatic reaction was performed as follows: 150
pM LAP (amino acid sequence: GFEIDKVWYDLDA), 5 piM w37vLpA, 500 pM picolyl azide
8, 1 mM ATP, and 5 mM Mg(OAc) 2 in 20% v/v glycerol in Dulbecco's phosphate-buffered
[7-ethynyl coumarin], [coumarin-triazole], % conversion to product
PM PM represented
40 0 0
37.5 2.5 12.5
35 5 25
30 10 50
25 15 75
20 20 100
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saline (DPBS) at 30 'C for 30 min. The reaction was quenched with EDTA (final concentration
50 mM) and analyzed on a Varian Prostar HPLC using a reverse phase C18 Microsorb-MV100
column (250 x 4.6 mm). Chromatograms were recorded at 210 nm. We used a 10-min gradient
of 30-60% acetonitrile in water with 0.1% trifluoroacetic acid at a flow rate of 1 mL/min. LAP
had a retention time of 7.5 min; after ligation to picolyl azide 8, the retention time increased to
11 min.
For 10-undecynoic acid ligation (Figure 5-12B), the enzymatic reaction was as follows:
150 pM LAP, 5 ptM W37vLplA, 500 iM 10-undecynoic acid, 1 mM ATP, and 5 mM Mg(OAc) 2
in 20% v/v glycerol in Dulbecco's phosphate-buffered saline (DPBS) at 30 'C for 30 min. The
reaction was quenched with EDTA (final concentration 50 mM) and analyzed as described for
picolyl azide ligation above. The retention time of the 1O-undecynoic acid-LAP adduct is 11 min.
Mass spectrometric analysis of LAP-probe conjugates (Figures 5-8B and 5-12C).
To characterize the LAP-picolyl azide 8 adduct (Figure 5-8B), the starred peak from Figure 5-8A
was manually collected and injected into an Applied Biosystems 200 QTRAP mass
spectrometer. The flow rate was 3 mL/min, and mass spectra were recorded under the positive-
enhanced multicharge mode. To characterize the 10-undecynoic acid-LAP adduct (Figure 5-
12C), the starred peak from Figure 5-12B was similarly collected and injected into the mass
spectrometer under 3 mL/min flow rate. Its mass spectrum was recorded under the negative-
enhanced multicharge mode.
Genetic constructs used are summarized in Table 2.
Mammalian and neuronal cell culture.
Human embryonic kidney (HEK) and HeLa were cultured in minimal essential medium (MEM,
Mediatech) supplemented with 10% v/v fetal bovine serum (PAA Laboratories). For imaging,
HEK cells were plated as a monolayer on glass coverslips. Adherence of HEK cells was
promoted by pre-coating the coverslip with 50 pg/mL fibronectin (Millipore).
For hippocampal neuron cultures, Spague Dawley rat pups were sacrificed at embryonic
day 18. Hippocampal tissue was digested with papain (Worthington) and DNaseI (Roche) and
plated on glass coverslips pretreated with poly-D-lysine (Sigma) and mouse laminin (Life
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Technologies) in L-glutamine-containing MEM (Sigma) supplemented with 10% v/v fetal
bovine serum (PAA Laboratories) and B27 (Life Technologies). At 3 days in vitro, half of the
growth medium was replaced with Neurobasal medium (Life Technologies) supplemented with
B27 and GlutaMAX (Life Technologies).
General protocol for cell-surface protein labeling with picolyl azide 8 ligase followed by
chelation-assisted CuAAC.
HEK cells were transfected at ~80% confluency with expression plasmids for LAP-tagged
neurexin-1p (400 ng for a 0.95 cm2 dish) and yellow fluorescent protein-tagged histone 2B
protein (H2B-YFP; 100 ng) using lipofectamine 2000 (Invitrogen). Twenty-four hours after
transfection, cells were treated with 10 ptM purified w37vLplA (prepared as previously
described ), 200 pM picolyl azide 8, 1 mM ATP, and 5 mM Mg(OAc) 2 in cell growth medium
for 20 min at room temperature. After excess LplA labeling reagents had been removed by
quickly replacing the medium 2-3 times with fresh growth medium, cells were further labeled
with 20 pM Alexa Fluor* 647-alkyne (Life Technologies), 40 IM CuSO 4, 200 pM BTTAA (or
THPTA), and 2.5 mM sodium ascorbate in Dulbecco's phosphate-buffered saline (DPBS) for 5
min at room temperature. Cells were immediately imaged after excess CuAAC labeling reagents
were removed by 2-3 quick washes with fresh growth medium.
Fluorescence imaging.
Cells were imaged in Tyrode's buffer or DPBS in epifluorescence or confocal modes. For
epifluorescence imaging, we used a Zeiss AxioObserver inverted microscope with a 40x oil-
immersion objective. CFP (420/20 excitation, 425 dichroic, 475/40 emission), Alexa Fluor* 647
(630/20 excitation, 660 dichroic, 680/30 emission) and differential interference contrast (DIC)
images were collected and analyzed using Slidebook software (Intelligent Imaging Innovations).
For confocal imaging, we used a Zeiss Axiovert 200M inverted microscope with a 40x oil-
immersion objective. The microscope was equipped with a Yokogawa spinning disk confocal
head, a Quad-band notch dichroic mirror (405/488/568/647), and 491 (DPSS), 561 nm (DPSS),
640 nm (DPSS) lasers (all 50 mW). YFP/Alexa Fluor* 488 (491 laser excitation, 528/38
emission), Alexa Fluor® 568 (561 laser excitation, 617/73 emission), Alexa Fluor* 647 (640 laser
excitation, 680/30 emission), and DIC images were collected using Slidebook software.
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Fluorescence images in each experiment were normalized to the same intensity ranges.
Acquisition times ranged from 10-1000 milliseconds.
Live-cell immunostaining with anti-lipoic acid antibody (Figure 5-9).
Live HEK cells were incubated with rabbit anti-lipoic acid antibody (Calbiochem) in cell growth
medium at 1:300 dilution for 10 min at room temperature, followed by two washes with cell
growth medium. Thereafter, cells were incubated with anti-rabbit secondary antibody conjugated
to Alexa Fluor* 568 (Life Technologies) in cell growth medium at 1:300 dilution for 10 min at
room temperature, followed by two washes with cell growth medium.
Multi-parameter comparison of labeling signals on live cells using lipoic acid ligase and
CuAAC (Figures 5-10).
HEK cells were transfected at 80-90% confluency with an expression plasmid for LAP-tagged
cyan fluorescent protein fused to the transmembrane domain of the PDGF receptor (LAP-CFP-
TM). Twenty-four hours after transfection, cells were treated with 200 tM picolyl azide 8 or 8-
azidooctanoic acid, 20 [tM purified LpIA (W37V variant for picolyl azide 8 ligation; wild-type
LpIA for 8-azidooctanoic acid ligation), 2 mM ATP, and 5 mM Mg(OAc) 2 in cell growth
medium for 20 min at room temperature. After excess LpIA labeling reagents had been removed
by quickly replacing the medium, 2-3 times, cells were further labeled with CuAAC using
various concentrations of CuSO 4 (10, 40, or 100 piM), and either THPTA or BTTAA ligand
added in 4-fold excess of the CuSO 4. All CuAAC labeling conditions were performed for 5 min
in DPBS at room temperature, in the presence of 20 piM Alexa Fluor* 647-alkyne and 2.5mM
sodium ascorbate. Cells were immediately imaged after excess CuAAC labeling reagents had
been removed by 2-3 quick washes with fresh growth medium.
To generate the graph in Figure 5-1 OC, Slidebook software was used to select > 90 single
cells for each condition, based on CFP fluorescence. For each single cell, the mean background-
corrected fluorescence was calculated for both the Alexa Fluor* 647 and CFP channels.
Background was measured from untransfected cells. Microsoft Excel was used to calculate and
average the single-cell Alexa Fluor* 647/CFP fluorescence intensity ratios for each labeling
condition.
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Cell surface labeling with an alkyne ligase and Alexa Fluor* 647-picolyl azide (Figure 5-
12D).
HEK cells were transfected with expression plasmids for LAP-tagged neurexin- 1p (400 ng for a
0.95 cm 2 dish) and H2B-YFP (100 ng) using lipofectamine 2000. 24 hr after transfection, cells
were treated with 10 pM purified W37vLplA, 200 iM I 0-undecynoic acid, 1 mM ATP, and 5 mM
Mg(OAc)2 in cell growth medium for 20 min at room temperature. After brief rinsing, cells were
further labeled with 20 ptM Alexa Fluor® 647-picolyl azide, 50 ptM CuSO4 , 250 pLM THPTA,
and 2.5 mM sodium ascorbate in DPBS for 5 min at room temperature. Cells were imaged live
after brief rinsing.
CellTiter-Glo analysis of cytotoxicity (Figure 5-14B).
HeLa cells were analyzed in 96-well plates. Transfected cells expressing LAP-tagged neuroligin-
1 were labeled 24 hours after transfection as described in Figure S8B. Thereafter, 100 pLL of
CellTiter-Glo reagent (Promega) was added into each well. The plate was shaken at 30 'C for 10
min, and the luminescence from each well was recorded with a SPECTRAmax dual-scanning
microplate spectrofluorometer. Measurements were performed in triplicate.
Labeling of LAP-neuroligin-1 in live dissociated neurons with picolyl azide 8 ligase
followed by chelation-assisted CuAAC (Figure 5-15).
Neurons were transfected at 5 days in vitro with expression plasmids for LAP-tagged neuroligin-
1 (500 ng for a 1.9 cm2 dish) and green fluorescent protein-tagged HomerIb (Homer-GFP; 100
ng for a 1.9 cm 2 dish) using Lipofectamine 2000, using half the amount of the manufacturer's
recommended reagent quantity to minimize toxicity. Neurons were labeled at 11 days in vitro
with 10 ptM purified W37vLp1A, 200 piM picolyl azide 8, 1 mM ATP, and 5 mM Mg(OAc) 2 in
preconditioned supplemented Neurobasal medium for 20 min at 37 'C. After brief rinsing in
preconditioned supplemented medium, neurons were further labeled with 20 ptM Alexa Fluor*
647-alkyne, 50 piM Tempol, 50 piM CuSO 4 , 250 ptM THPTA (or BTTAA), and 2.5 mM sodium
ascorbate in Tyrode's buffer for 5 min at room temperature. The labeling solution was then
replaced with supplemented Neurobasal medium containing 500 IM bathocuproine sulfonate,
which was incubated with neurons for 30 sec. Neurons were imaged live in Tyrode's buffer after
2 further washes with supplemented Neurobasal medium.
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Intracellular protein labeling with picolyl azide 8 ligase and CuAAC (Figure 5-17A)
HEK cells were transfected with expression plasmids for LplAW37I and LAP2-BFP-NLS. 16-24
hours after transfection, cells were treated with 200 tM picolyl azide 8 in full growth media for
1 hour, followed by a 1-hour washout period. Cells were then fixed with 3.7% formaldehyde and
methanol, and blocked in 0.5% casein in DPBS.
For CuAAC derivatization step, a reaction mixture was conducted as follows: 1 mM
CuSO 4, 100 ptM TBTA, and 2.5 mM freshly prepared sodium ascorbate were first combined and
incubated for 5-10 min at room temperature. A reaction buffer of 0.5% casein in DPBS was then
added, followed by 3.3 ptM cy5-alkyne. For labeling on a 0.95 cm2 dish (a 48-well plate well),
150 ptL of the reaction mixture was incubated with cells for 1 hour at room temperature, in the
dark and shaking. Thereafter, cells were washed 3 times in a wash buffer containing 0.1% casein
and 0.2% Triton X- 100 in DPBS before proceeding to imaging.
Intracellular protein labeling with picolyl azide 8 ligase and strain-promoted cycloaddition
(Figure 5-17B)
Live-cell intracellular picolyl azide 8 ligation was performed as described for Figure 5-17A.
After the washout period to remove excess picolyl azide 8, cells were further treated with 10 piM
monofluorinated cyclooctyne-carboxyfluorescein diacetate congjuate (MOFO-CFDA) in serum-
free media for 10 min at room temperature. Thereafter, cells were washed 3-4 times over 2 hours
before imaging.
Labeling of proteins in the cell's secretory pathway using picolyl azide 8 ligase and
chelation-assisted CuAAC (Figure 5-18)
HEK cells were transfected with expression plasmids for KDEL-LplAw37 AT57I,F 47 LH2 67R (200 ng
for 0.95 cm2 dish) and LAP4.2-neurexin-1p (400 ng). 16-24 hours after transfection, 100 piM
picolyl azide 8-acetoxymethyl ester was added to cells in serum-free media for 1 hour at 37 'C.
Thereafter, cells were rinsed 2-3 times over 10 min, and further labeled with 20 piM Alexa Fluor
647-alkyne, 50 piM CuSO 4, 300 piM BTTAA, and 2.5 mM sodium ascorbate in Dulbecco's
phosphate-buffered saline (DPBS) for 5 min at room temperature. Cells were immediately
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imaged after excess CuAAC labeling reagents were removed by 2-3 quick washes with fresh
growth medium.
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Chapter 6
A general and facile route for ester protection of sulfonated fluorophores
for cellular delivery
The work described in this chapter is being prepared for publication. Professor Justin Du Bois
(Stanford University) provided advice and guidance on the diazo-sulfonate coupling reaction.
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Introduction
Many of the brightest and most photostable small organic fluorophores, such as the
cyanines, Alexa Fluors, and many members of the ATTO dyes, cannot be used routinely for live-
cell intracellular protein imaging because they do not cross the plasma membrane. These are
overwhelming fluorophores of choice for single-molecule and super-resolution imaging in vitro,
on fixed cells, and at the cell surface, owing to their superior photophysical properties. For
instance, among all small organic fluorophores and fluorescent proteins, the cyanine dye cy5 and
its relative Alexa Fluor 647 produce STORM images with the highest spatial resolution in the
shortest amount of acquisition time, due to its high photon count, low on-off duty cycle (i.e. short
fraction of time the fluorophore stays in the on state), high photostability, and large number of
switching cycles before complete photobleaching occurs (1). Cy5 and Alexa Fluor 647, however,
have only been used inside living cells in a few instances, when they were delivered by labor-
intensive and intrusive means such as microinjection (2), electroporation (3), or bead-based
loading (3).
The lack of membrane permeability of these fluorophores stems from their negatively
charged sulfonate groups-present in one, two, three, or sometimes four copies per fluorophore
molecule. Sulfonation has been shown in many cases to improve the fluorophore's aqueous
solubility and reduce dye-dye association, the latter of which can lead to self-quenching (4).
Sulfonation therefore dramatically improves the photophysical properties of many fluorophores.
When the sulfonate groups are removed from cyanine dyes, for example, they become lipophilic
and prone to aggregation, and exhibit poorer photoswitching properties and faster
photobleaching (Dr. Joshua Vaughan, Zhuang Lab, unpublished results).
There exist many fluorophores bearing negatively charged phenoxyl and carboxyl
functional groups (e.g. coumarins, resorufin, fluorescein) whose cellular delivery can be
achieved by protecting the phenolates and carboxylates as carboxyesters, such as methyl, ethyl,
or acetoxymethyl ester (5,6,7). The carboxyester derivatives of the fluorophores are neutrally
charged and able to cross the cell membranes. Inside mammalian cells, carboxyesters are
deprotected by endogenous esterases to regenerate the parent fluorophore. However, such a
strategy cannot be directly applied to protection of sulfonates, for two reasons. First, simple
sulfonate esters are unstable, even to storage in solvents such as DMSO, because they are potent
electrophiles (8). Second, while hindered sulfonate esters such as neopentyl sulfonate ester or
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trifluoromethylbenzyl sulfonate ester are more stable under physiological conditions, these
sulfonate ester structures are not recognized or cleaved in vitro by pig liver esterase, one of the
most promiscuous esterases known (9), and therefore will not be deprotected inside mammalian
cells to give back the parent sulfonate moiety.
Recently, a novel strategy to chemically derivatize sulfonated fluorophores for
intracellular delivery has been reported by Dr. Stephen Miller of University of Massachusetts
Medical School (10). Instead of employing plain sulfonate esters, Miller et al synthesized a
double sulfonate/carboxylate ester, called AcOTFMB (for acetyl trifluoromethylbenzyl) (Figure
6-1). The overall moiety is neutrally charged so the AcOTFMB-protected fluorophores can
readily enter cells. Once inside cells, the acetate ester moiety of AcOTFMB can be deprotected
by endogenous esterases. This step unmasks an unstable phenolate, which undergoes 1,6-
elimination to produce a quinone methide by-product, and the original sulfonated fluorophore.
Hence, this strategy relies upon known reactivity of endogenous esterases towards acetate esters
to unmask a group that spontaneously fragments to reveal the deprotected sulfonated molecules.
Prior to its esterase-mediated unmasking, the sulfonate ester moiety of AcOTFMB is chemically
stable because the trifluoromethyl substitution sterically hinders any nucleophilic attack at the a-
carbon adjacent to the sulfonate.
CF 3
SOCl 0 O O Endogenous O O
"AcOTFMB" F ellular esterases oF 3
NMe 2  NMe2  NMe2  NMe2
Dansyl chloride Dansyl-AcOTFMB
CF3
Figure 6-1. A chemically stable but esterase-labile acetyl trifluoromethylbenzyl (AcOTFMB) protecting
group for sulfonates (10). AcOTFMB-derivatized dansylate ester can be synthesized via esterification of
dansyl chloride and the alcoholic form of AcOTFMB. Once inside cells, the acetate moiety of AcOTFMB
is cleaved by endogenous esterases, which triggers the formation of a quinone methide by-product, and
subsequent liberation of the sulfonated molecule.
Miller et al has demonstrated such sulfonate ester derivatization and cellular delivery on
dansyl fluorophores, a dim blue fluorophore (c = 3,500-4,000 M'cm-1) with excitation and
emission maxima at 355 and 490 nm respectively. The derivatization chemistry was performed
using a commercially available dansyl chloride and the alcohol form of AcOTFMB. For most
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fluorophores, the sulfonyl chlorides (or any other activated sulfonyl esters) are not commercially
available, and must be generated in situ from their sulfonic acid forms, using traditional
chlorinating agents like thionyl, phosphoryl, or oxalyl chloride, before reacting with the
AcOTFMB alcohol. However, we have found that the chemistry for the sulfonyl chloride
formation is incompatible with the delicate and electrophilic structures of cyanine dyes and other
fluorophores of greatest interest. Figure 6-2 shows mass-spectrometric analyses of the reaction
between diethyl cy5 and oxalyl chloride in NN-dimethylformamide (DMF), without any
addition of any alcohol. We observed two new products: the first minor fluorescent product
likely corresponds to a benign sulfonaldehyde by-product, while the second, major non-
fluorescent product is postulated to be a chlorinated by-product, resulting from chloride addition
to the polymethine chain of cy5. Others have also reported destruction of the fluorophore cores
under harsh treatment with chlorinating agents (11). Therefore, while the design of AcOTFMB
theoretically could be applied to any sulfonated fluorophore structure of interest, it has not yet
been applied to other fluorophore classes for cellular delivery, largely because of the difficulty in
synthesizing sulfonate esters of the desired fluorophores.
In this chapter, we explored a different chemistry for accessing esterase-cleavable
protected forms of sulfonated fluorophores. The chemistry is based on an acid-catalyzed
coupling between a sulfonate and a diazomethylene compound (Figure 6-3). Unlike traditional
syntheses of sulfonate esters, the sulfonate group of such diazo-sulfonate coupling reaction
functions to nucleophilically attack the diazo-bearing compound, which is activated in the
presence of a strong acid to form an electrophilic diazonium species. Using a model diazo
compound, ethyl diazoacetate, we found that the acid-catalyzed diazo-sulfonate coupling
reaction is very efficient, capable of producing quantitative reaction yields within minutes, under
room temperature, in a variety of organic and aqueous reaction solvents. Inspired by the
AcOTFMB structure, we then synthesized a new diazomethylene compound-methyl 2-(4-
acetoxyphenyl)-2-diazoacetate, or MAD-to contain a latent quinone methide moiety, and a
similar esterase-cleavable acetate ester trigger (Figure 6-3). We used MAD to successfully
protect the sulfonate groups of many excellent fluorophores, including those often used for
single-molecule and super-resolution imaging such as cy5, cy3B, and ATT0655. MAD-
protected fluorophores were delivered efficiently into cells, and could be targeted to specific
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intracellular proteins via a protein-based labeling method, HaloTag, as well as via our own lipoic
acid ligase-mediated labeling method.
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Figure 6-2. By-products formed upon reacting diethyl cy5 with oxalyl chloride in the presence of catalytic
DMF. A) Positive electronspray ionization mass spectrometric analyses of the diethyl cy5 starting
material and the two products are shown. B) Our proposed identities of the two by-products and the
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formation (leading to formation of product 1), no desired sulfonate ester was detected upon addition of an
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Diazo-sulfonate coupling to form sulfonate esters
CO2Me
0 0 0 o-
OH N2, 0 OO0 OHS O Endogenous Os 
-O 0
"MAD CO2Me cellular esterases C0 2Me
A desired sulfonated MAD-protected molecule A desired sulfonated
fluorophore/molecule for cellular delivery fluorophore/molecule
OO2Me liberated inside cells
Figure 6-3. A general method for protection of sulfonated fluorophores as esterase-cleavable acetoxy
benzyl sulfonate esters, based on diazo-sulfonate coupling. MAD: methyl 2-(4-acetoxyphenyl)-2-
diazoacetate.
Diazo-sulfonate coupling for sulfonate ester formation from a sulfonic acid precursor
We explored literature surrounding the syntheses of sulfonate esters for alternative
reactions to those utilizing an activated sulfonyl chloride intermediate. First, we found that while
there are reports of other activated electrophilic intermediates of sulfonic acids, such as
pentafluorophenyl sulfonate ester (12) or trichlorophenyl sulfonate ester (13), these activated
esters are synthesized via sulfonyl chlorides. Second, direct syntheses of sulfonate esters from
sulfonic acids exist, but these reactions also utilize chlorinating agents in some form to generate
the sulfonyl chloride intermediate in situ. We suspect that these non-traditional chlorinating
agents, including trichlorotriazine, zirconium(IV) chloride, cobalt(II) chloride, or silica chloride,
might still be able to mediate chloride addition to electrophilic dyes like cy5.
Since virtually all synthetic routes via an activated, electrophilic form of sulfonic acids
employ nucleophilic reagents that can destroy the fluorophore cores, we then surveyed literature
for sulfonate ester formation reactions using electrophilic reagents. There are few examples for
such a reaction, and the two that caught our eyes are 1) the Mitsunobu reaction, in which an
activated oxophosphonium form of an alcohol acts as an electrophile, and 2) electrophilic
substitutions on diazoalkanes. We decided to pursue the latter because diazonium is likely a
better leaving group than oxophosphonium, and there is the vast amount of precedence for
reactions between simple sulfonic acids and simple diazoalkanes (e.g. diazomethane,
diazoethane). However, as diazoalkanes are highly toxic and explosive, we decided to first
examine whether sufficient electrophilic reactivity is present in resonance-stabilized (and more
chemically stable) a-diazoketone or a-diazoester compounds. One such stabilized diazo
compound, ethyl diazoacetate (EDA), is commercially available.
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We first ran a model reaction between EDA and p-toluenesulfonic acid (TsOH), simply
by mixing the two components in dichloromethane without any additives for one hour, at
ambient temperature (Figure 6-4). EDA was supplied at > 10 molar equivalents compared to
TsOH. A new product, which we later confirmed to be the desired sulfonate ester ethyl 2-
(tosyloxy)acetate, can be isolated in 55% yield. Encouraged by the result, we then performed
similar diazo-sulfonate coupling using dansyl acid (5-dimethylamino-1 -naphthalene sulfonic
acid) and EDA. Upon performing the reaction in dichloromethane for our hour, we obtained low
isolated yields (-20%) of the desired sulfonate ester. We thought that the low reaction yield is a
result of dansyl acid's poor solubility in dichloromethane; changing the reaction solvents to polar
protic solvents, such as methanol and water, increases the isolated reaction yields slightly to
-30%.
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Figure 6-5. TLC and LC-MS analyses of ethyl diazoacetate (EDA)-diethyl cy5 coupling. A) Left, TLC
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We further tested EDA derivatization of diethyl cy5, a fluorophore structure containing
two sulfonate groups whose structure is incompatible with sulfonyl chloride formation
chemistries. The compound was found to be miscible in 2:1 water:acetonitrile (MeCN),
methanol, and DMF (1mg in 100 ptL solvent). We therefore tested the three solvent systems for
diazo-sulfonate coupling. Figure 6-5A shows thin-layer chromatographic (TLC) analyses of the
reactions. On the left, TLC analysis shows the formation two new product spots under the 2:1
water:MeCN condition, which retain the color and fluorescence of cy5. Further LC-MS analysis
(Figure 6-5B) shows that the two new spots correspond to monoprotected and diprotected
derivatives of cy5 with EDA (cy5-EDA and cy5-EDA2, respectively). On the right of Figure 6-
5B, analysis of the reaction yields in three solvent systems shows that the diazo-sulfonate
coupling indeed proceeds more readily in protic solvent systems (2:1 water:MeCN and
methanol), compared to polar, aprotic DMF. However, even in the optimal solvent systems and
in the presence of excess EDA, the diazo coupling with diethyl cy5 only produces ~50%
monoprotected product, and only -10% of the desired diprotected product (reaction yields
estimated via densitometry on TLC). As many sulfonated fluorophores can only be purchased in
milligram quantities, the current efficiencies of the diazo-sulfonate coupling reaction are not high
enough to be generally of use.
Improving efficiencies of the diazo-sulfonate coupling reaction via acid catalysis
0
Nuc:=
N O +H N O A O O
NN: -N S -OEt
OEt OEt -N2  Ar O O
H* Nuc:
Diazo compound Activated diazonium
electrophile
Figure 6-6. General mechanism of diazo-sulfonate coupling reaction.
Upon examining the mechanism of the diazo-sulfonate coupling (Figure 6-6), we realized
that the diazo functional group will have to be protonated as a diazonium species for it to become
highly electrophilic. In our current reaction conditions, the only sources of proton are the solvent
and the sulfonic acid starting material. Since it is difficult to obtain the sulfonic acid starting
material whose counterion is 100% H+, our major proton source is likely the solvent, explaining
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why we obtained higher reaction yields in protic solvents such as water and methanol.
Sulfonated compounds containing amino groups, such as the dansyl fluorophore, will further
hinder diazo coupling as their amines can act as proton sponges.
Previous literature examples of reactions between sulfonates and diazoalkanes can
proceed efficiently without requiring any other catalyst, since the intrinsic reactivity of
diazoalkanes used in reported examples is higher than a-diazoesters used in our studies. There is
one literature example, however, that makes use of fluorinated alcohols such as trifluoroethanol
and hexafluoro-2-propanol to promote the coupling reaction between sulfonates and an a-
diazoester (14), probably via facilitation of proton exchange. We tested both fluorinated alcohols
as reaction solvents and found that their use did not improve coupling between diethyl cy5 and
EDA, over conventional protic solvents that we have tried (data not shown).
To drive the reaction forward, we resorted to supply exogenous acids to the reaction. The
ideal acid would be a strong acid (pKa of a diazonium is -5) whose conjugate base is not
nucleophilic, to avoid competition with sulfonates in reacting with the diazonium species. We
identified three such acids: fluoroboric acid (HBF 4, pKa -0.4), hexafluorophosphoric acid (HPF6,
pKa -20), and perchloric acid (HCIO 4, pKa -10). We decided to explore only the first two acids,
as HC1O 4 is known to be shock-sensitive and can be difficult to handle.
Cy5-(EDA) 2 .- i
Cy5-EDA > Spot:Methyl ester hydrolyzed 1: diethyl cy5
by-product? 2: co-spot between diethyl cy5 and reaction mixture 3
Cy5 -> 3: coupling reaction with HBF 4 added
4: coupling reaction with HPF6 added
Spot: 1 2 3 4
Figure 6-7. TLC analysis of acid-catalyzed EDA-cy5 coupling. Reactions were allowed to proceed for 1
hour at ambient temperature before the analysis. Acids were supplied at 2 molar equivalent with respect
to cy5.
Figure 6-7 shows TLC analysis of the diazo-sulfonate coupling between diethyl cy5 and
EDA for one hour at ambient temperature, in the presence of 2 molar equivalent (with respect to
diethyl cy5) of either HBF 4 or HPF 6. In contrast to the uncatalyzed reaction in the previous
section, both acid-catalyzed reactions proceeded to almost completion, obtaining -90% yield of
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cy5-EDA2 based on TLC densitometric analysis. Further purification using normal-phase silica
and mass spectrometric analysis confirmed the isolated product as cy5-EDA 2. We decided to use
HBF4 in subsequent derivatizations, as it is a weaker acid than HPF6 and should be more user-
friendly. Under acid-catalyzed conditions, we also found that the coupling reaction time can be
much shorter than one hour, down to minutes.
Synthesis and characterizations of an esterase-labile diazo protecting group coupled to
sulfonated fluorophores
With a more optimal diazo-sulfonate coupling condition, we then designed an a-
diazoester compound with an esterase-cleavable moiety, similar to Miller's AcOTFMB. The
desired compound, methyl 2-(4-acetoxyphenyl)-2-diazoacetate, or MAD, was synthesized in two
steps from 4-hydroxyphenylacetic acid methyl ester in ~50% overall yield (Figure 6-8). The key
diazo transfer step was performed using p-acetamidobenzenesulfonyl azide (p-ABSA), which is
considered a safer, less reactive diazo transfer reagent compared to tosyl azide or triflyl azide
(15), though p-ABSA is only efficient for diazo transfer onto methylene compounds flanking by
one or two carbonyl group. For further in vitro and cellular testing of the protecting group's
esterase susceptibility, we synthesized a MAD-protected form of a dansyl fluorophore
successfully using the HBF 4-catalyzed reaction condition. As a control, we also synthesized
methyl 2-phenyl-2-diazoacetate (Figure 6-9), which is structurally identical to MAD but contains
no acetate ester trigger, as well as its dansyl derivative. We also included the previously
synthesized dansyl-EDA, which contains an esterase-labile ethyl ester moiety but likely cannot
be deprotected all the way to its free sulfonate state.
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HO. 0Ac2O 
H TEA, DCM, RT AcO O SO2N3 AcO O
OMe quantitative yield OMe DBU, MeCN, RT OMe
50% N2
methyl 2-(4-acetoxyphenyl)-2-diazoacetate
(MAD)
Figure 6-8. Synthesis of methyl 2-(4-acetoxyphenyl)-2-diazoacetate (MAD), an a-diazoester compound
containing an esterase-cleavable moiety.
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We proceeded to test in vitro and in cells whether MAD-protected fluorophores can be
cleaved efficiently by esterases. First, we tested whether in vitro treatment with pig liver esterase
(PLE) would result in cleavage of the different sulfonate esters on the dansyl dye, as judged by
TLC analysis. After 10 min treatment with 0.05 unit of PLE, we found that dansyl-MAD 1 can
be cleaved completely to the free sulfonate (Figure 6-9. third row). In contrast, the dansyl ester 2,
which lacks the acetate ester, was inert to esterase treatment. As expected, the ethyl ester of
dansyl-EDA 3 could be cleaved efficiently by PLE, but we interestingly observed significant
cleavage to the free dansyl acid. We postulated that after ethyl ester cleavage of dansyl-EDA 3,
the subsequent 3-exo-tet cyclization initiated by the carboxylate nucleophile can also occur to
release a-acetolactone and the free sulfonate. For dansyl-MAD 1 as well as dansyl ester 2, we
did not observe signs of cleavage of the a-methyl ester group, presumably because the bulky aryl
substitutions at the a-position prevent the sites from getting recognized by PLE (9).
We next employed a cellular assay as an additional test of cleavage of dansyl esters by
esterases. Dansyl esters are lipophilic and tend to stick to internal cellular membranes, whereas
dansyl acid is hydrophilic and can freely diffuse throughout the cell. The fluorescence of dansyl
esters is additionally enhanced when they are stuck to membranes (10). Bright, punctate dansyl
fluorescence thus is indicative of lack of deprotection of dansyl esters, whereas relatively dim,
diffuse staining pattern suggests clean deprotection of the ester by endogenous esterases in cells.
Upon loading dansyl esters 1-3 into HEK cells, we found that dansyl-MAD 1 gave the most
even, diffuse staining pattern in cells, consistent with the efficient cleavage of its double
carboxylate/sulfonate esters, also observed in vitro (Figure 6-9, fourth row). In contrast, dansyl
ester 2 yielded almost exclusively punctate staining, suggesting that the ester modification on the
dye remains intact and renders the dye very hydrophobic. Loading of dansyl-EDA 3 showed both
diffuse staining and punctate pattern, indicative of only ethyl ester deprotection or partial
sulfonate deprotection of the dye in cells.
Based on the evidence of esterase-mediated cleavage in vitro and in cellulo, we
concluded that MAD performs sufficiently well as an esterase-labile protecting group for
sulfonates, and proceeded to use it to derivatize sulfonated fluorophores for site-specific protein
labeling.
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Figure 6-9. In vitro and in cellulo characterizations of esterase-mediated cleavage of different dansyl
sulfonate esters. First row, structures of methyl 2-(4-acetoxyphenyl)-2-diazoacetate (MAD), its esterase-
inert analog, and ethyl diazoacetate (EDA). Second row, their corresponding dansyl ester derivatives.
Third row, TLC analyses of pig liver esterase (PLE)-mediated cleavage of dansyl sulfonate esters. 100
iM of each dansyl ester was incubated with 0.05 unit of PLE in 25% v/v methanol in phosphate buffered
saline for 10 min at room temperature. Fourth row, cellular loading study of dansyl sulfonate esters as an
indirect test of their susceptibility to esterase cleavage. 10 piM of each dansyl ester was loaded into HEK
cells for 10 min at room temperature, then immediately imaged.
Applying MAD protection to useful sulfonated fluorophores for specific protein labeling
To achieve cellular delivery and site-specific targeting of sulfonated fluorophores to
intracellular proteins, we next considered the choices of potential fluorophores as well as protein
labeling methods. For fluorophores, we were most interested in disulfonated cy5 (6 = 250,000 M-
I cm , QY = 0.3, excitation and emission maxima of 650 and 670 nm, respectively), as it is the
absolute best fluorophore for localization-based super-resolution imaging (1), for reasons
provided in the introduction of this chapter. We were also interested in cy3B (c = 130,000 MI
cm-1 , QY = 0.7, excitation and emission maxima of 558 and 572 nm, respectively)-a
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monosulfonated, rigidified form of cy3 but is 7-times brighter than cy3. Cy3B (has seen
extensive uses in fluorescent speckle microscopy, and is also the best orange-emitting
fluorophore for STORM (1), potentially permitting us to perform two-color super-resolution
imaging if we combine cy3B with a red fluorophore like cy5. Lastly, ATT0655 (E= 125,000 M-1
cmI, QY = 0.3, excitation and emission maxima of 663 and 684 nm, respectively) is an excellent
monosulfonated red fluorophore utilized for stimulated emission depletion microscopy (STED)
as well as STORM (16). Both cy3B and ATT0655 are zwitterionic dyes, after bioconjugation, so
they are intrinsically slightly membrane-permeable even without protection of their sulfonates.
ATT0655 in fact has been used in a number of examples for live-cell intracellular protein
imaging without the need to employ invasive methods for cellular delivery, including by us
(17,16), though protein labeling efficiencies could be hampered by the dye's low cellular loading
amount.
Among a plethora of protein labeling methods, we decided to first use HaloTag, a 35 kDa
self-labeling protein tag derived from bacterial chloroalkane dehalogenase, for its high labeling
specificity and speed (second-order rate constant of ~106 M' s- (18)), as well as for the ease of
syntheses of their chloroalkane recognition motif and the subsequent fluorophore conjugates. We
later employed peptide-directed, LplA-mediated labeling coupled with reverse-electron-demand
Diels-Alder cycloaddition (19) to achieve specific tagging of a sulfonated fluorophore on P-actin,
a cytoskeletal protein whose fusion to a large protein tag like HaloTag is detrimental to its
polymerization and nuclear entry (7).
To prepare sulfonated fluorophores for site-specific protein labeling, we synthesized cy5-
cy3B-, and ATT0655-chloroalkane conjugates via amide coupling of the dye's succinimidyl
ester derivative to 2-(2-((6-chlorohexyl)oxy)ethoxy)ethanamine. Subsequently, we performed
MAD protection on the fluorophore-chloroalkane conjugates. TLC analyses of the diazo-
sulfonate coupling reaction of MAD to cy5-, cy3B, and ATT0655-chloroalkane showed that all
reactions proceeded in quantitative yields to yield monoprotected forms of cy3B and ATT0655
conjugates, and the diprotected form of cy5 conjugate. Mass spectrometric analyses after normal-
phase silica gel purification confirmed the correct identities of each derivatized compound.
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Figure 6-10. Membrane-permeable, esterase-cleavable, and targetable variants sulfonated fluorophores
cy5, cy3B, and ATT0655. Structures of the fluorophores' chloroalkane derivatives (for targeting to
proteins via HaloTag) and subsequent MAD-derivatized forms are shown.
Intracellular protein labeling with membrane-permeable cy5-chloroalkane-MAD2
To perform intracellular labeling with HaloTag and membrane-permeable cy5 conjugate,
we co-expressed in HEK cells nucleus-targeted HaloTag and a CFP fluorescent protein marker.
Twenty-four hours after transfection, we inbucated cells with 100 nM cy5-chloroalkane-MAD2
in serum-free Dulbecco's modified eagle medium for 10 min, at 37 'C. Figure 6-11 depicts cell
images right after the labeling solution was removed and cells quickly washed with fresh growth
media (top row), as well as cell images after the two-hour washout period (bottom row), when
the media was changed every 30 min to remove excess, unlabeled dye. Imaging right after the
loading moment shows that upon cell entry, cy5-chloroalkane-MAD2 (and its deprotected
derivatives in cells) in untransfected cells exhibits punctate localization pattern, suggesting that
the dye might not be efficiently deprotected, or that the deprotected cy5-chloroalkane moiety is
still hydrophobic enough to stick to internal membranes. The loading pattern is also suggestive
of mitochondrial accumulation of the dye, which can occur if the dye translocates to the
mitochondrial matrix due to the influence of the organelle's voltage gradient, before its esters
can be deprotected in the cytosol by esterases. In transfected cells (expressing CFP), we were
able to already observe specific cy5 labeling signal in the cell nuclei over the background of
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excess dye (in cells pointed by white arrows), a testament to HaloTag's high labeling efficiency.
The signal-to-noise of nucleus-specific cy5 labeling over background in untransfected cells, as
well as in the cytosol of transfected cells, substantially improved after the two-hour washout
period.
Cy5 CFP + DIC Cy5 CFP + DIC
Right after
10min loading
After 2-hour
washout
F igu3re 6-11. Intracellular protein labeling with membrane-permeable cy5-chloroalkane-MAD 2. HEK cells
expressing nucleus-targeted HaloTag and a whole-cell cyan fluorescent protein (CFP) marker were
incubated with 100 nM cy5-chloroalkane-MAD2 in serum-free minimal eagle medium (MEM) for 10 min
at 37 'C. Cells were imaged right after the loading period (top row), and after a 2-hour washout period
(bottom row).
We next attempted to label HaloTag fusion to cytoskeletal proteins, P-actin and a-
tubulin, which constitute the microfilament and microtubule network respectively. Cy5 labeling
on these supposedly filamentous structures were also successful in HEK cells (Figure 6-12),
though due to overexpression of the recombinant HaloTag constructs and potential interference
of HaloTag on the proteins' polymerization kinetics, cy5 labeling pattern on both p-actin and a-
tubulin appeared to lack defined filamentous structures. Labeling on a-tubulin looks diffuse, but
is restricted to the cytosol. And while some labeling on cortical p-actin structures at the cell
membrane can be observed, other usual features of actin such as stress fibers were absent.
Labeling of the same Halotag-p-actin and HaloTag-a-tubulin constructs with commercially
available tetramethylrhodamine (TMR)-chloroalkane revealed similar labeling patterns on both
proteins as when cy5-chloroalkane-MAD 2 is used (Figure 6-12), suggesting that the aberrant
staining patterns are likely due to the HaloTag-protein constructs, not the fluorophore label.
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Figure 6-12.Live-cell cy5 labeling on HaloTag fusions to actin and tubulin. HEK cells expressing either
HaloTag-p-actin (top row) or HaloTag-a-tubulin (bottom row) and a CFP marker were labeled with cy5-
chloroalkane-MAD 2 as described in Figure 6-1 1. Right, labeling on the two cytoskeletal structures was
also performed with an intrinsically membrane-permeable tetramethylrhodamine (TMR)-chloroalkane.
Due to HEK cells' thick morphology, they are not suitable for super-resolution imaging
applications, which are typically performed in total-internal-reflection fluorescence microscopic
(TIRFM) mode and require that biological structures be close (within -200 nm) to the cell
membrane (20). We therefore switched to perform protein labeling in kidney fibroblast COS-7
cells, which have flatter morphology. However, we observed that the cellular loading efficiency
of cy5-chloroalkane-MAD 2 in COS-7 cells is not as good as in HEK cells, resulting in much
reduced labeling signal on HaloTag fusion proteins in COS-7 cells (data not shown). We also
hypothesized that aside from differences in dye uptake and membrane permissivity among cell
types, the cy5-chloroalkane-MAD2 molecule is so hydrophobic that it can form dye
microaggregates, reducing effective concentrations of the soluble portion of the dye which can
diffuse through the cell membrane.
To optimize cellular loading of cy5-chloroalkane-MAD 2 in COS-7 cells, we tried to
perform dye loading in the presence of a non-denaturing detergent Pluronic F-127, which has
been shown to improve aqueous solubility of hydrophobic fluorophores and ion sensors, such as
a Ca2+ fluorescent sensor Fura-2 (21). Indeed, at equimolar loading concentrations of cy5-
chloroalkane-MAD 2 (either 220 or 80 nM), the presence of 0.1% w/v Pluronic F-127 in the dye
loading solution allowed for at least 3-fold improvement in cy5 loading amount (judging from its
intracellular fluorescence) compared to when Pluronic was omitted (Figure 6-13). The higher
dye loading amount led directly to higher labeling efficiency, as strong, specific cy5 labeling
P-actin
a-tubulin
FilUf iw1
FilUf iw1
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signal could now be observed in the nuclei of transfected COS-7 cells (with a nuclear YFP
marker) expressing nucleus-targeted HaloTag. We are actively working to extend specific
labeling with cy5-chloroalkane-MAD 2to other HaloTag fusion proteins of interest.
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Figure 6-13. Optimizations of intracellular protein labeling with membrane-permeable cy5-chloroalkane-
MAD2 in COS-7 cells. COS-7 cells expressing nucleus-targeted HaloTag and a nuclear YFP marker were
incubated with the indicated concentration of cy5-chloroalkane-MAD 2 in serum-free MEM, in the
presence (left) or absence (right) of Pluronic F-127 for 15 min at 37 'C. Cells were imaged right after the
loading period (top panel), and after a 4-hour washout period (bottom panel).
Intracellular protein labeling with membrane-permeable cy3B-chloroalkane-MAD
With monosulfonated, zwitterionic cy3B-chloroalkane, it was unclear to us whether
MAD protection on the sulfonate group, which grants an overall positive charge to the molecule,
would improve cell loading over unprotected cy3B-chloroalkane (overall neutral charge, but
contains a local negatively charge on its sulfonate). We first compared cellular loading of cy3B-
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chloroalkane-MAD to that of unprotected cy3B-chloroalkane. It was found that cy3B-
chloroalkane-MAD enters cells much more readily than its unprotected form, and shows strong
accumulation in the mitochondria (Figure 6-l 4A). The mitochondrial localization, similar to
what we observed with cy5-chloroalkane-MAD 2, could be a combined result of the dye's
hydrophobicity, and faster translocation of the dye into the mitochondrial matrix before MAD
can be deprotected via cellular esterases.
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Figure 6-14. Intracellular protein labeling with membrane-permeable cy3B-chloroalkane-MAD. A)
Cellular loading of cy3B-chloroalkane-MAD versus unprotected cy3 B-chloroalkane into untransfected
COS-7 cells. 100 nM of either probe was incubated with cells in serum-free MEM for 10 min, then
immediately imaged. The inset image for cy3B-chloroalkane loading shows that the probe gets into cells,
but very minimally. B) Comparison of specific protein labeling upon using MAD-protected versus
unprotected cy3B. COS-7 cells expressing nucleus-targeted HaloTag and Histone 2B fused to YFP were
incubated with either probe at the indicated concentration in serum-free minimal eagle medium (MEM)
for 15 min at 37 'C. Cells were imaged after a 2-hour washout period. Unnormalized cy3B fluorescence
images are shown to highlight specific cy3B labeling in the cell nuclei in all cases. Normalized cy3B
images are shown so that cy3B labeling intensities across different probes and loading conditions can be
compared.
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More efficient cellular entry of cy3B-chloroalkane-MAD resulted in higher labeling
signal on cellular HaloTag fusion proteins, compared to unprotected cy3B-chloroalkane. Figure
6-14B shows cy3B labeling on COS-7 cells expressing nucleus-targeted HaloTag, using different
concentrations of protected and unprotected cy3B-chloroalkane. We found that 100-300 nM of
cy3B-chloroalkane-MAD loading followed by two-hour washout period can generate strong
labeling signal in the cell nuclei. Lowering cy3B-chloroalkane-MAD concentration to 30 nM, or
using unprotected cy3B-chloroalkane at as high concentration as 300 nM, did not produce
efficient labeling.
Labeling with cy3B-chloroalkane-MAD Labeling with cy3B-chloroalkane
cy3B cy3B cy3B cy3B
(intensity range 1) (intensity range 2) CFP + DIC (intensity range 1) (intensity range 2) CFP + DIC10nM
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Figure 6-15. Intracellular protein labeling with membrane-permeable cy3B-chloroalkane-MAD in HEK
cells. HEK cells expressing nucleus-targeted HaloTag and a CFP marker were incubated with either
cy3B-chloroalkane-MAD or cy3B-chloroalkane at the indicated concentration in serum-free minimal
eagle medium (MEM) for 15 min at 37 'C. Cells were imaged after a 2-hour washout period. Two
intensity ranges of cy3B images are shown. The wider range (range 1) highlights the much higher cellular
cy3B fluorescence upon using the protected cy3B probe, while the narrower range (range 2) shows the
specificity of labeling upon using the unprotected probe, despite the lower labeling intensity.
Interestingly, an analogous labeling experiment on nucleus-targeted HaloTag in HEK
cells, instead of COS-7 cells, yielded results that pointed to the potential disadvantage of using
the protected sulfonated probe for protein labeling. As we previously observed with labeling with
cy5-chloroalkane-MAD 2, HEK cells, compared to COS-7 cells, seem to permit better dye uptake
or diffusion into cells. Upon comparison of cy3B-chloroalkane vs. cy3B-chloroalkane-MAD for
labeling of nucleus-targeted HaloTag in HEK cells, we found that while the MAD-protected
form of cy3B yielded much higher labeling signal in the cell nuclei, the excess, off-target dye
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background in the cytosol was still high after 2-hour washout (Figure 6-15). Unprotected cy3B-
chloroalkane, on the other hand, can be used to produce specific labeling signal with high signal-
to-noise of labeling, despite the lesser amount of probe that got into cells.
Increasing labeling efficiency through trapping of sulfonated fluorophores in cells with
transport inhibitors
To further improve labeling signal with sulfonated fluorophores, we experimented with
the use of anionic transporter inhibitors to trap anionic dyes inside cells for a longer period,
prolonging labeling time. Katie White performed cellular loading test on cy3B-chloroalkane-
MAD in the presence of three anionic transporter inhibitors: probenecid, which inhibits organic
anion transport systems (22); Ko-143, which inhibits breast cancer resistance proteins
(BCRP/ABCG) (23); and MK-571, which inhibits multidrug resistance proteins (MRP/ABCC)
(24). It was found that MK-571 produces the highest amount of retained cy3B-chloroalkane
during loading. Applying the MK-571 inhibitor to protein labeling experiments involving
sulfonated fluorophores can further improve specific labeling signal, as demonstrated with cy3B-
chloroalkane-MAD labeling on HaloTag tethered to the cytosolic face of the ER membrane (via
fusion to the Cl(l-29) P450 sequence (25)) (Figure 6-16). We also tried different MK-571
loading protocols, including the application of the inhibitor before, during, and after incubation
with the labeling probe. It was found that co-incubation of the protected sulfonated dye (cy3B in
this case) with the transport inhibitor yielded the best labeling results (Figure 6-16).
300 nM cy3B-MAD
+ 50 PM MK-571 100 nM cy3B-MAD 300 nM cy3B-MAD
for 1 hour after + 50 pM MK-571 + 50 pM MK-571
300 nM cy3B-MAD dye loading during dye loading during dye loading
cy3B
-ER
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Figure 6-16. Optimizing cy3B labeling efficiency through use of an anionic transporter inhibitor. COS-7
cells expressing CI(1-29) P450-HaloTag and C1(1-29) P450-GFP were labeled with cy3B-chloroalkane-
MAD as indicated. Cells were imaged after a 2-hour washout period.
Intracellular protein labeling with membrane-permeable ATT0655-chloroalkane-MAD
We performed comparisons of cellular loading and labeling with ATT0655-
chloroalkane-MAD versus unprotected ATT0655-chloroalkane, analogous to our studies with
cy3B derivatives, and similarly found that MAD protection'on ATT0655-chloroalkane allowed
for better cellular entry of the probe, leading to higher ATT0655 labeling signal on nucleus-
targeted HaloTag in COS-7 cells (Figure 6-17A). The application of MK-571 anionic transport
inhibitor during ATTO65S-chloroalkane-MAD loading further increased specific ATT0655
labeling signal (data not shown). Figure 6-17B shows specific labeling of C1(1-29) P450-
HaloTag (for ER membrane localization) upon using 200 nM ATT0655-chloroalkane-MAD in
the presence of 50 ptM MK-571 inhibitor. A zoomed-in image shows that the ATT0655 signal
co-localizes well with the GFP marker for the ER.
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Figure 6-17. Intracellular protein labeling with membrane-permeable ATT0655-chloroalkane-MAD. A)
COS-7 cells expressing nucleus-targeted HaloTag and a nuclear YFP marker were incubated with either
ATT0655-chloroalkane-MAD or ATT0655-chloroalkane at the indicated concentration in serum-free
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minimal eagle medium (MEM) for 15 min at 37 'C. Cells were imaged after a 2-hour washout period. B)
COS-7 cells expressing CI(1-29) P450-HaloTag and C1(1-29) P450-GFP were labeled with 200 nM
ATT0655-chloroalkane-MAD in the presence of 50 pM MK-571. Cells were imaged after a 2-hour
washout period.
Two-step intracellular protein labeling with membrane-permeable ATT0655 using lipoic
acid ligase and Diels-Alder cycloaddition
While HaloTag labeling method offers high labeling specificity and speed, its large tag
size can be detrimental to the function of proteins HaloTag is fused to. In Chapter 4, we have
discussed a peptide-based labeling method based on the combination of LplA-mediated ligation
of an alkyl azide, followed by chemoselective derivatization using the strain-promoted
cycloaddition with strained alkynes. This labeling approach, however, is not optimal for
intracellular protein labeling, due to slow cycloaddition reactivities of the cyclooctynes (rate
constants up to 1 M s- (26)). Recently, Dan Liu and Anupong Tangpeerachaikul of our lab
have reported the application of a very fast, bioorthogonal reaction-reverse-electron-demand
Diels-Alder cycloaddition-to peptide-directed site-specific protein labeling inside living cells
(Figure 6-18) (19). A trans-cyclooctene cycloaddition reaction partner is first ligated onto LAP-
tagged proteins using a W37V variant of E.coli LplA. A tetrazine-fluorophore conjugate can then
be added to cells to effect cycloaddition onto LAP-ligated trans-cyclooctene, with second-order
rate constants as high as 104 M- s 1 (19). With only a 13-amino acid peptide required for
tagging, LplA-based labeling is especially beneficial for probe targeting onto proteins which
cannot tolerate fusions to large protein tags. We have previously discovered that p-actin is one
such protein (7).
O "Tz1"
O H Tetrazine-probe 0 H
TCO2 HN N conjugate HN TN
LptA""v, ATPH
13 amino-ackid LAP
Figure 6-18. Two-step protein labeling with LplA-mediated trans-cyclooctene ligation and Diels-Alder
cycloaddition. In the first step, LplA ligates a trans-cylclooctene derivative called TCO2 onto its acceptor
peptide, LAP, fused to a protein of interest. In the second step, cyclooctene-modified proteins can be
chemoselectively derivatized with a tetrazine-probe conjugate via reverse-electron-demand Diels-Alder
cycloaddition.
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To apply the two-step labeling approach with LplA and Diels-Alder reaction to protein
imaging with sulfonated fluorophores, we synthesized ATT0655 conjugate to a tetrazine variant
called Tzl, then protected ATTO655s sulfonate group with MAD via diazo coupling. To
perform labeling, COS-7 cells co-expressing LpIAW37V and nucleus-targeted LAP2-tagged blue
fluorescent protein (LAP2-BFP-NLS) were first incubated with the trans-cyclooctene substrate
for LpIA, called TCO2, for 30 minutes. After excess TCO2 was removed, cells were labeled with
various concentrations of ATT0655-Tzl-MAD, ranging from 80-750 nM, and in the presence or
absence of the MK-571 anionic transporter inhibitor. Figure 6-19 shows cell images after two-
hour washout period to remove excess labeling probes. ATT0655 specific labeling signal in the
cell nuclei was found to be higher under MK-571 treatment at all ATT0655 loading
concentrations, with the loading combination of 250 nM ATT0655-Tz1-MAD and 50 IM MK-
571 producing the highest signal-to-noise of labeling.
Labeling with MK-571 Labeling without MK-571
LAP2-BFP ATT0655 LAP2-BFP ATT0655
750 nM
250 nM
80 nM
750 nM
250 nM
Figure 6-19. Intracellular protein labeling with LplA-mediated trans-cyclooctene ligation and a
membrane-permeable ATT0655-tetrazine conjugate. COS-7 cells expressing LplAW37 v and nucleus-
targeted LAP2-BFP were first incubated with 200 pM TCO2 for 30 min. After 30-min washout period,
cells were further treated with ATT0655-Tzl-MAD at the indicated concentration, in the presence or
absence of MK-571 transporter inhibitor, for 10 min at 37 'C. Cells were imaged after another 2-hour
washout period.
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Two-color orthogonal protein labeling with two sulfonated fluorophores using lipoic acid
ligase and HaloTag
With LplA and HaloTag as two orthogonal intracellular protein labeling methods in hand,
we proceeded to perform two-color protein labeling with two membrane-permeable sulfonated
dyes. To image two differently labeled proteins within the same cell, we co-expressed in COS-7
cells LplAW37V, LAP2-tagged p-actin, and either CI(1-29) P450-HaloTag or HaloTag-
vimentin. After trans-cyclooctene TCO2 ligation, we performed fluorophores' derivatizations
with 250 nM ATT0655-Tzl-MAD and 200 nM cy3B-chloroalkane-MAD for 15 min, in the
presence of 50 pM MK-571 inhibitor. Figure 6-20 shows specific ATT0655 tagging onto p-actin
(via LpIA and Diels-Alder cycloaddition) and specific cy3B tagging onto CI(l-29)P450 or
vimentin (via HaloTag), within the same cell. Although the signal-to-noise of labeling obtained
from LpIA/Diels-Alder is still not as high as that obtained from HaloTag labeling, p-actin labeled
with ATT0655 via LpIA exhibits many characteristic features of actin, such as the cortical
subpopulation at the cell membrane or branched, fine actin filaments in the lamellipodia. This
can be contrasted to rare observations of filaments if p-actin were fused to a large protein tag like
HaloTag.
ATT0655 cy3B ATT0655 cy3B
(LAP-@-actin) (HaloTag-ER) cy3B + DIC (LAP-0-actin) (vimentin-HaloTag) cy3B + DIC
Field of view 1
Field of view 2
Field of view* 1
Field of view,, 2
U
Figure 6-20. Orthogonal targeting of two membrane-permeable sulfonated fluorophores using LpIA and
HaloTag. COS-7 cells expressing LplAW37V, LAP2-actin, and either CI(l-29) P450-HaloTag or
vimentin-HaloTag were first labeled with TCO2 for 30 min. After 30-min washout period, cells were
incubated with 250 nM ATT0655-Tzl-MAD, 200 nM cy3B-chloroalkane-MAD, and 50 PM MK-571
for 15 min. Cells were imaged after a 2-hour washout period.
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Conclusion
In summary, we have developed facile chemistry for the installation of an esterase-labile
protecting group onto diverse sulfonated fluorophores. The chemistry is based on an acid-
catalyzed coupling between a sulfonate and a diazomethylene compound, and proceeds
efficiently on different sulfonated structures, in both organic and aqueous conditions. A newly
designed diazo compound, methyl 2 -(4-acetoxyphenyl)-2-diazoacetate, or MAD, allows
attachment of an esterase-cleavable group onto sulfonated fluorophores. MAD-protected
fluorophores, including cy5, cy3B, and ATT0655, can be delivered into mammalian cells
efficiently without the need of any invasive method, and used for site-specific labeling and
imaging of proteins.
Many of the best fluorophores for STORM super-resolution imaging in all emitting
regions are sulfonated and not membrane-permeable. In fact, the current best fluorophores for
each emission region are all sulfonated: ATT0488 (green), cy3B (orange), cy5/Alexa Fluor
647/Dyomics 654 (red), and cy7/Alexa Fluor 750 (far-red) (1). These fluorophores are currently
limited to uses in fixed cells, at the cell suface, or inside cells only if invasive delivery means are
used. Our chemistry potentially allows for this repertoire of fluorophores to be routinely accessed
for intracellular labeling applications. We have started to explore the potential of MAD-protected
fluorophores for super-resolution imaging of proteins inside living cells. The efforts are further
described in Chapter 7.
The chemistry and the protecting group design are not without limitations, however.
First, the chemistry is likely not compatible with acid-sensitive compounds. We have also found
that diazo coupling is very low-yielding when performed on sulfonated fluorophores which
contain proximal amino groups, such as ATT0488 and ATT0532. And, so far, we have not
tested the chemistry on fluorophore structures that contain other potential nucleophiles, such as
carboxylates or phenolates, that can compete with sulfonates in reacting with the diazonium
species. The protecting group also introduces a large hydrophobic bulk onto sulfonated
fluorophores, which can ironically impede their cellular delivery due to formation of insoluble
microaggregates. The problem is especially exacerbated if the starting fluorophore contains
many sulfonate groups (such as cy5), resulting in the need to modify all of them with
hydrophobic protecting groups. A next generation of diazo-based sulfonate protecting groups
that is more hydrophilic, yet uncharged, will allow applications of diazo-sulfonate coupling to
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more diverse sulfonated fluorophore structures-such as Alexa Fluor 405 (3 sulfonates), Alexa
Fluor 568 (2 sulfonates, one carboxylate), and Alexa Fluor 647 (4 sulfonates)-concomitant with
successful cellular delivery of these fluorophores.
Beyond derivatizations of sulfonated fluorophores, the diazo-sulfonate coupling should
be extensible to protection of sulfonated small molecules for cellular delivery or to improve in
vivo stability in circulation. The sulfonate functional group is generally avoided in drug design,
preciously because of permeability issues, but might possess untapped therapeutical potential.
For instance, sulfonates might be able to form strong electrostatic interactions with positively
charged amino acids like lysine and arginine, which can be exploited in drug design, similar to
what has been done for phosphate-arginine interactions (27).
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Experimental methods
General synthetic methods. Chemicals were purchased from Sigma-Aldrich, Alfa Aesar, TCI
America, Fisher Scientific, Adesis Inc, EMD, Avocado Research Chemicals, or Life
Technologies. Analytical thin-layer chromatography was performed using 0.25 mm silica gel 60
F2 54 plates and visualized with 254 nm UV light or with bromocresol green. 'H NMR spectra
were recorded on a Bruker Avance 400 MHz or a Varian Inova 500 MHz spectrometer. All
samples were dissolved in CDCl 3, CD 30D, D20, or d6-DMSO and chemical shifts (6) are
expressed in parts per million relative to residual solvent peak as an internal standard.
Abbreviations are: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad. Coupling
constants (J) are reported in hertz (Hz).
Liquid chromatographic-mass spectrometry (LC-MS) analysis was performed on reverse-
phase HPLC (Shimadzu UFLC XR) equipped with an SPD-20A dual-wavelength UV detector
and a C18 column (Shimadzu, 4.6mm x 50 mm dimension) linked to an Applied Biosystems
QTRAP 200 electrospray ionization mass spectrometer. For preparative-scale HPLC
purification, we used a Varian Prostar 210 HPLC equipped with Agilent 325 UV/Vis dual-
wavelength detector, Agilent 440-LC fraction collector, and a Microsorb C18 column (Varian, 5
pm particle size, 21mm x 250 mm dimension).
Synthesis of ethyl diazoacetate coupling products
0
'b 0
Ethyl 2-(tosyloxy)acetate (Tosyl-EDA conjugate). To an ice bath-chilled solution of ethyl
diazoacetate (30 mg, 0.26 mmol) in anhydrous dichloromethane (1 mL) was added p-
toluenesulfonic acid (TsOH, 50 mg, 0.26 mmol) in small portions over 5 min at 0 'C. The ice
bath was then removed, and the reaction was allowed to stir at room temperature for one hour.
TsOH remained largely insoluble but TLC analysis of dichloromethane solution indicated a new
product formation. After one hour, dichloromethane and water were then added to dilute the
reaction mixture. The layers were separated, and the aqueous layer was extracted with
dichloromethane twice. The combined organic layers were washed with brine, dried over
MgSO4, and concentrated in vacuo. The residual mixture was purified using silica gel
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chromatography. Ethyl diazoacetate was first eluted out using 10:1 hexanes:ethyl acetate; the
new product was then eluted using 4:1 hexanes:ethyl acetate. Concentration of the desired
fractions yielded the desired compound as beige oil (37 mg, 55% yield). Rf = 0.41 in 4:1
hexanes:ethyl acetate. 'H NMR (500 MHz, CDCl 3): 6 7.83 (d, 2H, J = 9.0 Hz), 7.35 (d, 2H, J
9.0 Hz), 4.57 (s, 2H), 4.18 (q, 2H, J = 7.0 Hz), 2.44 (s, 3H), 1.23 (t, 3H, J = 7.0 Hz). "C NMR
(125 MHz, CDCl3): 6 166.3, 145.6, 132.8, 130.2, 128.4, 65.0, 62.2, 22.0, 14.3.
0
NMe 2
Dansyl-EDA conjugate. To an ice bath-chilled solution of ethyl diazoacetate (4 ptL, 0.040 mmol)
in anhydrous dichloromethane (0.5 mL) was added dansyl acid (10 mg, 0.040 mmol). The ice
bath was then removed, and the reaction allowed to stir at room temperature for 1 hour. Despite
poor solubility of dansyl acid in dichloromethane, TLC analysis (1:1 Hexanes:ethyl acetate)
indicated formation of a new product (Rf = 0.86, green fluorescence under long UV excitation),
which can be differentiated from the dansyl acid starting material (Rf = 0, blue fluorescence).
After one hour, dichloromethane and water were then added to dilute the reaction mixture. The
layers were separated, and the aqueous layer was extracted with dichloromethane twice. The
combined organic layers were washed with brine, dried over MgSO 4, and concentrated in vacuo.
The residual mixture was purified using silica gel chromatography. Ethyl diazoacetate was first
eluted using 10:1 hexanes:ethyl acetate; the new product was then eluted using 4:1 hexanes:ethyl
acetate. Concentration of the desired fractions yielded the desired compound (-2.5 mg). ESI-MS:
[M+H]* m/z 338.11 calculated, 338.2 observed.
0 0
N 4/ 0
Cy5-EDA conjugates. To a solution of diethyl cy5 (1 mg, 0.002 mmol) in 2:1 water:acetonitrile
(100 ptL) was added ethyl diazoacetate (5 ptL, 0.050 mmol). The reaction was stirred at room
temperature for 1 hour, after which it was analyzed on TLC (65:25:5 chloroform:methanol:acetic
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acid, Figure 6-5A). The crude reaction mixture was further analyzed by LC-MS. We used a 12-
min gradient of 10-100% acetonitrile in water with 0.1% trifluoroacetic acid at a flow rate of 0.2
mL/min. Diethyl cy5, cy5-EDA, and cy5-(EDA) 2 have retention times of 7.1, 10.4 and -11.2
minutes respectively. Concurrent ESI-MS analyses confirmed the identities of each HPLC peak:
cy5-EDA [M+H]* m/z 657.23 calculated, 657.4 observed; cy5-(EDA) 2 [M+H]* m/z 743.27
calculated, 743.5 observed (Figure 6-5C).
Synthesis of a-diazoester compounds
H
N
Ac2O
HO O TEA, DCM, RT AcO O SO2N3
OMe quantitative yield OMe DBU, MeCN, RT OMe
50% N2
methyl 2-(4-acetoxyphenyl)-2-diazoacetate
(MAD)
Methyl-2-(4-acetoxyphenyl)acetate. To a solution of methyl-4-hydroxyphenylacetic acid (500
mg, 3 mmol) in anhydrous dichloromethane (DCM, 7.5 mL) was added triethylamine (TEA, 620
ptL, 4.5 mmol) and acetic anhydride (350 ptL, 3.75 mmol). The reaction was stirred for twelve
hours at room temperature. The reaction mixture was then washed with 1:1 water:IM HCI
solution, water, 1:1 water:saturated NaHCO 3 solution, and brine, then dried over Na2SO4, and
concentrated in vacuo to yield methyl 2-(4-acetoxyphenyl)acetate as pale yellow oil (604 mg,
96% yield). Rf = 0.69 in 1:1 hexanes:ethyl aceate. IH NMR (500 MHz, CDCl 3): 6 7.28 (d, 2H, J
= 8.0 Hz), 7.03 (d, 2H, J = 8.0 Hz), 3.68 (s, 3H), 3.61 (s, 2H), 2.29 (s, 3H).
Methyl-2-(4-acetoxyphenyl)diazoacetate (MAD). To an ice bath-chilled solution of methyl 2-(4-
acetoxyphenyl)acetate (100 mg, 0.48 mmol) and p-acetamidobenzenesulfonyl azide (p-ABSA,
138 mg, 0.58 mmol) in anhydrous acetonitrile (2 mL) was added 1,8-diazabicyclo[5.4.]undec-7-
ene (DBU, 102 mg, 0.67 mmol). The reaction mixture turned yellow immediately after DBU
addition (indicative of the formation of the diazo compound). The ice bath was removed, and the
reaction was allowed to stir at room temperature for three hours, after which the reaction mixture
was diluted in water and ethyl acetate. The layers were separated, and the aqueous layer was
extracted with ethyl acetate three times, washed with saturated NaHCO 3 solution three times, and
washed with brine. The combined organic layers were dried over Na2SO4, and concentrated in
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vacuo. The resulting residue was purified by silica gel chromatography (hexanes, then 95:5
hexanes:ethyl acetate, then 93:7 hexanes:ethyl acetate). Fractions were collected and
concentrated to yield the desired product as bright yellow solid (54 mg, 49% yield). Rf= 0.38 in
4:1 hexanes:ethyl acetate. I H NMR (500 MHz, CDCl 3): 6 7.48 (d, 2H, J = 9.0 Hz), 7.12 (d, 2H, J
= 9.0 Hz), 3.86 (s, 3H), 2.30 (s, 3H). 3C NMR (125 MHz, CDCl 3): 6 169.7, 165.8, 148.9, 129.8,
125.3, 123.4, 122.5, 52.3, 21.4.
OMe
N 2
Methyl-2-diazo-2-phenylacetate was prepared from phenylacetic acid via a diazo transfer
reaction with p-ABSA, similar to the preparation of MAD above. H NMR (500 MHz, CDCl 3): 6
7.49 (dd, 2H, J = 8.0, 1.0 Hz), 7.39 (dd, 2H, J = 8.0, 7.5 Hz), 7.19 (tt, 1 H, J = 7.5, 1.0 Hz), 3.87
(s, 3H).
Synthesis of dansyl sulfonate esters
OAc
0 0
N  CO 2Me N , CO 2Me
NMe 2  NMe2
Dansyl-MAD Dansyl-methyl 2-phenylacetate
Dansyl-MAD. To a slurry of dansyl acid (30 mg, 0.119 mmol) in acetonitrile (1 mL) was added
methyl-2-(4-acetoxyphenyl)diazoacetate (80 mg, 0.358 mmol) and fluoroboric acid (50%
solution in water, 100 ptL, 0.476 mmol). The reaction was stirred at room temperature for 15
min, after which ethyl acetate and saturated NaHCO 3 were added to dilute the mixture. Layers
were separated, and the aqueous layer was extracted once more with ethyl acetate. The combined
organic layers were concentrated in vacuo, and the resulting residue purified under silica gel
chromatography (hexanes, then increased the polarity gradually to reach 8:2 hexanes:ethyl
acetate). Fractions were collected and concentrated to yield dansyl-MAD (-3 mg). The diazo
coupling yield on dansyl acid is consistently low despite excess supply of HBF 4. ESI-MS:
[M+H]* m/z 458.13 calculated, 457.7 observed.
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Dansyl-methyl-2-phenylacetate was synthesized in a similar manner as dansyl-MAD.
ESI-MS: [M+H]+ m/z 400.11 calculated, 400.2 observed.
Synthesis of fluorophore-chloroalkane conjugates
H2N O O $CI H0 6 H
N-- P. FI, N O O C
FI"U O' TEA, DMF, RT 06
Fluorophore (Fl)- Fluorophore-chloroalkane conjugate
succinimidyl ester
2-[2-(6-chloro-hexyloxy)-ethoxy]-ethylammonium hydrochloride was synthesized as previously
described (18). The succinimidyl ester forms of cy5 and cy3B were purchased from GE
Healthcare. The succinimidyl ester form of ATT0655 was purchased from Sigma-Aldrich.
A general reaction condition for chloroalkane conjugation to all three fluorophores is as
follows: to a solution of fluorophore-succinimidyl ester (1mg) in anhydrous DMF (100 p.L) was
added 2-[2-(6-chloro-hexyloxy)-ethoxy]-ethylammonium hydrochloride (~5 tL, 0.022 mmol)
and triethylamine (-3 tL, 0.022 mmol). The reaction was allowed to stir in the dark for at least 6
hours. The reaction mixture was then diluted in 1:1 water:acetonitrile to bring up the total
volume to -1 mL, and subjected to preparative-scale HPLC purification. We used a Microsorb
C 18 column (Varian, 5 ptm particle size, 21mm x 250 mm dimension) with 10 mL/min flow rate;
the HPLC was equipped with a 1 mL injection loop. The elution gradient varied according to the
nature of the fluorophore:
For cy5-chloroalkane purification, we used a 30-min gradient of 0-50% acetonitrile in
water. Cy5-chloroalkane eluted at minute 24. ESI-MS: [M+H] + m/z 863.53 calculated, 863.2
observed.
For cy3B- and ATT0655-chloroalkane purification, we used a 30-min gradient of 0-90%
acetonitrile in water. Both cy3B-chloroalkane and ATT0655-chloroalkane eluted at minute 29.
Cy3B-chloroalkane ESI-MS: [M+H]* m/z 767.39 calculated, 767.0 observed. ATT0655-
chloroalkane ESI-MS: [M+H]* m/z 734.36 calculated, 733.6 observed.
After the desired fractions were collected, acetonitrile was removed in vacuo, and the
resulting aqueous residue lyophilized to yield fluorophore-chloroalkane as dry powder.
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Synthesis of MAD-protected fluorophore-chloroalkane conjugates
OAc
MeO 2C I0.
N2  ~ CO2MeN2 1
RSO3 ~ R' O'
HBF 4  O OAc
MeCN or 9:1 MeCN:MeOH
A general reaction condition is as follows: to a solution of fluorophore-chloroalkane (0.3-1 mg)
in 50 p.L acetonitrile (for cy3B and ATT0655 conjugates) or 9:1 acetonitrile:methanol (for cy5
conjugate) was added HBF 4 (50% solution in water, 1 pL) and methyl 2-(4-
acetoxyphenyl)diazoacetate (typically > 10 molar equivalent) at room temperature. Reactions
were monitored via TLC (65:25:5 chloroform:methanol:acetic acid) for conversion of the
fluorophore to its MAD-protected form. More methyl 2-(4-acetoxyphenyl)diazoacetate was
added until the reaction went to completion, as judged by TLC. The reaction mixture was then
loaded directly onto a silica gel column for purification. MAD-protected fluorophores can be
eluted with 8:2 chloroform:methanol.
Note that we have tried reverse-phase purification of the fluorophores quite extensively
on C18 and C8 columns. We found that the MAD-protected compounds stick to both types of
column and do not elute as sharp peaks.
Cy5-chloroalkane-MAD 2 ESI-MS: [M+H]* m/z 1275.93 calculated, 1275.3 observed.
Cy3B-chloroalkane-MAD ESI-MS: [M+H]* m/z 973.60 calculated, 975.8 observed.
ATT0655-chloroalkane-MAD ESI-MS: [M+H]* m/z 940.54 calculated, 939.7 observed.
In vitro analysis of esterase-mediated cleavage of different dansyl sulfonate esters (Figure
6-9)
The reaction was performed as follows in an eppendorf tube: 100 [M dansyl ester and 0.05 unit
of porcine liver esterase (ammonium sulfate suspension, ~5.4 unit/pL, Sigma-Aldrich) in 25%
v/v methanol in PBS pH 7.4. The reaction was allowed to proceed for 10 min at room
temperature, before TLC analysis (in 1:1 hexanes:ethyl acetate). Visualization was performed an
Alpha Innotech Chemilmager 5500 instrument using 365 nm UV light for excitation.
Cellular loading study of different dansyl sulfonate esters (Figure 6-9)
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Untransfected HEK cells were treated with 10 pM dansyl ester in serum-free medium for 10 min
at room temperature. Cells were rinsed briefly with full growth media before imaging.
Genetic constructs used are summarized in Table 2.
General protocol for intracellular protein labeling with membrane-permeable MAD-
protected fluorophore-chloroalkane conjugates
Cells expressing a desired HaloTag fusion protein were treated with 100-300 nM of MAD-
protected fluorophore in serum-free DMEM for 15 min at 37 'C. Thereafter, cells were washed
for additional 2-3 hours before imaging.
For labeling with cy5-chloroalkane-MAD 2, it is recommended that 0.1% w/v pluronic F-
127 is used during dye loading to facilitate aqueous solubility of cy5-chloroalkane-MAD 2.
For labeling with cy3B- and ATT0655-chloroalkane-MAD, it is recommended that 50
ptM MK-571 is used during dye loading to enhance dye accumulation inside cells and maximize
labeling intensity.
Intracellular protein labeling with LplA and Diels-Alder cycloaddition (Figure 6-19)
COS-7 cells were transfected with expression plasmids for LplA W37V (50 ng per 0.95 cm2 dish)
and LAP2-BFP-NLS (400 ng) using lipofectamine 2000. Eighteen hours after transfection, cells
were treated with 200 pM TCO2 in serum-free medium for 30 min at 37 'C, followed by a
washout period of 30 min. A relatively short washout time of 30 min is crucial since we
observed decreased labeling efficiency when the TCO2 washout step is prolonged, presumably
because TCO2 is destroyed inside cells before it can react with tetrazines. After the TCO2
ligation step, cells were incubated with ATT0655-Tzl-MAD (Tzl was a gift from Anupong
Tangpeerachaikul) at specified concentrations for 10 min at 37 'C. Cells were rinsed for 2 hours
before imaging.
Two-color labeling of intracellular proteins with HaloTag and LpIA (Figure 6-20)
COS-7 cells were transfected with expression plasmids for LpIAW37V (50 ng), a LAP-fusion
protein (400 ng) and a HaloTag fusion protein (400 ng) using lipofectamine 2000. Eighteen
hours after transfection, cells were treated with 200 ptM TCO2 in serum-free medium for 30 min
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at 37 'C, followed by a washout period of 30 min. Cells were further incubated with 250 nM
ATT0655-Tzl-MAD, 200 nM cy3B-chloroalkane-MAD, and 50 pM MK-571 in serum-free
medium for 15 min at 37 'C. Cells were rinsed for 2 hours before imaging.
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Chapter 7
Applications of protein labeling and dye delivery methods to super-resolution imaging
The work described in this chapter was done in collaboration with Dr. Graham Dempsey and
Professor Xiaowei Zhuang of Harvard University and is being prepared for publication.
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Introduction
As described in Chapter 1, many fluorescence-based super-resolution imaging techniques
developed in recent years (1,2,3) have enabled visualization of cellular features well below the
diffraction-limited resolution of -200 nm. In particular, stochastic optical reconstruction
microscopy, or STORM (4,5,6)-an imaging technique which relies on sequential imaging and
localizing individual photoswitching fluorophores that densely label the target structure-has
produced the best spatial resolution upon imaging biological structures to date, achieving a near-
molecular lateral resolution of-4 nm (7) upon imaging actin microfilament structures. Such high
spatial resolution can only be obtained with the use of small organic fluorophores like cy5 and
Alexa Fluor 647, which provide much higher photon output compared to the best fluorescent
proteins (8). However, the lack of genetic encoding of these organic fluorophores means that
these probes require a means to target them to the biomolecule of interest inside cells, preferably
without the addition of bulk that can alter the biomolecule's properties. Moreover, the best-
performing organic fluorophores are sulfonated and not membrane-permeable, further hindering
their potential intracellular labeling applications.
Our efforts in Chapter 2-5 have resulted in developments of new peptide-directed protein
labeling methods generalizable to any organic fluorophores that work on fixed cells, at the cell
surface, and inside living cells, while the work described in Chapter 6 allows efficient delivery of
sulfonated fluorophores into cells. In this chapter, we describe applications of such protein
labeling and sulfonated dye delivery methods to super-resolution imaging of proteins in all three
cellular environments, and demonstrated some advantages of our methods over existing
techniques. First, in fixed cells, we showed that due to its small label size and its ability to
generate high-density labeling, LplA-mediated protein labeling can be used to improve the
spatial resolution of STORM upon imaging biological structures, over traditional means to target
fluorophores like immunofluorescence staining. Second, at the neuronal cell surface, we used
LplA to direct a fluorophore label to the synaptic adhesion protein neuroligin- 1, to potentially
elucidate its spatial distribution within the synapses. With LplA, we could avoid artificial
clustering of neuroligin-1, a problem observed when live-cell immunostaining was used to detect
the surface pool of the protein. And lastly, we showed that STORM imaging of proteins inside
living cells can be performed with membrane-permeable variants of sulfonated fluorophores,
thus avoiding the need to use invasive methods to introduce these dyes into cells.
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Improving STORM resolution through covalent attachment of cyanine dyes via lipoic acid
ligase
For imaging of intracellular proteins in fixed cells where the membrane permeability of
the labeling probe is not a concern, organic fluorophores of choice for STORM such as cy5 and
its related structure Alexa Fluor 647 are most typically targeted to a desired protein using
antibody conjugation. However, staining with antibodies often results in low labeling density due
to their weak affinities towards protein targets. Lower labeling density directly degrades imaging
resolution according to the Nyquist criterion, which states that the sampling frequency (in this
case, the desired spatial resolution) should be equal to or larger than twice the largest frequency
that is to be recorded (the distance between two labeled molecules) (9). If a spatial resolution of
10 nm is desired, for example, one needs to achieve labeling on molecules at every 5 nm.
Moreover, the antibody's large size (10-15 nm (10)) can further add spatial uncertainty between
the protein target and its label. For instance, Graham found that the use of two tiers of antibodies
(a primary antibody against tubulin, followed by a dye-conjugated secondary antibody) to label
and image microtubule filaments under STORM revealed the average filament diameter of 56
nm, ~30 nm broader than the expected width of microtubules of 25 nm based on electron
microscopic data (11). When a single layer of antibodies (directly labeled primary antibodies)
was used, the measured microtubule fiber diameter was shrunk to 40 nm, consistent with the
closer placement of the fluorophores to the fibers (Graham Dempsey, unpublished results). The
spatial resolution of STORM is thus determined not only by the intrinsic photophysical
properties of the label and the labeling density, but also by the size of the label itself.
STORM imaging of vimentin filaments labeled via lipoic acid ligase
We investigated whether LplA's small tag size and potentially high labeling efficiency
can be used to further improve STORM imaging of biological structures. To test the efficacy of
LplA-mediated labeling for STORM, we chose vimentin intermediate filaments as the protein
target. Intermediate filaments are coiled-coil dimers that further associate to form higher-order
oligomers, are ~-10-15 nm in diameter as measured under electron microscopy (12,13), and form
dense filamentous network within the cell that can be difficult to resolve using conventional
fluorescence microscopy. To achieve high labeling efficiency on fixed cells, we resorted to the
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two-step labeling approach described in Chapter 4, based on enzymatic azide ligation, followed
by chemoselective derivatization with the copper-catalyzed azide-alkyne cycloaddition
(CuAAC). Both labeling steps were performed post-cell fixation to maximize labeling efficiency.
Cy5 was chosen as the fluorophore for derivatization due to many of its superior photophysical
properties as outlined in the introduction of Chapter 6, especially in the context of STORM. To
effect labeling, COS-7 cells expressing LAP2-tagged vimentin (LAP tag at the C-terminus of
vimentin) were fixed, blocked, labeled with 8-azidooctanoic acid (azide 7) using wild-type LplA,
then labeled with cy5-alkyne under CuAAC. Once labeled, STORM imaging was performed in
an imaging buffer containing p-mercaptoethanol, which is required for robust photoswitching of
cy5, and an oxygen scavenging system to minimize photobleaching. A strong red laser source
(647 nm) was used to continuously suppress and image cy5 fluorescence, while a weak violet
laser source (405 nm) was used to turn on fluorescence on a sparse subset of cy5 molecules.
Figure 7-1 shows a side-by-side comparison of conventional fluorescence images and
STORM images of vimentin filaments in the same field of view of a single COS-7 cell. As
expected, several ultrastructural details of the intermediate filaments such as overlapping
filaments were obscured under conventional fluorescence imaging (resolution of -200 nm), but
were clearly revealed under STORM (resolution of -20-25 nm for the particular set up we used).
LAP2-tagged vimentin filaments appear to have generally uniform widths, and are much more
concentrated in the perinuclear region compared to the leading edge of the cell. Cy5 labeling we
observed on LAP2-tagged vimentin was specific and dense. We performed an additional control
experiment to show that the photon output of cy5 was not affected by the CuAAC reaction
conditions (data not shown; CuAAC on fixed cells was most optimal when using TBTA as a Cul-
stabilizing ligand, but unlike water-soluble click ligands like THPTA and BTTAA, TBTA has no
ROS-supressing properties).
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Figure 7-1. STORM imaging of vimentin intermediate filaments labeled via LplA and CuAAC. Fixed
COS-7 cells expressing LAP2-tagged vimentin were tagged with azide 7 via LplA-mediated ligation, then
with cy5-alkyne via CuAAC. A comparison of conventional fluorescence images in A) and C), to
STORM images in B) and D) is shown. Under STORM, individual vimentin filaments can be resolved.
Images in C) and D) correspond to the boxed region in A). Scale bars, 2 pm in A) and B), and 500 nm in
C) and D). Figure credit: Dr. Graham Dempsey (Harvard).
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Comparisons of STORM images of vimentin labeled with different methods
We proceeded to assess whether cy5-labeled vimentin via LplA/CuAAC can provide
STORM images with comparable quality to vimentin labeled via other conventional methods
such as immunofluorescence staining and fusion to a fluorescent protein. For immunostaining,
we used primary antibodies specific for endogenous vimentin as well as for a c-myc epitope tag,
the latter for detection of LAP-tagged vimentin via immunostaining (the construct contains a c-
myc at the same site as LAP). Secondary antibodies were conjugated to Alexa Fluor 647, which
has an identical cyanine core structure as cy5 but contains two more sulfonate groups, as well as
to cy3, which serves to turn on cy5 fluorescence when the sample is excited with a weak 561 nm
laser source (similar to what the 405 nm laser does in the absence of cy3). For vimentin fusion to
a fluorescent protein, we chose a photoconvertible fluorescent protein mEos2 (14). mEos2 is the
best performing fluorescent protein to date for STORM due to its higher photon output per
switching event relative to other fluorescent proteins (14). Expression patterns of all recombinant
vimentin constructs were evaluated in COS-7 cells, at around 24 hours after transfection.
Figure 7-2 shows STORM images of vimentin obtained from four labeling methods:
LplA labeling on vimentin-LAP2-c-myc; anti-c-myc immunostaining against vimentin-LAP2-c-
myc; immunostaining against endogenous vimentin; and vimentin-mEos2 fusion. A few
observations can be made from the images. First, the vimentin-mEos2 STORM image shows
vimentin fibers with a significantly larger and more non-uniform width compared to other
labeled vimentins. This is likely due to fiber aggregation artificially induced by the
oligomerization tendency of mEos2 fluorescent protein (14). Recombinant LAP-tagged
vimentin, either labeled by LplA or by anti-c-myc staining did not show aberrant fiber patterns as
the peptide tag is truly monomeric. While the STORM image generated from LplA-labeled
vimentin and staining against endogenous vimentin appears to be of similar labeling density (and
slightly higher than anti-c-myc staining on vimentin-LAP2-c-myc), LplA labeling has an
advantage of live-cell compatibility over traditional immunostaining, as it can be paired with
other cell-compatible bioorthogonal chemistries such as strain-promoted (15) or Diels-Alder
cycloaddition for live-cell labeling (16).
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Figure 7-2. STORM imaging of vimentin intermediate filaments with different tags. Labeling methods
(clockwise from top left) are: immunostaining against endogenous vimentin; immunostaining against c-
myc tag on recombinantly expressed vimentin-LAP2-c-myc; LplA and CuAAC labeling on recombinant
vimentin-LAP2-c-myc; and vimentin-mEos2 fusion. The reporter fluorophore used for the two
immunostained samples is Alexa Fluor 647, while cy5 was used for LplA/CuAAC-labeled sample. Scale
bars, 500 nm except for the mEos2 image (250 nm). Figure credit: Dr. Graham Dempsey.
To differentiate the resolution of STORM images obtained upon using different label
sizes, we analyzed the width (diameter) of vimentin filaments labeled by either LplA/CuAAC or
by immunostaining against endogenous vimentin (label size difference crudely illustrated in
Vimnentin-LAP
(c-myc staining)
Vimnentin-LAP
(LplA labeling)
235
Figure 7-3). To perform fiber width analysis, Graham manually selected 10-15 short, straight
segments of labeled vimentin filaments, obtained the cross-sectional distribution of fluorophore
localizations of each fiber segment, and generated a cumulative histogram of localization
distributions representative for each labeling method. As the resulting distributions for both
methods of vimentin tagging appeared normal, Gaussian fit was applied, and the full width at
half maximum (FWHM) value were used as an approximation for the average width of vimentin
filaments.
We obtained the vimentin filament width of -35 nm for LplA-labeled, LAP-tagged
vimentin, and -44 nm width for immunostained endogenous vimentin (Figure 7-3). While the 9
nm resolution improvement is significant, we were puzzled at the small reduction in vimentin
filament width upon switching for two-tiered antibody labeling to a small peptide tag, given the
10-15 nm size of each layer of antibodies compared to -3 nm length of the LAP petide when
fully extended. There are at least two possibilities that might explain both discrepancies. First,
the labeling densities on both LplA-labeled vimentin and immunostaining vimentin, while
similar, might not be adequate to achieve the resolution defined by the instrumental limit (20-25
nm). This in turn limits differentiation of resolutions obtained from the two labeling methods.
Second, our assumption that antibodies would coat vimentin in a similar way that they coat
microtubules might be incorrect. Rather than projecting a sum of apparent antibody sizes as in
the case of microtubule immunostaining, anti-vimentin antibody might bind to vimentin
filaments in an unexpected configuration or angle that obscures width analysis.
We were also confused about why the STORM-measured vimentin filament widths are
far from the 10-15 nm width measured under electron microscopy (12,13), given that the
STORM microscope setup we used is capable of providing imaging resolution down to 20-25 nm
in other instances. We again thought that inadequate labeling density on the filaments is the
culprit. For future experiments, suppression of endogenous vimentin expression in COS-7 cells
could help improve expression and labeling density on recombinant LAP-tagged vimentin.
Explorations of STORM microscope setups with intrinsically higher imaging resolution, such as
the recently reported dual-objective setup which can obtain < 10 nm lateral resolution (17), will
further elucidate whether vimentin filament widths closer to 10-15 nm can be achieved with
STORM, and whether the use of a small label like the LAP tag will make a bigger difference in
improving STORM imaging resolution.
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Figure 7-3. Fiber width analyses of vimentin with different tags. Left column, representative STORM
images from each labeling method. Middle column, cross-sectional profiles of filaments aligned by the
center of each filament. Gaussian fit was applied to each distribution to give FWHM values of 35, 44, and
69 nm for LplA-labeled vimentin, immunostained vimentin, and vimentin-mEos2 respectively. FWHMs
are used as approximations for average diameters (widths) of fibers. In case of vimentin-mEos2, the
filaments have non-uniform widths. Right column, schemes representing different labels on vimentin
filaments. Figure credit: Dr. Graham Dempsey.
We also performed the width analysis on vimentin-mEos2, and found the width of even
the thinnest fibers to be > 69 nm (Figure 7-3). Since filament bundles of vimentin-mEos2 are so
irregularly shaped because of mEos2-induced fiber aggregation, the use of a truly monomeric
form of mEos is needed if we want to fairly compare the performance of mEos to cy5 targeted
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via LplA for STORM, based on fluorophore properties and label sizes. Recently, such
monomeric mEos derivatives, called mEos3.1 and mEos3.2 have been described (18).
Conclusion
In summary, through imaging of vimentin intermediate filaments in fixed cells, we
demonstrated that LplA-mediated labeling, which only requires a small peptide directing tag, can
provide improvement in the spatial resolution compared to the use of immunostaining to direct
labeling, though the current spatial resolution improvement of ~9 nm is less than what we
expected given the size differences between antibodies and the LAP tag. We also highlighted one
of the main advantages of LplA-mediated labeling method over fluorescent proteins in that
artifacts due to the use of a large, oligomerizing tag can be avoided.
Preliminary STORM imaging of a neuronal synaptic adhesion protein neuroligin-1 via
lipoic acid ligase
Synaptogenesis is mediated by the recruitment of specific adhesion and scaffold proteins
that stabilize contacts formed between an axon and a dendrite (19). Among an assortment of
adhesion protein interactions, the interactions between presynaptic neurexins and their
postsynaptic partners neuroligins are special because they are specific to synapses (19).
Neurexin-neuroligin interactions are further modulated by the presence of different splice forms
of both proteins (20), and the pairing of different isoforms of the two proteins is suggested to
play roles in defining synaptic differentiation and specificity (21). In particular, a neuroligin
isoform neuroligin-1 is exclusively found at excitatory synapses and modulates synapse
formation and/or maturation there (22), whereas neuroligin-2 is found only at inhibitory synapses
(23).
Despite their well-recognized roles as synapse-stabilizing adhesion proteins, the
ultrastructural organization of neurexins and neuroligins at the synapses, which can provide
further fundamental insight into the functions of these proteins, remains relatively unknown.
Because the size of dendritic spines (24) (spine dimensions shown in Figure 7-4A) is close to the
diffraction limit, conventional fluorescence microscopy cannot be used to reveal detailed
localizations of protein components in the spines, or at the synapses. Immunogold electron
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microscopy has been used to examine the high-resolution localization of neuroligin-l and 2 at
the synapses (22,25,26); neuroligins in these studies were labeled with primary antibodies raised
against endogenous neuroligins. All studies could identify the presence of gold particles in the
synaptic cleft or at the postsynaptic density, suggestive of the presence of neuroligins there.
However, due to the sparse labeling density of gold particles and some non-specific labeling due
to weak affinity of anti-neuroligin antibodies, it is hard to make a definitive conclusion where the
surface, complex-forming pools of neuroligins are located within the synapses: at the synaptic
cleft (neurotransmitter release zone), at the periphery of the synapse (bordering the transmitter
release zone), or both. The suggested localization of neuroligins within the synaptic cleft is also
in contrast with the localization of the catenin/cadherin adhesion system, which is known from
well-stained electron microscopic studies to be exclusively at the periphery of the synapse (27).
High-resolution analysis of the localization of neuroligins' binding partners neurexins
cannot even be performed, due to lack of good antibodies against neurexins.
We wished to examine localizations of neurexins and neuroligins at the synapses using
STORM, which has previously been used to visualize several other components of the neuronal
synapses via fluorescence immunostaining against endogenous proteins (28). The main
advantage of fluorescence-based super-resolution imaging over electron microscopy is the ability
to perform multi-color imaging to look at several proteins simultaneously, which can then be
used to assess relative locations of these synaptic proteins. The main disadvantage of STORM is
that the technique does not provide intrinsic contrast of several structures of the synapses, such
as the postsynaptic density or the membranes of the synaptic cleft and vesicles, which typically
can be used as reference points for where the target protein is localized. Aside from looking at
the adhesion proteins' localizations under STORM, we are also interested in testing the
hypothesis that synaptic activity regulates trafficking of neurexins and neuroligins (29), and
examined membrane insertion patterns of both proteins upon activity stimulation. We decided to
first pursue neuroligin-I as our protein target, since the protein is known to remain synaptic even
when highly overexpressed (29).
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Figure 7-4. STORM imaging of synaptic adhesion protein neuroligin-1. A) Spine dimensions and relative
(speculated) positions of neuroligin-l to the postsynaptic density (PSD). The PSD is represented by one
of its main scaffold proteins, Homer, which is fused to GFP. Alexa Fluor 647 is attached to the
extracellular face of neuroligin-1 via LplA-mediated picolyl azide ligation, followed by CuAAC (30).
Detailed protocols for such two-step labeling on neurons are described in Chapter 5. B) STORM images
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of Alexa Fluor 647-labeled neuroligin-1 in 11-day old rat hippocampal neurons. First and second rows,
conventional images of Homer-GFP and Alexa Fluor 647-labeled neuroligin-1 show good overlap across
three fields of view. Third row, STORM images of neuroligin-1 (cyan puncta) overlaid with conventional
images of Homer (white) show clustering of neuroligin-l on one side of the synapses (indicated by white
arrows). Scale bars, 500 nm. Figure credit: Dr. Graham Dempsey.
In order to selectively and densely label the surface, potentially neurexin-binding pool of
neuroligin-1, we used the two-step labeling approach described in Chapter 5, based on enzymatic
ligation of copper-chelating picolyl azide, followed by derivatization with neuron-compatible
CuAAC. Our small molecule-based labeling reagents should be able to pass through the small
dimensions of the synaptic cleft (-30 nm width) comfortably, unlike antibodies or nanoparticle-
based reagents. To effect labeling, we transfected 5-day old hippocampal rat neuron cultures
with plasmids for GFP fused to Homerlb (a postsynaptic scaffold protein) and LAP4.2-tagged
neuroligin-1. On day 11, we performed picolyl azide 8 ligation and CuAAC derivatization with
Alexa Fluor 647-alkyne, then fixed the neurons before proceeding to STORM imaging.
Figure 7-4B shows good co-localization of Homerlb-GFP (top row) and Alexa Fluor
647-tagged neuroligin-1 (middle row) under conventional fluorescence imaging in three different
fields of view. Furthermore, overlays of STORM images of Alexa Fluor 647-tagged neuroligin-1
and conventional images of Homer-GFP (bottom row) indicate clear clustering of neuroligin-1
(white arrows) on one side of many spines, possibly on the synaptic side. The continuously
labeled patches of neuroligin-1 that cover most of the spine surface seemed to suggest that unlike
the catenin/cadherin adhesion proteins, the surface pool of the protein is present within the
synaptic cleft, consistent with results from immunogold electron microscopic studies. Whether
the neuroligin-1 patches extend beyond the neurotransmitter release zone remains unclear. We
are in the process of obtaining two-color STORM imaging of LAP-tagged neuroligin-1 with a
pre- or a postsynaptic marker, so that the relative positions of neuroligin-1 to other synaptic
proteins can be assessed.
As a control, we also used anti-c-myc immunostaining to detect the surface pool of c-
myc-tagged LAP4.2-neuroligin-l on neurons. We observed extremely punctate neuroligin-1
clusters on Homer-GFP-expressing spines, suggesting that the multivalent antibodies can
artificially induce neuroligin crosslinking/aggregation (Figure 7-5).
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ighure 7-5. STORM imaging of live-cell-immunostained c-myc-LAP4.2-neuroligin-1 in 11-day-old
cortical neurons shows extreme clustering of neuroligin-1. STORM images of Alexa Fluor 647-labeled
neuroligin-1 (cyan puncta; Alexa Fluor 647 labeling was performed via anti-c-myc antibody) overlaid
with conventional images of Homer-GFP (white) are shown. Scale bars, 500 nm. Figure credit: Dr.
Graham Dempsey.
Preliminary STORM imaging with membrane-permeable sulfonated fluorophores
We have shown in Chapter 6 that membrane-permeable, esterase-labile variants of
sulfonated fluorophores cy5, cy3B and ATT0655 can be synthesized via diazo-sulfonate
coupling and used for intracellular protein labeling. Upon coupling to all three fluorophores to a
chloroalkane linker for HaloTag protein targeting (31), we obtained the best signal-to-noise of
labeling with membrane-permeable ATT0655, even though ATT0655 is not the most preferred
fluorophore for STORM due to its low photon output of -1000 per switching cycle (8)
(compared to -4000 photons of cy5 (8)). We decided to first proceed to STORM imaging with
ATT0655. To demonstrate the use of membrane-permeable ATTO655 for STORM, we targeted
the dye to various intracellular structures with HaloTag. These included vimentin, the
endoplasmic reticulum (ER) and clathrin-coated pits (CCPs). For targeting to the ER, HaloTag
was fused to the C l(1-29) P450 sequence (32), which tethers the protein to the cytosolic face of
the ER membrane. For targeting to CCPs, HaloTag was fused to clathrin light chain (CLC).
STORM imaging of A TT0655-labeled proteins in fixed cells
Figures 7-6, 7-7, and 7-8 show conventional and sub-diffraction-limited images of fixed
COS-7 cells expressing vimentin-HaloTag, CI(1-29) P450-HaloTag, and HaloTag-CLC
respectively. All cell samples were labeled with ATT0655-chloroalkane-MAD in the presence
of anionic transporter inhibitor MK-571. Imaging was performed in an imaging buffer containing
Field of view 1 Field of view 2
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p-mercaptoethanol and an oxygen scavenging system. A strong red laser source (647 nm) was
used to continuously suppress and image ATT0655 fluorescence, while a weak violet laser
source (405 nm) was used to turn on fluorescence on a sparse subset of ATTO655 molecules.
STORM images of vimentin-HaloTag in Figure 7-6 show the expected morphologies of
vimentin intermediate filaments, similar to what we have observed with LAP-tagged vimentin.
Interestingly, despite the large tag size of 35 kDa, HaloTag fusion to vimentin does not seem to
cause aberrant aggregation of vimentin fibers as observed with vimentin fusion to mEos2. This
suggests that mEos2-induced fiber aggregation is likely caused by the oligomerizing tendency of
the fluorescent protein, not its size. Figure 7-7 shows STORM images of the ER, which two
distinct morphologies of the ER-sheets and tubules, corresponding to the rough ER and the
smooth ER respectively (33)-can be readily observed. Lastly, STORM images of clathrin-
coated pits allow visualization of the hollowed structure of individual CCPs (Figure 7-8), with
more ATT0655 localizations towards the edge of the pits and fewer localizations at the pit
center, consistent with previously reported STORM images of CCPs (34,35). In all three cases,
ATTO655 labeling density on the intracellular protein structures seem sufficiently high to
generate STORM images of similar quality as previously obtained with immunostaining with
cy5 or Alexa Fluor 647 (35).
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Fiure 7-6. STORM imaging of ATTO655-labeled vimentin intermediate filaments. COS-7 cells
expressing vimentin-HaloTag were labeled live with ATTO655-chloroalkane-MAD, then fixed for
STORM imaging. A comparison of conventional fluorescence images in A) and C), to STORM images in
B) and D) is shown. Images in C) and D) correspond to the boxed region in A). Scale bars, 2 tm in A)
and B), and I ptm in C) and D). Figure credit: Dr. Graham Dempsey.
C)A
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Figure 7-7. STORM imaging of ATT0655-labeled endoplasmic reticulum. COS-7 cells expressing Cl(1-
29) P450-HaloTag were labeled live with ATT0655-chloroalkane-MAD, then fixed for STORM
imaging. A comparison of conventional fluorescence images in A) and C), to STORM images in B) and
D) is shown. Images in C) and D) correspond to the boxed region in A). Scale bars, 2 ptm in A) and B),
and I ptm in C) and D). Figure credit: Dr. Graham Dempsey.
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Figure 7-8. STORM imaging of ATT0655-labeled clathrin-coated pits. COS-7 cells expressing HaloTag-
clathrin light chain were labeled live with ATT0655-chloroalkane-MAD, then fixed for STORM
imaging. A comparison of conventional fluorescence images in A) and C), to STORM images in B) and
D) is shown. Images in C) and D) correspond to the boxed region in A). Scale bars, 2 pm in A) and B),
and 500 nm in C) and D). Figure credit: Dr. Graham Dempsey.
cl)
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STORM imaging of A TT0655-labeled proteins in living cells
We next tested whether ATTO-labeled cellular structures inside living cells can be
imaged under super-resolution. COS-7 cells expressing Cl(1-29) P450-HaloTag were labeled
with ATT0655-chloroalkane-MAD in the presence of MK-571. After excess dye was removed
from cells, we proceeded directly to STORM imaging. Imaging was performed in an imaging
buffer containing an oxygen-scavenging system without addition of thiols, as ATTO655 can
photoswitch efficiently without the addition of potentially cytotoxic thiols (8) (unlike cy5 and
Alexa Fluor 647). Compared to fixed-cell imaging, live-cell STORM images were acquired at a
much faster frame rate (-500 Hz compared to 30-60 Hz for fixed-cell imaging), with a higher
656 nm laser intensity (-15 kW/cm 2 compared to -2 kW/cm2 for fixed-cell imaging) to achieve
fast photoswitching. ATTO655 localizations collected from every 1000 frame were compiled
into one STORM "snapshot," giving the temporal resolution of snapshot imaging of 2 seconds.
Figure 7-9 shows time-coursed snapshots of ATT0655-labeled ER in a living COS-7
cell, where events of ER tubules extending and retracting could be observed. Graham further
characterized the spatial resolution of these live-cell STORM images, using the Nyquist
sampling criterion (2-dimensional resolution 2/NA(0.5); N = localization density (36)). He
found that at a temporal resolution of 2 seconds, the spatial resolution was -80 nm at the start of
the acquisition, then degraded to -100 nm after 20 seconds of imaging due to ATT0655
photobleaching. At a reduced temporal resolution of 4 or 6 seconds, the initial spatial resolution
improved to -60 nm and - 45 nm, respectively. Such temporal and spatial resolutions are not yet
comparable to the state-of-the-art live-cell STORM resolutions, in which three-dimensional
super-resolution images of biological structures can be acquired with -30 nm lateral spatial
resolution and -1-2-second temporal resolution (34). We are looking to improve our obtainable
resolutions upon protein imaging by switching to use better fluorophores for STORM, such as
cy5.
247
Figure 7-9. Live-cell STORM imaging of ATT0655-labeled ER. COS-7 cells expressing C 1(1-29) P450-
HaloTag were labeled live with ATT0655-chloroalkane-MAD, then imaged under STORM. Shown in
this figure are STORM snapshots that were constructed for every 1000 frames of ATT0655
photoswitching movies (corresponding to 2 sec of real-time imaging time). Arrows indicate extension or
retraction of ER tubules that could be observed over 16 seconds. Scale bars, 500 nm.
t = 14 sec t = 16 seet = 12 sec
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Conclusion
In this final chapter, we describe our ongoing efforts in implementing new tools for
protein labeling and dye delivery to super-resolution imaging. First, lipoic acid ligase was used
in conjunction with copper-catalyzed azide-alkyne cycloaddition to site-specifically target cy5 to
vimentin intermediate filaments. STORM imaging of vimentin labeled via LplA reveals at least
-9 nm improvement in spatial resolution over vimentin labeled with other conventional means,
such as immunofluorescence staining and fluorescent protein fusion. A similar targeting
approach with LplA and CuAAC with a copper-chelating azide was also used to label synaptic
adhesion protein neuroligin-1 in living neurons. Preliminary STORM imaging of neuroligin-1
highlights its synaptic localization. Near-future studies will aim to explore, through multi-color
STORM imaging, how adhesion proteins like neurexin and neuroligin are positioned with
respect to other key proteins at the synapses, such as neurotransmitter receptors or scaffold
proteins at the postsynaptic density. Lastly, we demonstrated the utility of membrane-permeable,
esterase-labile protected forms of sulfonated fluorophores for STORM imaging. A membrane-
permeable variant of ATTO655, in combination with HaloTag targeting, was used to image
vimentin filaments, the endoplasmic reticulum, and clathrin-coated pits in fixed cells, as well as
to image the ER under super-resolution in living cells.
While our super-resolution imaging results are preliminary and have not yielded any new
biological insight, we hope that the toolsets we have created-a unique combination of
minimally perturbative labeling and the ability to deliver and target the best fluorophores to
cellular proteins-will eventually have an impact on biological studies at the nanoscale. For
instance, the study of nuclear actin discussed in Chapter 3 will benefit from a labeling strategy
that detects all forms of actin in cells, and can provide super-resolution readout. The
multicomponent nature of enzyme-mediated labeling also lends itself to creative applications,
such as location- or interaction-specific labeling, that potentially expand the utilities of methods
described here for super-resolution imaging.
There are still several limitations to our lipoic acid ligase labeling method that will hinder
its applications to super-resolution imaging. Most importantly, even when equipped with the best
fluorophores, the poorer live-cell labeling sensitivity of LplA compared to fluorescent proteins or
other protein-based labeling methods will degrade STORM imaging resolution. Continuing
efforts in improving probe ligation kinetics-both through enzyme engineering and development
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of even more efficient bioorthogonal chemistries-will be crucial in making LplA-mediated
labeling method even more useful for super-resolution applications.
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Experimantal methods
Genetic constructs used in this chapter are summarized in Table 2.
LpIA-mediated azide 7 ligation and CuAAC on LAP-vimentin for STORM (Figure 7-1)
COS-7 cells plated in a LabTek II 8-well chambered coverglass (Nunc) were transfected with an
expression plasmid for LAP2-tagged vimentin (400 ng DNA per well) using lipofectamine 2000.
16-24 hours after transfection, cells were fixed with 2% formaldehyde in PHEM buffer (25 mM
HEPES, 10 mM EGTA, 60 mM PIPES, 2 mM MgC 2 , pH 6.9) for 15 min at room temperature.
A blocking solution (0.5% casein and 0.5% Triton X-100 in DPBS) was then applied for at least
I hour at room temperature, or for overnight at 4 'C.
For the LplA-mediated azide 7 ligation step, a reaction mixture was assembled as
follows: 10 pM purified wild-type LplA, 250 pM azide 7, 1 mM ATP, and 5 mM Mg(OAc) 2 in
0.5% casein in DPBS. For labeling on a 0.95 cm2 dish (a well of the 8-well LabTek II
coverglass), 150 ptL of the reaction mixture was incubated with cells for 20 min at 30 'C.
Thereafter, cells were washed 3 times in a wash buffer containing 0.1% casein and 0.2% Triton
X-100 in DPBS.
For CuAAC derivatization step with cy5-alkyne, a reaction mixture was assembled as
follows: 1 mM CuSO4 , 100 pM TBTA, and 2.5 mM freshly prepared sodium ascorbate were first
combined and incubated for 5-10 min at room temperature. A reaction buffer of 0.5% casein in
DPBS was then added, followed by 3.3 ptM cy5-alkyne. For labeling on a 0.95 cm 2 dish, 150 ptL
of the reaction mixture was incubated with cells for 1 hour at room temperature, in the dark and
shaking. Thereafter, cells were washed 3 times in a wash buffer containing 0.1% casein and
0.2% Triton X- 100 in DPBS before proceeding to imaging.
Sample preparations for vimentin labeled via other labeling methods (Figure 7-2)
(These cell samples were prepared by Dr. Graham Dempsey)
For immunostaining against endogenous vimentin, COS-7 cells were plated in LabTek II 8-well
chambered coverglass, fixed 16-24 hours after transfection using 2% formaldehyde in PHEM, as
above, and blocked in 3% BSA and 0.5% Triton X-100 in DPBS for 15 min. Vimentin
immunofluorescence staining was performed with ~1 gg/ml anti-vimentin antibody (V9 clone,
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Life Technologies) in 3% BSA and 0.5% Triton X-100 in DPBS for 30 min at room temperature.
After washing 3 times with 0.2% BSA and 0.1% Triton X-100 in DPBS, cells were incubated
with -2.5 pig/ml donkey anti-mouse antibody conjugated to cy3 (GE Healthcare) and Alexa
Fluor 647 (Life Technologies) in 3% BSA and 0.5% Triton X-100 in DPBS for 30 min at room
temperature. After washing 3 times with 0.2% BSA and 0.1% Triton X-100 in DPBS, cells were
fixed for a second time with 3% formaldehyde and 0.1% glutaraldehyde in DPBS for 10 min.
For immunostaining against c-myc epitope tag on vimentin-LAP2-c-myc, COS-7 cells
expressing vimentin-LAP2-c-myc were similarly fixed and blocked as above. C-myc
immunofluorescence staining was performed with -4 pg/ml mouse anti-c-myc antibody
(Calbiochem) in the same blocking buffer for 40 min at room temperature. Secondary antibody
staining was performed with donkey anti-mouse antibody conjugated to cy3 and Alexa Fluor
647, as above.
For vimentin-mEos2, COS-7 cells were transfected with an expression plasmid for
vimentin-mEos2 (400 ng DNA per well) using lipofectamine 2000. 16-24 hours after
transfection, cells were fixed in 2% formaldehyde in PHEM.
Labeling of LAP-neuroligin-1 in dissociated neurons with picolyl azide 8 ligase followed by
chelation-assisted CuAAC for STORM (Figure 7-4).
Dissociated rat hippocampal neurons plated in a LabTek II 8-well chambered coverglass were
transfected at 5 days in vitro with expression plasmids for LAP-tagged neuroligin-1 (250 ng
DNA per well) and green fluorescent protein-tagged Homerlb (Homer-GFP; 50 ng DNA) using
Lipofectamine 2000. Neurons were labeled at 11 days in vitro with 10 piM purified wnvLp1A,
200 ptM picolyl azide 8, 1 mM ATP, and 5 mM Mg(OAc)2 in preconditioned supplemented
Neurobasal medium for 20 min at 37 'C. After brief rinsing in preconditioned supplemented
medium, neurons were further labeled with 20 pM Alexa Fluor 647-alkyne, 50 IM Tempol, 50
IM CuSO4 , 250 iM THPTA, and 2.5 mM sodium ascorbate in Tyrode's buffer for 5 min at
room temperature. The labeling solution was then replaced with supplemented Neurobasal
medium containing 500 piM bathocuproine sulfonate, which was incubated with neurons for 30
sec. After one more wash with supplemented Neurobasal medium, neurons were fixed with pre-
warmed (to 37 C) 4% formaldehyde in 4% sucrose in PBS pH 7.4 for 10 min, then washed
twice with DPBS.
252
Live-cell c-myc immunostaining of c-myc-LAP4.2-neuroligin-1 in dissociated neurons for
STORM (Figure 7-5)
Dissociated rat cortical neurons plated in a LabTek 11 8-well chambered coverglass were
transfected at 5 days in vitro with expression plasmids for LAP-tagged neuroligin-1 (250 ng
DNA per well) and green fluorescent protein-tagged Homerlb (Homer-GFP; 50 ng DNA) using
Lipofectamine 2000. At day 11 in vitro, neurons were labeled with ~6 pg/ml mouse anti-c-myc
antibody in preconditioned supplemented Neurobasal medium for 10 min at 37 'C. After brief
rinsing in preconditioned supplemented medium, neurons were further labeled with -4 pg/ml
goat anti-mouse antibody conjugated to Alexa Fluor 647 (Life Technologies) for 10 min at 37
*C. After one more wash with supplemented Neurobasal medium, neurons were fixed with pre-
warmed (to 37 'C) 4% formaldehyde in 4% sucrose in PBS pH 7.4 for 10 min, then washed
twice with DPBS.
Labeling of HaloTag fusion proteins with membrane-permeable ATT0655-chloroalkane
for STORM (Figures 7-6 to 7-9)
COS-7 cells plated in a LabTek II 8-well chambered coverglass were transfected with an
expression plasmid for the desired HaloTag construct (400 ng DNA per well). 16-24 hours after
transfection, cells were labeled with 200 nM ATT0655-chloroalkane-MAD in serum-free
DMEM, in the presence of 50 tM MK-571 anionic transport inhibitor, for 15 min at 37 *C. After
3-4 washes over 2 hours to remove excess dye, cells were either fixed (Figures 7-6 to 7-8) or
imaged live (Figure 7-9). Cell fixation methods differed depending on the expressed HaloTag
constructs.
For COS-7 cells expressing vimentin-HaloTag, cells were fixed with 2% formaldehyde in
PHEM buffer for 15 min, then washed twice with DPBS.
For COS-7 cells expressing C1(1-29) P450-HaloTag, cells were fixed with 3%
formaldehyde and 0.1% glutaraldehyde in DPBS for 10 min at room temperature, then washed
twice with DPBS. It is important that no other permeabilization step is performed after the
fixation, as we have seen decreased ATT0655 labeling density on the ER with treatment with
detergents such as 0.5% Triton X-100.
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For COS-7 cells expressing HaloTag-clathrin light chain, cells were fixed with 4%
formaldehyde in PBS for 15 min at room temperature, then washed twice with DPBS.
Fixed-cell STORM imaging
(STORM imaging experiments were all performed by Dr. Graham Dempsey)
For fixed-cell imaging of cy5-, Alexa Fluor 647-, and ATT0655-labeled cell samples, we used
the imaging buffer recipe as follows: 143 mM p-mercaptoethanol, 0.5 mg/mL glucose oxidase,
10 pg/mL catalase, 10% w/v glucose, and 10 mM NaCi in 50 mM Tris pH 8.0. Samples were
constantly illuminated with a 647 nm laser at -1-2 kW/cm2 , to both excite the fluorophore and
switch them to a dark, non-fluorescent state. To maintain adequate localization density, a weak
405 nm laser was used to activate cy5 directly. Alternatively, if an activator fluorophore such as
cy3 was present, a weal 532 nm laser was used for cy5 activation.
For fixed-cell imaging of mEos2, we used DPBS as an imaging buffer. Samples were
2illuminated with a 568 nm laser at -1-2 kW/cm . A weak 405 nm laser was used to photoconvert
mEos2.
STORM images were recorded at 30-60 Hz frame rates, and analyzed as previously
described (8,35).
Live-cell STORM imaging of ATT0655
ATT0655-labeled COS-7 cells were placed in serum-free, phenol red-free high glucose medium
containing 1% glucose oxidase, 1% catalase, and 2.5% w/v glucose. Samples were illuminated
with a 656 nm laser at -10-15 kW/cm2 , and a weak 405 nm laser was used for fluorophore
reactivation. Localization movies were recorded at 500 Hz frame rate, and analyzed as
previously described (34). To construct a STORM snapshot, localizations obtained from every
non-overlapping 1000 frame were compiled.
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Table 2. Summary of genetic constructs
Bacterial expression constructs
Name Features Variants Details
LpIA in pQE2 EcoRl-Hise-Ndel-Lpal- W37Vt1, A, GS, Wild-type gene from John 
Cronan (Univ.
Stop L of Illinois)
LplA mammalian expression constructs
His 6-Nhel-mCherry-mChery-pl i BamHI-FLAG-LplA-Stop- Wild-type, W371 FLAG: DYKDDDDK
npcDNA3 EcoRp
LplA in pcDNA3 Hise-Nhel-linker-BamHI- Wild-type, W37V' Linker: MTGGQQMGRDLYDDDDFLAG-LplA-Stop-EcoRlI W371
Intracellular LAP expression constructs
LAP-YF inpcDA3 Hise-Nhel-LAP-BamHl- LAP2, LAP2: GFEIDKVWYDLDALAP-YF inpcDA3 YFP-Stop-EcoRI LAP2(K-A)
LAP2-BFP in pcDNA3 Hise-Nhel-LAP-BamHl-BFP-Stop-EcoRI
LAP2-YFP-NLS in His 6-Nhel-LAP-BamHI- NLS:
pcDNA3 YFP-NLS-Stop-EcoRl PKKKRKVDPKKKRKVDPKKKRKV
LAP2-W-actin in Nhel-HA-LAP2-XhoI-Actin- HA: YPYDVPDYALAP2-p-avctoin Nhe-HL - Derived from mApple-p-actin fromClontech vector Stop-BamHl Michael Davidson (FSU)
Vimentin-LAP2 in EcoRI-Vimentin-BamHl- c-myc: EQKLISEEDLVimntin-LAP2ton LAP2-c-myc-Stop-Noti Derived from vimentin-mApple from
Clontech vector LMichael Davidson (FSU)
LAP2-MAP2 in Nhel-HA-LAP2-Xhol- Derived from EGFP-MAP2 from Birka
Clontech vector MAP2-Stop-BamHI Hein (Max Planck)
Cell-surface LAP expression constructs
Ig k-chain signal sequence:
LAP4.2-CFP in Ig k-chain signal METDTLLLWVLLLWVPGSTGDLA sequence-HA-LAP4.2- LAP4.2: GFEIDKVWHDFPA
pDisplay CFP-c-myc-TM-stop TM: transmembrane domain of the
PDGF receptor
LAP4.2-neurexin-1p in NXN signal sequence-LAP-nee n EcoRl-c-myc-LAP4.2-
pECFP-N1 Spel-NXN-stop
LAP4.2-neuroligin-1 in NLG1 signal sequence-
pNICEAgel-c-myc-LAP4.2-Bgill-pNICE NLG1-stop-Hindill
HaloTag expression constructs
HaloTag-S-actin in Nhel-HA-HaloTag-Xhol-
Clontech vector Actin-Stop-BamHl
HaloTag-a-tubulin in Nhel-HA-HaloTag-Xhol-
Clontech vector Tubulin-Stop-BamHl
Vimentin-HaloTag in EcoRl-Vimentin-BamHl-
Clontech vector HaloTag-c-myc-Stop-Notl
C(1 -29) P450-HaloTag BglIl-C1(1-29) P450 signal C1(1-29) P450 signal sequence:C - P-Ho sequence-Hindlil- MDPVVVLGLCLSCLLLLSLW
in pEGFP-N1 HaloTag-c-myc-Notl KQSYGGG
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Other constructs:
pHT2-(NLS) 3 (for mammalian expression of nucleus-targeted HaloTag) was a gift from
Promega. Vimentin-mEos2 plasmid was a gift from Prof. Michael Davidson (Florida State
University). Dr. Graham Dempsey cloned the expression plasmid for HaloTag-clathrin light
chain.
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